
<html lang="en"     class="pb-page"  data-request-id="a846f5e8-e54f-4267-a5e1-3550c0c57f71"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.5b01956;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde" /></meta><meta name="dc.Creator" content="Benjamin L.  Barthel" /></meta><meta name="dc.Creator" content="Erin L.  Mooz" /></meta><meta name="dc.Creator" content="Laura Elizabeth  Wiener" /></meta><meta name="dc.Creator" content="Gary G.  Koch" /></meta><meta name="dc.Creator" content="Tad H.  Koch" /></meta><meta name="dc.Description" content="Anthracyclines are a class of antitumor compounds that are successful and widely used but suffer from cardiotoxicity and acquired tumor resistance. Formaldehyde interacts with anthracyclines to enh..." /></meta><meta name="Description" content="Anthracyclines are a class of antitumor compounds that are successful and widely used but suffer from cardiotoxicity and acquired tumor resistance. Formaldehyde interacts with anthracyclines to enh..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 26, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01956" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01956" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01956" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01956" /></link>
        
    
    

<title>Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01956" /></meta><meta property="og:title" content="Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0017.jpeg" /></meta><meta property="og:description" content="Anthracyclines are a class of antitumor compounds that are successful and widely used but suffer from cardiotoxicity and acquired tumor resistance. Formaldehyde interacts with anthracyclines to enhance antitumor efficacy, bypass resistance mechanisms, improve the therapeutic profile, and change the mechanism of action from a topoisomerase II poison to a DNA cross-linker. Contrary to current dogma, we show that both efficient DNA cross-linking and potent synergy in combination with formaldehyde correlate with the anthracycline’s ability to form cyclic formaldehyde conjugates as oxazolidine moieties and that the cyclic conjugates are better cross-linking agents and cytotoxins than acyclic conjugates. We also provide evidence that suggests that the oxazolidine forms in situ, since cotreatment with doxorubicin and formaldehyde is highly cytotoxic to dox-resistant tumor cell lines, and that this benefit is absent in combinations of formaldehyde and epirubicin, which cannot form stable oxazolidines. These results have potential clinical implications in the active field of anthracycline prodrug design and development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01956"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01956">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01956&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01956&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01956&amp;href=/doi/10.1021/acs.jmedchem.5b01956" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2205-2221</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01940" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01965" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+L.++Barthel">Benjamin L. Barthel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin+L.++Mooz">Erin L. Mooz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura+Elizabeth++Wiener">Laura Elizabeth Wiener</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+G.++Koch">Gary G. Koch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tad+H.++Koch">Tad H. Koch</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry and Biochemistry, University of Colorado Boulder, Boulder, Colorado 80309, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div><div class="corresp-info"><strong>*</strong>Phone 303-492-6193; fax 303-492-5894; e-mail <a href="/cdn-cgi/l/email-protection#1e6a7f7a3075717d765e7d7172716c7f7a71307b7a6b"><span class="__cf_email__" data-cfemail="b8ccd9dc96d3d7dbd0f8dbd7d4d7cad9dcd796dddccd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01956&amp;href=/doi/10.1021%2Facs.jmedchem.5b01956" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2205–2221</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 16, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 December 2015</li><li><span class="item_label"><b>Published</b> online</span>26 February 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 March 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01956" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01956</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2205%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBenjamin%2BL.%2BBarthel%252C%2BErin%2BL.%2BMooz%252C%2BLaura%2BElizabeth%2BWiener%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D5%26contentID%3Dacs.jmedchem.5b01956%26title%3DCorrelation%2Bof%2Bin%2BSitu%2BOxazolidine%2BFormation%2Bwith%2BHighly%2BSynergistic%2BCytotoxicity%2Band%2BDNA%2BCross-Linking%2Bin%2BCancer%2BCells%2Bfrom%2BCombinations%2Bof%2BDoxorubicin%2Band%2BFormaldehyde%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2221%26publicationDate%3DMarch%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01956"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">935</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01956" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;L. Barthel&quot;},{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;L. Mooz&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Elizabeth Wiener&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;G. Koch&quot;},{&quot;first_name&quot;:&quot;Tad&quot;,&quot;last_name&quot;:&quot;H. Koch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;2205-2221&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01956&quot;},&quot;abstract&quot;:&quot;Anthracyclines are a class of antitumor compounds that are successful and widely used but suffer from cardiotoxicity and acquired tumor resistance. Formaldehyde interacts with anthracyclines to enhance antitumor efficacy, bypass resistance mechanisms, improve the therapeutic profile, and change the mechanism of action from a topoisomerase II poison to a DNA cross-linker. Contrary to current dogma, we show that both efficient DNA cross-linking and potent synergy in combination with formaldehyde correlate with the anthracycline’s ability to form cyclic formaldehyde conjugates as oxazolidine moieties and that the cyclic conjugates are better cross-linking agents and cytotoxins than acyclic conjugates. We also provide evidence that suggests that the oxazolidine forms in situ, since cotreatment with doxorubicin and formaldehyde is highly cytotoxic to dox-resistant tumor cell lines, and that this benefit is absent in combinations of formaldehyde and epirubicin, which cannot form stable oxazolidines. These results h&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01956&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01956" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01956&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01956" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01956&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01956" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01956&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01956&amp;href=/doi/10.1021/acs.jmedchem.5b01956" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01956" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01956" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01956%26sid%3Dliteratum%253Aachs%26pmid%3D26881291%26genre%3Darticle%26aulast%3DBarthel%26date%3D2016%26atitle%3DCorrelation%2Bof%2Bin%2BSitu%2BOxazolidine%2BFormation%2Bwith%2BHighly%2BSynergistic%2BCytotoxicity%2Band%2BDNA%2BCross-Linking%2Bin%2BCancer%2BCells%2Bfrom%2BCombinations%2Bof%2BDoxorubicin%2Band%2BFormaldehyde%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D5%26spage%3D2205%26epage%3D2221%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292236" title="Aldehydes">Aldehydes</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a>,</li><li><a href="/action/doSearch?ConceptID=291993" title="Nucleic acid structure">Nucleic acid structure</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/jmcmar.2016.59.issue-5/20160310-01/jmcmar.2016.59.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Anthracyclines are a class of antitumor compounds that are successful and widely used but suffer from cardiotoxicity and acquired tumor resistance. Formaldehyde interacts with anthracyclines to enhance antitumor efficacy, bypass resistance mechanisms, improve the therapeutic profile, and change the mechanism of action from a topoisomerase II poison to a DNA cross-linker. Contrary to current dogma, we show that both efficient DNA cross-linking and potent synergy in combination with formaldehyde correlate with the anthracycline’s ability to form cyclic formaldehyde conjugates as oxazolidine moieties and that the cyclic conjugates are better cross-linking agents and cytotoxins than acyclic conjugates. We also provide evidence that suggests that the oxazolidine forms in situ, since cotreatment with doxorubicin and formaldehyde is highly cytotoxic to dox-resistant tumor cell lines, and that this benefit is absent in combinations of formaldehyde and epirubicin, which cannot form stable oxazolidines. These results have potential clinical implications in the active field of anthracycline prodrug design and development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The anthracycline class of antineoplastic agents is represented in current chemotherapy protocols by four compounds: doxorubicin (dox, <b>1</b>), daunorubicin (dau, <b>2</b>), idarubicin (ida, <b>3</b>), and epirubicin (epi, <b>4</b>) (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). The class shares the structural features of a tetracyclic anthraquinone ring system coupled to an amino sugar (daunosamine) via a glycosidic linkage. Structural differences between the agents are minimal; ida differs from dau by modification at the 4-position, dox is equivalent to dau in all respects except for a hydroxyl moiety at the 14-position, and epi and dox differ only in the stereochemistry of the hydroxyl group at the 4′-location in the daunosamine.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Clinical Anthracyclines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Structures are shown for doxorubicin, daunorubicin, idarubicin, and epirubicin as well as for the oxazolidine derivative of doxorubicin, doxazolidine.</p></p></figure><div class="NLM_p">Clinically, the anthracyclines are some of the most successful anticancer drugs ever developed, with dox being the most commonly used. Applications are wide-ranging and the compounds are used across a broad spectrum of both solid (carcinomas and sarcomas) and nonsolid tumors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The accepted mechanism of action derives from interaction with topoisomerase II (topo II) through formation of a stable ternary complex of cut DNA–drug–topo II. The religation of the DNA is inhibited by the presence of the drug, resulting in double-strand DNA breaks.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> Other modes of action have been demonstrated, though their contributions to the clinical effectiveness of the drugs are unclear.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> Successful treatment with anthracyclines is hindered most significantly by both acute and chronic cardiotoxicity, leading to congestive heart failure in the long term.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Furthermore, anthracyclines are susceptible to the development of resistance by a variety of mechanisms, the most relevant of which results from P170 glycoprotein (P170gp)-mediated export of the drug from the cell.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a></div><div class="NLM_p">A growing body of evidence points toward the conclusion that anthracyclines may be activated to greater potencies either by coadministration with formaldehyde-releasing compounds or by inclusion of formaldehyde in the structure. In recent years, we have synthesized and characterized several compounds falling into the latter category, the most relevant of which is doxazolidine (doxaz, <b>5</b>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The oxazolidine moiety results from reaction of formaldehyde with the cis configuration of the vicinyl aminol on daunosamine to form a geminyl aminol (<b>6a</b>), which then ring-closes either directly or via the Schiff base (<b>6b</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, top). Doxaz is 1–4 orders of magnitude more potent than dox against a broad spectrum of human cancer cell lines, including those that are resistant to dox.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> This gain in potency is achieved without a corresponding increase in toxicity toward cardiomyocytes, resulting in greatly increased therapeutic potential. Reaction with an additional equivalent of formaldehyde results in pseudodimerization of doxaz units to form doxoform (doxF, <b>7</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> which is also highly toxic, likely through rapid hydrolysis to free the two units of doxaz. Corresponding structures have been hypothesized or synthesized with dau.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In contrast, consistent with literature precedent,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> the <i>trans</i>-amino alcohol found in epi does not result in stable oxazolidines upon reaction with formaldehyde but instead favors the formation of a bicyclic structure consisting of two epi units and three units of formaldehyde known as epiform (epiF, <b>10</b>; <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, bottom). While epiF does display increased cytotoxicity over epi and overcomes resistance, it is far less potent than doxaz or doxF. Each of these anthracycline–formaldehyde conjugates is hydrolytically unstable to varying degrees. Doxaz and doxF are the most unstable, exhibiting half-lives of approximately 3 min.<a onclick="showRef(event, 'ref15 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref17">(15, 17)</a> EpiF is more stable with respect to hydrolysis to aminols <b>8</b> and <b>9</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The half-life under physiological conditions is approximately 2 h, and loss of the formaldehyde from <b>8</b> and <b>9</b> to form epi was not observed at pH 7.4.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Reaction of Dox (top) and Epi (bottom) with Formaldehyde<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(Top) Dox (<b>1</b>) reacts with formaldehyde to form aminol (<b>6a</b>) and Schiff base (<b>6b</b>) in equilibrium. The ring then closes to form doxaz (<b>5</b>). With excess formaldehyde, doxaz pseudodimerizes to form doxoform (<b>7</b>). (Bottom) Epi (<b>4</b>) reacts to form the aminol (<b>8a</b>), which is also likely in equilibrium with a Schiff base (<b>8b</b>). Another equivalent of formaldehyde can react to form the bisaminol (<b>9</b>), which can combine with <b>8a/8b</b> to form epiform (<b>10</b>). In the case of epi, no stable oxazolidine product is formed. Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><div class="NLM_p">The presence of formaldehyde in anthracycline treatments results in a significant modification of the mechanism of action. As stated before, the primary mechanism of action for anthracyclines is inhibition of the religation of DNA via topo II. Deficiency in this enzyme is sufficient to reduce sensitivity to dox by approximately 10-fold but results in very little change to doxaz sensitivity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Mass spectrometry and other experiments from our lab and others indicate that the presence of formaldehyde enables direct DNA alkylation at 5′-GC-3′ sequences by dox,<a onclick="showRef(event, 'ref15 ref17 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref15 ref17 ref21 ref22">(15, 17, 21, 22)</a> dau,<a onclick="showRef(event, 'ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref23">(21, 23)</a> and epi<a onclick="showRef(event, 'ref20 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref20 ref24 ref25">(20, 24, 25)</a> in sensitive and resistant cell lines, thus allowing function independent of topo II. Coldwell et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> have demonstrated that dox–formaldehyde conjugates can form with clinically relevant concentrations and endogenous formaldehyde, although the contribution of these cross-links to the clinical effect of dox is currently unclear. In the current model for cross-link formation with anthracycline–formaldehyde conjugates, adducts are formed by attack on the formaldehyde carbon by the 2-amino group of a tautomer of a guanine base in the minor groove of DNA (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The “virtual cross-link” is completed by hydrogen bonding between the drug’s 9-OH and the guanine on the opposite strand.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. DNA–Drug Adduct Formation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>We believe that tautomerization of guanine results in an attack by the exocyclic amine on the formaldehyde carbon (shown with asterisks) of the oxazolidine, Schiff base, and/or aminol. At 5′-GC-3′ sequences, the result is a virtual cross-link, in which the drug is covalently bonded to guanine on one strand while hydrogen-bonded to guanine on the opposite strand. Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><div class="NLM_p last">Here, we present evidence that the oxazolidine moiety is the critical structural feature that allows highly efficient DNA cross-linking and that combinations of anthracyclines and formaldehyde are highly synergistic only when stable oxazolidine formation is possible. Our data suggest, in opposition to what has been dogmatic in anthracycline–formaldehyde interactions, that the oxazolidine is capable of forming in situ and that the significant potentiation of anthracycline activity by formaldehyde is primarily a result of that formation. Our work suggests that significant clinical benefit may be gained by combining oxazolidine-capable anthracyclines with treatments that elevate tumor formaldehyde levels, particularly with drug-resistant tumors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Doxazolidine Induces Sequence-Dependent, Functionally Relevant DNA Cross-Links in Living, Cellular Systems</h3><div class="NLM_p">Previous work from our lab has demonstrated that incubation of doxaz, via the dimer doxoform, with short sequences of GC-rich DNA results in alkylation of the DNA by the drug.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Furthermore, results from our lab and others have shown that, under conditions in which oxidation–reduction processes allow for the production of formaldehyde, DNA-drug adducts form in a sequence-specific manner.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> Much of this work, along with the crystal structure of daunorubicin covalently bound to DNA,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was produced in cell-free systems using isolated DNA and tightly controlled conditions. We now demonstrate widespread cross-linking activity from doxaz in a complex and dynamic cellular system utilizing the alkaline single-cell gel electrophoresis (SCGE) assay, commonly referred to as the comet assay (see <a href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf" class="ext-link">Supporting Information</a> for a cartoon). In this assay, cells are treated with the prospective genotoxic agent and then embedded in agarose, lysed, and electrophoresed under alkaline conditions. The free ends and small fragments of DNA that result from strand breaks will migrate through the gel, while large, intact DNA does not. Thus, after staining, the structures resemble comets in which the density of the stain in the tail is indicative of the extent of DNA strand breaks.</div><div class="NLM_p">Initially, we treated cells as adherent cultures, followed by washing, trypsinizing, counting, and diluting prior to lysis in the agarose gels. However, in this form, we found that the assay was poorly reproducible; untreated cells varied significantly in the extent of DNA damage (data not shown). Subsequent tests indicated that handling of the cells during trypsinization was of critical importance. Since we planned to extensively utilize the comet assay to test many different conditions of drug combinations, the protocol was modified to reduce experimental variability resulting from trypsinization of individual treatment groups. Instead, a large population of cells was trypsinized as a whole and then divided into treatment groups, which were treated in suspension. This had the added benefit of allowing the cells to be embedded into the gel and lysed more quickly after removal of the drugs, thereby preventing cellular repair machinery from masking any genotoxic effects.</div><div class="NLM_p">Using our modified comet assay protocol, we tested the genotoxic effects of dox, epi, and doxaz over 90 min of treatment in both dox-sensitive MIA PaCa-2 human pancreatic carcinoma cells and dox-resistant NCI/ADR-RES (ADR) human ovarian carcinoma cells (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). As expected, 100 μM dox and 100 μM epi both induced significant increases in DNA damage content (<i>p</i> < 0.001) for both cell lines versus untreated cells. The dox-sensitive MIA PaCa-2 cells showed a greater change upon dox treatment than the dox-resistant ADR cells (<i>p</i> < 0.001). In MIA PaCa-2 cells, 100 μM epi and 100 μM dox resulted in equivalent DNA damage and equal responses in the IC<sub>50</sub> assay: 620 and 630 nM for dox and epi, respectively (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, for ADR cells, the comet results did not directly compare to the relative toxicities of the drugs. Interestingly, epi had a greater DNA-damaging effect than dox in a 90 min treatment, but only dox displayed measurable toxicity in an IC<sub>50</sub> assay (66 μM); the IC<sub>50</sub> for epi was beyond the range of the experiment. When the cells were treated with 250 nM doxaz (IC<sub>50</sub> 22 nM for ADR and 48 nM for MIA PaCa-2), there was no increase in comet tail density. Even with treatment at 10 μM, a dose that corresponds to 200–500 times the IC<sub>50</sub> value in these cell lines, there was no indication of DNA strand breaks. These results demonstrate that the equal growth-inhibitory effect of doxaz in both dox-sensitive and dox-resistant cells is accompanied by the same effect on DNA and that doxaz is mechanistically different in cells than dox. Given this equivalence and the observation that untreated ADR cells are a more uniform population, subsequent comet assays were performed primarily in this cell system.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lack of DNA strand cleavage from doxaz treatment. NCI/ADR-RES ovarian cancer cells and MIA PaCa-2 pancreatic cells were treated with either vehicle, dox, epi, or doxaz in suspension for 90 min and then analyzed for DNA damage by the comet assay and silver staining. Individual comets were scored by CometScore software, and the fraction of the cellular DNA in the tail was plotted (A). Each point represents the comet derived from a single cell, and the bars are the population mean ± standard deviation. The gray boxes about the mean represent the 95% confidence interval. Sample images of each of the treated populations are shown for (B–F) NCI/ADR-RES and (G–K) MIA PaCa-2 cells: control (B and G), 100 μM dox (C and H), 100 μM epi (D and I), 10 μM doxaz (E and J), and 250 nM doxaz (F and K). Each image is shown on the same scale, and the bar below panel D represents 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Significance (<i>p</i>-Values) from Pairwise <i>t</i>-Tests for Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> within Each Cell Line and across Cell Lines<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">MIA PaCa-2, untreated</th><th class="colsep0 rowsep0" align="center" char=".">MIA PaCa-2 + dox (100 μM)</th><th class="colsep0 rowsep0" align="center" char=".">MIA PaCa-2 + epi (100 μM)</th><th class="colsep0 rowsep0" align="center" char=".">MIA PaCa-2 + doxaz (250 nM)</th><th class="colsep0 rowsep0" align="center" char=".">MIA PaCa-2 + doxaz (10 μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADR, untreated</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.927</td><td class="colsep0 rowsep0" align="char" char=".">0.702</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADR + dox (100 μM)</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.518</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADR + epi (100 μM)</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADR + doxaz (250 nM)</td><td class="colsep0 rowsep0" align="char" char=".">0.085</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.454</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADR + doxaz (10 μM)</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.967</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Note that the descending diagonal refers to <i>p</i>-values comparing the cell lines within the same treatment and that <i>p</i>-values for treatment comparisons in NCI/ADR-RES (ADR) cells are in the lower triangle while those in MIA PaCa-2 cells are in the upper triangle of the table. With adjustment for multiple comparisons with the Bonferroni–Holm method, statistical significance at the 0.05 level applies to all pairwise treatment comparisons with <i>p</i> < 0.01.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for 90-Min Treatments of NCI/ADR-RES and MIA PaCa-2 Cells<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug</th><th class="colsep0 rowsep0" align="center">NCI/ADR-RES</th><th class="colsep0 rowsep0" align="center">MIA PaCa-2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dox</td><td class="colsep0 rowsep0" align="left">–4.2 ± 0.1 (66 μM)</td><td class="colsep0 rowsep0" align="left">–6.21 ± 0.05 (620 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">epi</td><td class="colsep0 rowsep0" align="left">>−4 (>100 μM)</td><td class="colsep0 rowsep0" align="left">–6.20 ± 0.02 (630 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">doxaz</td><td class="colsep0 rowsep0" align="left">–7.7 ± 0.1 (22 nM)</td><td class="colsep0 rowsep0" align="left">–7.30 ± 0.1 (48 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">formaldehyde</td><td class="colsep0 rowsep0" align="left">–3.2 ± 0.1 (610 μM)</td><td class="colsep0 rowsep0" align="left">–3.30 ± 0.07 (530 μM)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Values are shown as log molar ± standard deviation for at least two independent measurements performed in triplicate. In parentheses are the values on a linear scale.</p></div></div></div><div class="NLM_p">To further test the ability of doxaz to cross-link DNA, ADR cells were first treated with 15 mM hydrogen peroxide for 10 min to induce nonspecific DNA strand breaks. The peroxide-treated cells were then treated with dox, epi, or doxaz for 90 min. We hypothesized that cross-linking ability would be indicated by a reduction in tail staining density, as the free ends that result from peroxide treatment could potentially be bridged by the cross-linking agent and prevented from migrating through the gel.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Treatment of ADR cells with either 100 μM dox or epi increased comet tail density beyond that of peroxide alone (<a class="ref internalNav" href="#fig2" aria-label="Figures 2">Figures 2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A), further confirming their ability to induce strand breaks in chromosomes. However, upon treatment with 10 μM doxaz, the resulting comets displayed a dramatic decrease in the density of the tails relative to peroxide treatment alone (<i>p</i> < 0.001, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Taken together these data provide support for the model that doxaz does not function via induction of strand-break lesions in the cellular DNA, as do the other anthracyclines tested, but instead functions as a DNA cross-linking agent. These data are in agreement with previous results for isolated DNA<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and show that doxaz treatment results in widespread cross-linking of DNA, which is detectable by a comet assay.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sample comets for dox, epi, and doxaz. A suspension of NCI/ADR-RES cells was treated with either (top row) phosphate-buffered saline (PBS) or (second row)15 mM hydrogen peroxide for 10 min to induce DNA damage. The cells were pelleted, and the medium was replaced with medium containing no drug (left column), 100 μM dox (second column), 100 μM epi (third column), or 10 μM doxaz (last column) and analyzed as described in the text. All images are representative of the population as a whole and are shown at the same scale (black scale bar indicates 50 μm). The separation between 10 μM doxaz and the rest of the panels is to indicate that the rest of the panels belong to the same experiment, while the doxaz micrographs came from a second experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Doxaz cross-linking activity by comet assay. Hydrogen peroxide (15 mM, 10 min) to introduce DNA damage was followed by a 90-min treatment of ADR cells with either 100 μM dox or epi (A) or 10 μM doxaz (B) and analyzed by the comet assay. Sample images for some conditions are shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> (bottom row). Each data point represents the comet derived from a single cell, and the bars are the population means and standard deviations. Gray boxes surrounding the means represent the 95% confidence interval of the means. A full statistical analysis of panel A is discussed in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>. For panel B, the <i>p</i>-values relating to pairwise <i>t</i>-tests with the Satterthwaite approximation for degrees of freedom were all less than 0.001 and thereby statistically significant at the 0.05 level via the Bonferroni–Holm method to adjust for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Having established that doxaz treatment results in cross-linking of cellular DNA, we wanted to show that the lesion is sequence-specific against the background of a complex DNA sequence as well as show that the lesions have functional consequences that are distinct from dox treatment. To address this, we assessed the ability of the drugs to inhibit the activity of two restriction endonucleases against the full-length plasmid pcDNA3.1. In our previous experiments, doxF showed cross-linking ability when exposed to the short sequence (GC)<sub>4</sub>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> On the basis of this result, we hypothesized that functionally relevant doxaz cross-links would display greater inhibitory activity against <i>Not</i>I, which cuts at the GC-heavy sequence 5′-GC/GGCCGC-3′, than would dox. We further hypothesized that dox and doxaz would show similar inhibitory activity against <i>Nde</i>I, which cuts at the AT-rich sequence 5′-CA/TATG-3′. The experimental design is described in detail in Supporting Information and the results are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf" class="ext-link">Figures S1–S4</a>. We observed that dox and doxaz behaved similarly for <i>Nde</i>I (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf" class="ext-link">Figures S1 and S2</a>) but doxaz showed far greater inhibitory activity against <i>Not</i>I (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf" class="ext-link">Figures S3 and S4</a>) and resulted in a relatively long-term total blockage of endonuclease activity. Therefore, we conclude that, against both simple and complex DNA sequences, doxaz–DNA cross-links are formed quickly and preferentially in GC-heavy sequences and that these lesions are functionally distinct from lesions that result from exposure to dox.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cytotoxic Activity of Dox, but Not Epi, Is Synergistic with Formaldehyde</h3><div class="NLM_p">As observed, treatments with either dox or epi result in increased comet tail density, which is consistent with their activities as topo II inhibitors, resulting in double-strand DNA breaks. Previously reported combinations of dox and, to a lesser extent, epi with formaldehyde-releasing prodrugs result in DNA cross-linking and synergy in cell killing assays.<a onclick="showRef(event, 'ref25 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref25 ref31 ref32">(25, 31, 32)</a> Since these reports followed the discovery of doxaz, these effects were hypothesized to be due to released formaldehyde reacting with dox; however, the prodrugs also release inhibitors of chromatin remodeling enzymes, which complicates analysis of the combination. We were interested in testing the hypothesis that formaldehyde is indeed responsible for these effects but also in observing whether a significant difference existed between dox and epi, since the former can cyclize to an oxazolidine with formaldehyde while the latter cannot. To address these questions, we treated both MIA PaCa-2 and ADR cells with dox or epi in combination with various concentrations of formaldehyde (derived from formalin). Given the previous results, which indicate that doxaz very quickly cross-links DNA, we also hoped to demonstrate that synergistic effects of anthracycine–formaldehyde conjugates could be seen after treatments as short as 30 min. When treated with dox alone for 30 min (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, black bars) or 90 min (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, gray bars), MIA PaCa-2 cells responded with IC<sub>50</sub> values of approximately 4 and 0.6 μM, respectively. Formaldehyde toxicity was detected only at the 90-min time point (530 μM, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), while doxaz was similarly toxic at both treatment times (51 and 48 nM). When dox was combined with low doses of formaldehyde (150, 100, and 67 μM, which allow 75–100% cell survival over 90 min), the resulting IC<sub>50</sub> values were 3.5–9.5-fold lower than for dox alone; moreover, the extent of IC<sub>50</sub> depression was dose-dependent with respect to formaldehyde concentration. When the data were plotted as an isobologram (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B), the combinations clearly fell under the additive line, suggesting a strong synergistic interaction. This is further demonstrated by the combination index calculated for the points: CI = 0.4, where CI < 1 is synergistic, 1 is additive, and >1 is antagonistic. With 30-min treatments, increased sensitivity to the combination was observed to a lesser extent; 150 μM formaldehyde resulted in a 4-fold IC<sub>50</sub> drop (from 3.8 to 0.95 μM) as opposed to 9.5-fold with 90-min treatments. Since formaldehyde treatment alone failed to produce a usable IC<sub>50</sub> value after 30-min treatments, isobolograms could not be constructed; however, since there was no observed toxicity from 30 min of formaldehyde treatment, a measurable response over dox alone is likely due to synergistic effects of the combination.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Synergy between formaldehyde and dox. MIA PaCa-2 (A, B) and NCI/ADR-RES (C, D) cells were treated with dox, formaldehyde (form), doxaz, or combinations of dox and formaldehyde for 30 min (black bars) or 90 min (gray bars), and IC<sub>50</sub> values were determined (A, C). The arrow in part A indicates that IC<sub>50</sub> was beyond the scope of the experiment. In part C, all combinations were tested at 90 min but not all were tested at 30 min; conditions not tested are shown by asterisks. The resulting 90-min IC<sub>50</sub> values were then plotted as isobolograms (B, D), where the IC<sub>50</sub> concentrations of dox (<i>y</i>-axis) and formaldehyde (<i>x</i>-axis) alone are shown as gray circles and the IC<sub>50</sub> concentrations of combinations are shown as open diamonds. The points in all panels represent the mean ± standard deviation of at least two independent measurements performed in triplicate. In part D, all points have error bars, but in many cases, they are smaller than the size of the points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Like MIA PaCa-2 cells, ADR cells responded synergistically to combinations of dox and formaldehyde. Compared to MIA PaCa-2, however, the effects were far more pronounced, owing to the dox-resistant phenotype of ADR cells. Dox IC<sub>50</sub> values were 220 and 66 μM for treatments of 30 and 90 min, respectively, while for formaldehyde, the values were around 600 μM for both times (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C and <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). When dox was combined with formaldehyde, the dox IC<sub>50</sub> dropped 55-, 85-, and 173-fold for 67, 100, and 150 μM formaldehyde, respectively, for a 90-min treatment. The range of formaldehyde concentrations tested was extended lower (10, 25, and 50 μM), which resulted in 2.5–46-fold IC<sub>50</sub> reduction. For 30 min, the IC<sub>50</sub> reductions were 9–300-fold over the standard range (67–150 μM) of formaldehyde. Similar to MIA PaCa-2 cells, the 90-min combinations were profoundly synergistic at all combinations when plotted as an isobologram (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D), and the CI values ranged from 0.02 to 0.2.</div><div class="NLM_p">While dox–formaldehyde combinations were significantly synergistic, the same was not true for epi–formaldehyde combinations. When epi was combined with formaldehyde for 90 min in MIA PaCa-2 cells, there was no observed reduction in the IC<sub>50</sub> over epi alone (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A); the IC<sub>50</sub> varied between 0.5 and 1.1 μM. In an isobologram, the combinations were generally additive to antagonistic (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). Since no effect was observed at 90 min, the shorter treatment time was not tested. In ADR cells, where a 90-min IC<sub>50</sub> for epi was not measurable, the combinations with formaldehyde also failed to yield an IC<sub>50</sub> (data not shown), suggesting that any interaction between epi and formaldehyde was not synergistic enough to bring toxicity into the range of the assay.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Lack of synergy between epi and formaldehyde. MIA PaCa-2 cells were treated with epi for 90 min, as well as with combinations of epi and formaldehyde. IC<sub>50</sub> values were determined (A), and those values were then plotted as an isobologram with IC<sub>50</sub> values for epi and formaldehyde alone (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These results demonstrate that formaldehyde can greatly increase the toxicity of anthracycline treatments over the short term but only when the anthracycline is capable of forming an oxazolidine ring. This leads to the surprising conclusion that coadministration of dox and formaldehyde is yielding an oxazolidine moiety in situ. Additionally, these experiments are potentially informative as to the location of oxazolidine formation. High levels of P170gp are expressed by ADR cells, resulting in active removal of dox from the cellular interior. As we have shown, doxaz is not sensitive to the presence of P170gp and retains its cytotoxic activity in the ADR cells. Likewise, the ability of dox–formaldehyde cotreatments to elicit a response in the ADR cells indicates that the dox–formaldehyde conjugate is insensitive to P170gp and suggests that conjugation occurs prior to entry into the cytoplasm. A possibility is that the reaction between formaldehyde and dox is an in situ reproduction of our previous bench methods for synthesis of doxaz and the dimer doxF, which utilized a biphasic system of aqueous buffer and chloroform. As doxaz and doxF were formed, which are both uncharged at physiological to slightly acidic pH, they concentrated in the chloroform, where they were protected from hydrolysis. A similar system could be in use here, where doxaz and/or doxF concentrate in the hydrophobic interior of the plasma membrane, where it would be similarly protected from hydrolysis. From the plasma membrane reservoir, the drug–formaldehyde conjugates can then diffuse out to interact with DNA.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Dox–Formaldehyde Combinations Cross-Link DNA More Effectively Than Epi–Formaldehyde Combinations</h3><div class="NLM_p">If the oxazolidine moiety is indeed being synthesized in situ, a comet assay should show doxaz-like cross-linking activity from the dox–formaldehyde combination. Therefore, ADR cells were treated with 15 mM hydrogen peroxide to induce DNA strand breaks, followed by single-agent treatments or various combinations of formaldehyde (100 μM), dox (5 and 100 μM), and epi (5 and 100 μM) for 90 min (<a class="ref internalNav" href="#fig6" aria-label="Figures 6">Figures 6</a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). As before, treatment with peroxide resulted in widespread damage, indicated by migration of DNA from the head to the tail (mean population of 6% DNA in the tail for control and 47% in the tail for peroxide). Formaldehyde (100 μM), owing to its own cross-linking activity, caused a small DNA shift back toward the comet head: 47% in the tail for peroxide alone versus 36% in the tail for formaldehyde and peroxide. As single agents, both 100 μM dox and 100 μM epi resulted in increased tail density. Surprisingly, both drugs (at those doses) also combined with 100 μM formaldehyde to show cross-linking activity, though the effect is significantly stronger with dox (10% in the tail) than with epi (18% in the tail). When the concentration of anthracycline was reduced to 5 μM, both drugs still showed cross-linking activity, but the differences between them were much larger. While the combination of epi and formaldehyde was just barely better than formaldehyde alone (32% vs 36% in the tail, <i>p</i> = 0.0258), the combination of dox and formaldehyde still exhibited profound cross-linking activity; it was significantly better than both formaldehyde alone (22% vs 36% in the tail, <i>p</i> < 0.001) and epi–formaldehyde (22% vs 32%, <i>p</i> < 0.001).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Micrographs for evidence of cross-linking activity from cotreatments with formaldehyde and anthracyclines. ADR cells were treated with nothing (control) or hydrogen peroxide (15 mM for 10 min) followed by formaldehyde (form) alone or in combination with either dox or epi. Anthracyclines were added at 100 μM (top panels) or 5 μM (bottom panels). In each panel, the black scale bar equals 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comet assay for evidence of cross-linking activity from anthracycline–formaldehyde cotreatments. Cells were treated under the conditions described (peroxide, 15 mM, 10 min; drugs/formaldehyde, 90 min). Formaldehyde was always added at 100 μM, while dox and epi were either 100 or 5 μM as shown below the plot. Columns 1, 2, 4, and 7 are reproduced from <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, as they are all part of the same experiment. Each data point represents the comet resulting from a single cell. The population mean and standard deviations are shown by the line and error bars, while the gray box surrounding the mean indicates the 95% confidence interval about the mean. All <i>p</i>-values for pairwise <i>t</i>-tests with the Satterthwaite approximation for degrees of freedom are less than 0.001 for each comparison, with the exception of groups 3 (H<sub>2</sub>O<sub>2</sub> + form) versus 9 (H<sub>2</sub>O<sub>2</sub> + form + 5 μM epi; <i>p</i> = 0.0258), and groups 6 (H<sub>2</sub>O<sub>2</sub> + form + 5 μM dox) versus 8 (H<sub>2</sub>O<sub>2</sub> + form + 100 μM epi; <i>p</i> = 0.0076). Statistical significance at the 0.05 level applies to all pairwise treatment comparisons via the Bonferroni–Holm method to adjust for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These results further support the conclusion that the oxazolidine moiety is capable of forming in situ from combinations of dox and formaldehyde. It also suggests that the oxazolidine is far more efficient at cross-linking DNA than acyclic forms. Interestingly, when doses of the drugs are very high, cross-links can be observed with both dox and epi. We believe this indicates that both cyclic and acyclic species have cross-linking activity and that, at high concentrations, enough genomic DNA is cross-linked to make cyclic and acyclic forms appear similar. However, when the drug concentration is reduced 20-fold, the difference between the two forms is much more obvious. When challenged with lower doses of anthracyclines, only dox, with its vicinal <i>cis</i>-aminol, can form the oxazolidine structure and cause high levels of genomic DNA cross-linking. Previous work indicated activation of cell-death pathways, increased cytotoxicity, and cross-linking activity from cell treatments with epi and formaldehyde-releasing prodrugs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Given the data here, we conclude that, with longer reaction times, we would observe such synergy and cross-linking from cotreatments of epi and formalin-derived formaldehyde. It is curious that although the IC<sub>50</sub> experiments in ADR cells presented here had epi concentrations as high as 100 μM, the experiments failed to demonstrate measurable IC<sub>50</sub> values despite signs of cross-linking activity. This leads to the supposition that epi–DNA adducts are less stable than dox–DNA adducts, though earlier reports also demonstrated that DNA adducts from both drugs have approximately the same stability.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Those experiments were performed in cell-free systems; possibly, in the complex environment of the cell, the adduct stabilities differ, by either passive mechanisms or active cellular repair. The resulting differences could be responsible for the lack of epi–DNA adducts causing cell death when short-term treatments are employed.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structural Analysis of Doxoform Synthesis and Hydrolysis</h3><div class="NLM_p">The experiments presented so far provide strong evidence that oxazolidine is a more effective DNA cross-linking agent and a far more toxic species than linear formaldehyde conjugates. However, the oxazolidine and aminol moieties were not being compared in the same structural background; a better comparison would be between oxazolidine and linear conjugates of dox. Therefore, we were curious about the possibility of synthesizing, characterizing, and potentially isolating some of the intermediates of the reaction between dox and paraformaldehyde. Indeed, with epi, some years ago we partially characterized moderately stable aminol structures resulting from epiF hydrolysis.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> If the dox aminol intermediates are stable and isolable under conditions compatible with cell culture, we could then directly address the question of toxicity and/or DNA cross-linking activity of the acyclic aminol versus the cyclic oxazolidine.</div><div class="NLM_p">To observe and characterize formaldehyde adducts intermediate between doxorubicin and doxazolidine, DMSO-<i>d</i><sub>6</sub> solutions of doxazolidine and/or doxoform were hydrolyzed with D<sub>2</sub>O and monitored by 500-MHz <sup>1</sup>H NMR. In previous experiments, epiF was hydrolyzed with 95% phosphate-buffered D<sub>2</sub>O/5% DMSO-<i>d</i><sub>6</sub>. However, under these conditions, samples of doxF were insoluble and precipitated. Therefore, pilot experiments were performed in which mixtures of doxaz/doxF were hydrolyzed with stepwise addition of D<sub>2</sub>O up to 20% (at which point the samples began to precipitate) and followed over time. Measurements taken soon after the addition of D<sub>2</sub>O were hard to shim and of poor quality, perhaps owing to both difficulties in mixing the sample in the NMR tube and the exothermicity during mixing of dimethyl sulfoxide (DMSO) and D<sub>2</sub>O. After several minutes of vortexing at room temperature, the spectral quality improved greatly and indicated that the system reached an equilibrium prior to the first interpretable NMR spectrum. Subsequent spectra showed little to no change, even after multiple days, suggesting that doxF and epiF exhibit similar behavior upon hydrolysis. The equilibrium was then perturbed by the addition of more D<sub>2</sub>O. Observations in the 5′-CH<sub>3</sub> region of the spectra (δ 1.0–1.3 ppm) demonstrated that the doublet corresponding to these protons in doxF decreased with increasing concentrations of D<sub>2</sub>O, while additional doublet signals, likely corresponding to a combination of dox, doxaz, and/or potential intermediates, increased. We also observed both pattern migration and peak broadening, which we attributed to the changing solvent properties, and we hypothesized that characterization of intermediates may be best addressed with the more stable solvent conditions of a closely monitored synthesis of doxF.</div><div class="NLM_p">A controlled synthesis of doxaz and doxF in the NMR tube was performed by reacting approximately 1.5 equiv of washed paraformaldehyde with dox free base in DMSO-<i>d</i><sub>6</sub>. The reaction was followed by NMR, both one-dimensional (1D) <sup>1</sup>H NMR and homonuclear two-dimensional correlation spectroscopy (COSY). After 1 h, three intermediates (i<sub>a</sub>, i<sub>b</sub>, and i<sub>c</sub>, with doublets at δ 1.16, 1.10, and 1.05 ppm, respectively) were visible in the 5′-CH<sub>3</sub> region (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A). None of these intermediates contained the AX pattern indicative of an oxazolidine moiety in the region δ 4–5 ppm (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B) and are likely linear formaldehyde adducts similar to those in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The first appearance of an oxazolidine (δ 4.24 and 4.41 ppm) occurred by 3.5 h, coincident with the appearance of a fourth doublet at δ 1.19 ppm, and was assigned to doxaz. By 20 h of reaction, the composition was quite complicated and the relative intensities of the 5′-CH<sub>3</sub> doublets had changed significantly; doxaz increased, as did a downfield doublet at δ 1.22 ppm, which corresponds to doxF. With approximately 3 days of reaction time, the complicated mixture had simplified considerably and consisted almost entirely of three species: doxF, doxaz, and an additional species with a 5′-CH<sub>3</sub> doublet at δ 1.16 ppm that was later identified as unreacted doxorubicin. We also observed a small amount of unreacted paraformaldehyde. With additional time (7 and 14 days), the fractions of both doxaz and dox continued to slowly decline while that of doxF increased.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0010.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <sup>1</sup>H NMR spectra for slow synthesis of doxF in DMSO-<i>d</i><sub>6</sub>. The region from approximately 0.95 to 1.3 ppm encompasses the 5′-CH<sub>3</sub> resonance region (A), and the mid-downfield region of 3.9–4.6 ppm encompasses the AX patterns from oxazolidines (B). The sole doublet observed at the initial condition, which contains only dox free base (<b>1</b>), is quickly joined by doublets for three intermediates (i<sub>a</sub>, i<sub>b</sub>, and i<sub>c</sub>) after 1 h of reaction with approximately 1.5 equiv of washed paraformaldehyde. Between 3.5 and 20 h of reaction time, signals for doxF (<b>7</b>) and doxaz (<b>5</b>) are observed. After 20 h, the reaction progresses increasingly to <b>7</b>, <b>5</b>, and unreacted <b>1</b>, while all other intermediates disappear. The rise of 5′-CH<sub>3</sub> signals for <b>7</b> and <b>5</b> is accompanied by the appearance of oxazolidine AX patterns for each (Ox<sub>7</sub> and Ox<sub>5</sub>). All spectra were obtained at 500 MHz at room temperature in DMSO-<i>d</i><sub>6</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Proposed Structures for Intermediates between Dox (<b>1</b>) and DoxF (<b>7</b>) in DMSO-<i>d</i><sub>6</sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>In synthesis, minor intermediates i<sub>a</sub>, i<sub>b</sub>, and i<sub>c</sub> are hypothesized, and doxaz–aminol (<b>11</b>) is not observed. In hydrolysis, <b>11</b> and doxaz (<b>5</b>) are relatively stable. Only with the addition of TFA is <b>1</b> re-formed, which occurs without visible production of i<sub>a</sub>, i<sub>b</sub>, or i<sub>c</sub>. Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><div class="NLM_p">Following 16 days of reaction, at which point the majority of the mixture was doxF, the reaction was reversed by addition of D<sub>2</sub>O to the NMR sample. Owing to the quickly established equilibrium we have described, spectra were taken approximately 30 min after D<sub>2</sub>O addition to allow for chemical and thermal equilibration. As before, the fraction of doxF decreased with increasing D<sub>2</sub>O (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). However, the peak patterns resulting from the hydrolysis reaction were not the same as those observed during the synthesis phase. While the 5′-CH<sub>3</sub> doublet for doxaz increased slowly with higher D<sub>2</sub>O, surprisingly, the peaks for dox changed very little (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). This shows that doxaz is more stable to hydrolysis than doxF and that, under these conditions, little to no hydrolysis of the oxazolidine ring was occurring. This was confirmed by observations in the δ 4–5 ppm region, which showed that while the oxazolidine signals of doxF were decreasing, the same was not true for the oxazolidine signals of doxaz (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B). Of particular interest was the very early appearance of a new 5′-CH<sub>3</sub> doublet, which was accompanied by a new pair of coupled doublets at δ 4.51 and 4.41 ppm (the latter under the downfield doublet for the doxaz AX pattern). The combination of chemical shift and small coupling constant (4 Hz) is indicative of geminal coupling of protons on a methylene carbon between two heteroatoms in a five-membered ring<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and therefore highly suggestive of an oxazolidine moiety. We assigned this species as the doxaz–aminol intermediate (<b>11</b>) between doxaz and doxF. Doxaz–aminol was not observed during the synthetic phase, and its change was greater with additional D<sub>2</sub>O than the change in doxaz. These data suggest that this structure is relatively well stabilized by the presence of D<sub>2</sub>O and perhaps that the reaction of doxaz with residual paraformaldehyde was facilitated by concentrations of D<sub>2</sub>O up to 10–12%. At the highest D<sub>2</sub>O concentration (16%), there was nearly equal (∼40%) representation of doxF and the combination of doxaz and doxaz–aminol, as indicated by the doublets in the 5′-CH<sub>3</sub> region of the spectrum, while dox remained unchanged at 18% of total integration.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0011.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <sup>1</sup>H NMR spectra of hydrolysis of doxF with increasing concentrations of D<sub>2</sub>O. The region from approximately 0.95 to 1.3 ppm encompasses the 5′-CH<sub>3</sub> resonance region (A), and the mid-downfield region of 3.9–4.6 ppm encompasses the AX patterns from oxazolidines (B). Oxazolidine signals for <b>7</b> (Ox<sub>7</sub>), <b>5</b> (Ox<sub>5</sub>), and <b>11</b> (Ox<sub>11</sub>) are indicated. The last row shows the fully hydrolyzed state after addition of 0.1% TFA. All spectra were obtained at 500 MHz at room temperature in DMSO-<i>d</i><sub>6</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Under these conditions, the stability of doxaz was serving as the functional end point; with each 2% increase in D<sub>2</sub>O, the magnitude of the changes was minimized and we were unable to observe any hydrolysis products downstream of doxaz. Moreover, the addition of much more D<sub>2</sub>O would have resulted in precipitation of most of the species present. Therefore, we concluded that complete characterization and isolation of a relatively pure sample of a strictly acyclic formaldehyde adduct of dox is unlikely. However, to show that additional hydrolysis of the system was still possible, trifluoroacetic acid (TFA) was added to a final concentration to 0.1%. Under these conditions, doxaz, doxaz–aminol, and doxF immediately disappeared and dox was the only detectable species remaining.</div><div class="NLM_p last">Initially, the goal of these experiments was to characterize and, if possible, isolate an acyclic formaldehyde adduct of dox. The synthetic phase provided useful information and showed that the synthesis of doxaz and doxF from dox free base and low concentrations of paraformaldehyde proceeded in a manner that was more complicated than we have previously appreciated. Even with very low paraformaldehyde concentrations in DMSO, doxaz and doxF appear early in the reaction when the sample is still a complicated mixture also containing dox and multiple intermediates. Therefore, the acyclic aminol is not a synthetically isolable end point when DMSO is used as a solvent. In a similar manner, attempting to produce a relatively pure sample of an acyclic intermediate by hydrolyzing doxF was hampered by the combination of poor water solubility of the drugs and relative stability of doxaz and doxaz–aminol. It is interesting that the synthesis produces at least three acyclic intermediates, while the hydrolysis phase failed to show evidence of any, instead producing doxaz–aminol, which was not detectable in the synthetic phase. While it was possible that the broad peaks in the hydrolysis experiment obscured additional intermediate peaks, there was no evidence of this in the COSY spectra. From these data, we conclude that while the acyclic aminol species is a required intermediate between dox and doxaz, it is too transient to lend itself to characterization or isolation.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Slow Release of Doxaz Is More Potent Than Slow Release of Acyclic Schiff Base Conjugates of Dox and Formaldehyde</h3><div class="NLM_p">We have shown that there are marked differences in biological activity between dox and epi when they are combined with formaldehyde. These data are informative, but a better comparison would be between the different types of adducts within a setting of equivalent structure. The NMR experiments already presented show that any comparison of the cytotoxicity of cyclic versus acyclic formaldehyde adducts of dox must be done through indirect methods, as the acyclic adducts of dox are not isolable in a purity that allows for good biological characterization.</div><div class="NLM_p">Previously, our lab produced and characterized doxsaliform (doxSF, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), a prodrug that releases the dox–formaldehyde Schiff base according to simple first-order kinetics.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The release is governed by a time-release mechanism deriving from elimination of a salicylamide trigger with an aqueous half-life of 57 min. A comparison of doxSF with doxaz released enzymatically at approximately the same rate is a better test of the efficacy of acyclic versus cyclic formaldehyde conjugates of anthracyclines.</div><figure id="sch4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Activation of Doxorubicin–Formaldehyde Prodrugs Doxsaliform (doxSF, <b>12</b>) and Pentyl PABC-doxaz (PPD, <b>13</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(Top) DoxSF undergoes a first-order elimination of salicylamide with a half-life of 57 min under physiological conditions to release the dox–formaldehyde Schiff base <b>6b</b>. In aqueous medium, <b>6b</b> is in equilibrium with aminol <b>6a</b>. (Bottom) PPD is enzymatically cleaved by pig liver esterase (PLE) to release doxaz (<b>5</b>). Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><div class="NLM_p">Owing to the need to synthesize and characterize otherwise unneeded doxSF specifically for this experiment, direct head-to-head comparisons were not made. Instead, the literature IC<sub>50</sub> value for a 3-h treatment with doxSF was used.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> To limit the effects only to those deriving from formaldehyde conjugates, the tests were conducted in ADR cells. In these cells, doxSF has an IC<sub>50</sub> slightly more than 10-fold lower than dox (0.8 μM versus 10 μM), showing that acyclic dox–formaldehyde conjugates are more efficacious than dox alone. To release doxaz slowly, cells were treated with pig liver esterase (PLE) and the doxaz prodrug PPD (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Enzyme concentrations varied between 0.05 and 10 units/mL, where the definition of a unit is the amount of enzyme necessary to catalyze the conversion of 1 μM PPD per hour in a 50 μM reaction. The ADR cells express below-average levels of the primary human enzyme responsible for activating PPD (CES2) and responded to a 3-h treatment with PPD alone with an IC<sub>50</sub> of approximately 2000 nM (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>A).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> When PPD was co-added with PLE, all combinations were 30–300-fold more potent than doxSF; the IC<sub>50</sub> value varied between 30 and 3 nM and was dependent upon the amount of enzyme present in the treatment. Above 2.5 units/mL, the IC<sub>50</sub> failed to decrease with increasing enzyme, most likely indicating 100% conversion of PPD to doxaz. As an additional comparison, the cell density of each treatment group was compared at 800 nM, the IC<sub>50</sub> value for doxSF (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>B). In this analysis, the combinations of PPD and PLE were 25–500-fold more potent than doxSF.</div><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0012.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Cytotoxicity and kinetics of enzymatically released doxaz. In treatments of ADR cells with the doxaz prodrug PPD (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) and pig liver esterase (PLE), very little enzyme is required to elicit a profound cytotoxic effect, indicated by a large reduction of the IC<sub>50</sub> value relative to PPD treatment alone (A). The IC<sub>50</sub> value of the dox–aminol prodrug doxSF (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) is shown by a dotted line. When the PPD/PLE combinations were compared to doxSF at its 800 nM IC<sub>50</sub> value, the combinations resulted in 25–500-fold less growth (B), with most of the conditions resulting in near-complete cell death. In HPLC assays, 1 μM PPD reaction with three concentrations of PLE was well fit by first-order kinetics in which half-life was inversely correlated with enzyme concentration (C). In panels A and B, all bars represent the average and standard deviation of duplicated triplicate measurements. In panel C, the points are the average of duplicate measurements; error bars (standard deviation) are present for all points but in many cases are smaller than the size of the point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Even at very low enzyme levels, slow release of doxaz is much more toxic than slow release of the dox Schiff base, providing strong evidence that the oxazolidine moiety confers much greater cytotoxic activity. To properly compare PPD and doxSF, it was important to assess the approximate rate of doxaz release from PPD under these enzymatic conditions. Assessing enzymatic rates with low levels of PPD is difficult due to the limit of detection in our HPLC system, which is approximately 100–200 nM, while the cells respond to much lower concentrations. We determined in pilot experiments that reproducible kinetic measurements could be performed at PPD concentrations as low as 1 μM, which was the highest concentration used in the cell experiments. Therefore, the activity of three different concentrations of PLE on 1 μM PPD was followed by observing the appearance of dox as a function of time (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>C). Each data set is well fit by a first-order kinetics model (<i>R</i><sup>2</sup> values all greater than 0.993), and the half-lives are inversely proportional to the amount of enzyme added. These data indicate that PLE concentrations between 0.5 and 0.25 unit/mL will produce doxaz at a rate approximately equivalent to the release of the dox Schiff base from doxSF. Importantly, since catalytic systems increasingly exhibit first-order kinetics as substrate concentrations decrease to values much lower than <i>K</i><sub>M</sub>,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> it is likely that 0.25–0.5 unit/mL will produce half-lives in the range of 1 h for the full concentration range used in the cell experiment. These enzyme values produce IC<sub>50</sub> values of 4.7 nM for 0.5 unit/mL and interpolate to 8–12 nM for 0.25 unit/mL, compared to 800 nM for doxSF releasing the Schiff base at the same rate.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73473" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73473" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There is ample evidence that the cytotoxic and DNA cross-linking activities of anthracyclines can be potentiated by formaldehyde, either by prior reaction or by combination with formaldehyde prodrugs. Of particular importance is our observation that the dox–formaldehyde conjugate doxaz is extremely potent, even in cell lines with P170gp-mediated resistance to anthracyclines. This potency is accompanied by very efficient DNA alkylation activity that results in adducts which are functionally inhibitory in a sequence-specific manner. We also provide evidence that the oxazolidine resulting from formaldehyde reacting with the vicinal <i>cis</i>-aminol in dox confers far greater DNA alkylation activity and cytotoxicity than formaldehyde conjugates in which the formaldehyde is carried in an acyclic form, such as the aminol or Schiff base. We were surprised, however, to observe that doxaz is produced in situ; cotreatments with dox and formaldehyde show considerably synergistic cytotoxicity and are far better at cross-linking cellular DNA than formaldehyde alone, even in P170gp-positive cells. From these data, we conclude that dox and formaldehyde are rapidly reacting in a water-excluded location, such as the hydrophobic interior of the membrane. When epi was combined with formaldehyde, we failed to observe any synergistic cell death and a dampened DNA cross-linking effect. We attribute this to the vicinal <i>trans</i>-aminol in the daunosamine of epi, which permits only linear formaldehyde conjugates as opposed to the oxazolidine moiety in the case of dox. In attempting to address the possibility of direct cytotoxic comparisons of cyclic versus acyclic formaldehyde adducts of dox, we demonstrated that the acyclic intermediates between dox and doxF are not viable end points in either the synthetic or hydrolytic directions, making isolation and subsequent direct treatment of cells impossible. However, we did show that when they are released from prodrugs at equal rates, the oxazolidine is far more cytotoxic than the Schiff base of dox, which is required in approximately 100-fold greater concentration to achieve an equivalent effect.</div><div class="NLM_p">These data make clear that the oxazolidine moiety is of critical importance for both the efficient cross-linking activity and high cytotoxicity observed in anthracycline-formaldehyde conjugates, though the exact molecular nature of that importance is still unclear. We found that the oxazolidine moiety was more stable than expected, even in the presence of modest concentrations of water. This stability and the natural affinity of the anthraquinone moiety for DNA could lead to a substantial nuclear buildup of doxaz, which then either directly cross-links DNA or hydrolyzes to the aminol or Schiff base prior to alkylation. Evidence in favor of the oxazolidine moiety as the primary structure responsible for efficient cross-linking is provided by the low potency of doxSF, which we expect has a similar nuclear buildup prior to activation due to its intact anthraquinone system.</div><div class="NLM_p">In moving forward with development of potential clinical applications for formaldehyde-activated anthracyclines, the questions of which species does the cross-linking and the exact kinetics of formaldehyde elimination are probably only academic in nature. It is relevant, however, that the ability of an anthracycline aminol to close to an oxazolidine is an important part of activation by formaldehyde to a highly potent drug. We have shown that another anthracycline with a vicinal <i>cis</i>-aminol, daunorubicin, can also be reacted with formaldehyde to form the potent conjugates daunoform and daunozolidine.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> We predict that other anthracyclines with similar stereochemistry to daunosamine, such as idarubicin, will also exhibit great increases in potency when activated with formaldehyde or formaldehyde-releasing prodrugs.</div><div class="NLM_p last">Interestingly, it may also be possible to sidestep the stereochemistry limitation on oxazolidine formation. Work by Crabb et al. in 1986<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> confirmed that model <i>cis</i>- and <i>trans</i>-aminols react with formaldehyde to produce oxazolidines in the case of the former but products analogous to epidoxoform in the latter. However, when the amino group of the trans isomer was alkylated to form a monomethyl group, the trans isomer was then capable of oxazolidine formation. We therefore propose that the anthracycline equivalent, <i>N</i>-methylepidoxorubicin, may react with formaldehyde to form <i>N</i>-methylepidoxazolidine. Given the results presented here, we expect this hitherto-unsynthesized compound to exhibit a selective increase in anticancer activity over cardiotoxicity and profound DNA cross-linking ability that we observe with doxazolidine. Such a result would release the stereochemical limitation on potently cytotoxic anthracycline–formaldehyde interactions.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Remarks</h3><div class="NLM_p last">Doxorubicin hydrochloride was prepared from clinical preparations of lactose-containing doxorubicin hydrochloride (gifted from FeRx, Inc., Aurora, CO), first separated from the lactose as the free base, then dissolved in DMSO and acidified with hydrochloric acid. Doxazolidine and doxoform were synthesized and verified by <sup>1</sup>H NMR as previously described<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> from the same clinical material and dissolved in DMSO that had been dried for several days over 4 Å molecular sieves activated in a vacuum drying oven. NMR spectra were acquired on a Varian Unity Inova spectrophotometer (Palo Alto, CA) at 500 MHz in deuterated solvents from Cambridge Isotope Laboratories, Inc. (Andover, MA). Unless otherwise noted, all spectra were acquired at ambient temperature (20 ± 1 °C). The spectra were analyzed with MestReNova software, version 10 (Mestrelab Research S.L., Santiago de Compostela, Spain). Chemical shift values are reported in parts per million (ppm) on the δ scale and standardized to the residual solvent peak. Epirubicin hydrochloride was gifted from Pharmacia-Upjohn-Farmitalia (Milan, Italy) and Sicor, Inc. (Milan, Italy). The concentrations of all anthracycline stock solutions in DMSO were measured by absorbance at 480 nm on a Hewlett-Packard/Agilent 8452A diode-array instrument, using a constant extinction coefficient of 11 500 M<sup>–1</sup>·cm<sup>–1</sup> in 75% DMSO/25% water. Analytical HPLC was performed on an Agilent 1050/1100 hybrid instrument equipped with a 1050 series autoinjector, a 1100 series UV/visible diode-array detector, and a 1046A fluorescence detector. An Agilent Zorbax octadecylsilyl (C18) reverse-phase column (4.6 mm i.d. × 150 mm, 5 μm) was used, and the mobile phases were mixtures of acetonitrile (MeCN) and acidic phosphate buffer (15 mM KH<sub>2</sub>PO<sub>4</sub>, pH 4.6). Elution from the column used timetable and mobile-phase conditions as follows: 0 min (20% MeCN, 1 mL/min), 6.5 min (45% MeCN, 1 mL/min), 8 min (70% MeCN, 2 mL/min), 12 min (70% MeCN, 2 mL/min), and 13 min (20% MeCN, 1 mL/min). The presence of anthracycline compounds was detected by monitoring absorbance at 480 nm. All chemicals were purchased from Aldrich (Milwaukee, WI) or Fisher Scientific, Inc. (Fair Lawn, NJ) unless otherwise noted. The purity of all compounds used was verified to be greater than or equal to 95% by a combination of NMR and HPLC.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Tissue Culture</h3><div class="NLM_p last">Human pancreatic cancer line MIA PaCa-2 (pancreatic) was purchased from the American Type Culture Collection and was grown in high-glucose Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal calf serum (Atlanta Biologicals, Flowery Branch, GA) and penicillin–streptomycin (final concentrations of 200 units/mL penicillin and 200 μg/mL streptomycin; Lonza, Allendale, NJ). Trypsin [10× stock of 0.5% trypsin, 5.3 mM ethylenediaminetetraacetic acid (EDTA)] was purchased from Atlanta Biologicals. Dox-resistant human ovarian cancer line NCI/ADR-RES (ovarian) was a gift from William Wells (Michigan State University, East Lansing MI) and was cultured in RPMI-1640 medium containing the same concentrations of fetal calf serum, penicillin, and streptomycin. The cells were maintained in a humidified incubator with 95% air/5% CO<sub>2</sub> at 37 °C. Plates and flasks were purchased from Corning, Inc. (Corning, NY) and Sarstedt, Inc. (Newton, NC).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Growth Inhibition Assays</h3><div class="NLM_p">The day prior to treatment, cells were seeded into 96-well plates at a density of 1000 cells/well. After incubation overnight, the medium was replaced with fresh complete medium into which the drugs and/or formaldehyde (derived from formalin) were diluted to their final concentrations. Control wells received equivalent concentrations of drug solvent only [DMSO for dox, doxaz, and epi; phosphate-buffered saline (PBS) for formaldehyde], which was standardized to 1% in all wells. The cells were treated for either 30 or 90 min, after which the treatment medium was removed, the wells were gently rinsed with fresh medium, and new fresh medium was added. The cells were grown either until the control wells reached 80% confluency or for 5 days, whichever occurred first. The cells were then fixed with 5% formaldehyde in phosphate-buffered saline for 10–15 min and stained with filtered 0.1% crystal violet in deionized water. The plates were rinsed in tap water and allowed to dry before the stain was redissolved with 1:1 2-propanol/2% sodium dodecyl sulfate in deionized water. The optical density of the wells was read in an EnVision 2102 plate reader (PerkinElmer Inc., Waltham, MA), monitoring absorbance at 600 nm. IC<sub>50</sub> values were calculated by performing nonlinear least-squares analysis, fitting the fractional staining (relative to control wells) to a variable-slope sigmoidal dose–response model (GraphPad Prism 5.0, GraphPad Software Inc., La Jolla, CA). Initial investigations examined dox, doxaz, epi, or formaldehyde in isolation to determine their respective IC<sub>50</sub> values and curve shapes. The drugs were then treated in combination with various sublethal doses of formaldehyde. Combination index values for IC<sub>50</sub> of the combination (CI) were calculated with the Chou–Talalay equation:<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a><span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/jm-2015-01956b_m001.gif" alt="" /></img></span>where (combined<sub>50</sub>)<sub>A</sub> and (combined<sub>50</sub>)<sub>F</sub> are the doses of anthracycline and formaldehyde, respectively, that result in 50% inhibition in combination, while (alone<sub>50</sub>)<sub>A</sub> and (alone<sub>50</sub>)<sub>F</sub> are the doses that result in 50% inhibition in isolation. Where it was impossible to measure (alone<sub>50</sub>)<sub>A</sub>, such as with epi in NCI/ADR-RES cells, no combinations were performed and no CI was calculated.</div><div class="NLM_p last">To examine how equimolar dox and formaldehyde affect cells, 1000 NCI/ADR-RES cells/well were plated as described. The cells were then treated with complete medium containing either dox alone or equimolar combinations of dox and formaldehyde in the range from 50 nM to 10 μM. Each dose was tested for 3, 6, or 48 h, after which the medium was replaced and cells were allowed to grow until the vehicle-treated wells reached 80% confluency or 5 days, whichever was shorter. The wells were fixed and stained as described.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Single-Cell Gel Electrophoresis (Comet) Assays</h3><div class="NLM_p">Initially, cells in log-growth phase were trypsinized and seeded into 6- or 12-well plates at a density of approximately 200 000–400 000 cells/well and allowed to adhere overnight (at least 16–18 h). Treatment then commenced the following morning, followed by trypsinization and embedding of 8000–10 000 cells/gel. However, the DNA integrity of untreated cells was highly variable and subsequent tests indicated that trypsinization time and handing of the cells in trypsin had significant effects on results, with short trypsinization and rough handling generally producing the highest levels of detectable DNA damage. Therefore, to reduce experimental variability, the following optimized protocol was adopted.</div><div class="NLM_p">A single population of NCI/ADR-RES or MIA PaCa-2 cells in log-growth phase was trypsinized until they detached from the plate without resorting to physical agitation. A suspension of single cells was created by gently pipetting the trypsin/cell mixture with a 1000 μL pipet. The trypsin reaction was then stopped by adding it to at least 4 volumes of complete medium. The quality of the suspension and density of the cells was checked with a hemocytometer. For analysis of drug treatments alone, the cells were diluted in medium to a concentration of 50 000 cells/mL and treated with either 100 μM dox, 100 μM epi, or doxaz at high (10 μM) and low (0.250 μM) doses for 90 min at 37 °C with periodic mixing. Control cells were treated with DMSO, which was standardized to 1% in all treatments. Following the treatment period, the cells were centrifuged in a tabletop centrifuge at 1200<i>g</i> for 5 min. The cell pellets were resuspended in 50 μL of PBS, from which 10 μL (8000–10 000 cells) was mixed with 90 μL of melted 0.5% agarose held at 40 °C. This mixture was quickly applied to agarose-coated glass microscope slides (coated in 1.5% agarose and dried for 1–2 h at 58 °C), coverslipped, and allowed to gel for 10–15 min at 4 °C. The coverslips were removed and the slides were placed into cold alkaline lysis buffer (2.5 M NaCl, 10 mM Tris, pH 10.5, and 100 mM Na<sub>2</sub>EDTA, with 5% DMSO and 1% Triton X-100 added immediately before use) and lysed for 2 h at 4 °C. The gels were then equilibrated in cold alkaline electrophoresis buffer (300 mM NaOH and 1 mM Na<sub>2</sub>EDTA) for 20 min at 4 °C before electrophoresis in an ice bath for 20 min at 25 V (300 mA limit). The gels and slides were carefully transferred to cold neutralization buffer (500 mM Tris, pH 7.5) for 10 min and then rinsed with three changes of cold deionized water (3–5 min each). The slides were prepared for silver staining consistent with previously described protocol.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The slides were fixed with 5 mM ZnSO<sub>4</sub>, 5% glycerol, and 15% acetic acid for 10 min at room temperature, then rinsed three times with deionized water and allowed to dry completely overnight. The slides were then rehydrated for 60 s and stained (5% sodium carbonate, 0.068% ammonium acetate, 0.068% silver nitrate, 0.17% silicotungstic acid, and 0.051% formaldehyde), which was typically complete in 6–10 min. The slides were dipped once in deionized water and then placed in 10% acetic acid for 10 min at room temperature. Finally, the slides were rinsed, dried, and photographed with a bright-field microscope [VistaVision (VWR Inc., Radnor, PA) equipped with a Samsung TL350 digital camera]. Scoring of grayscale images was performed with CometScore Freeware, version 1.6.1.13 (TriTek Corp, Sumerduck, VA), and typically 100–200 comets were scored per gel.</div><div class="NLM_p last">For treatment with hydrogen peroxide to induce DNA damage, cells were suspended to a density of 325 000 cells/mL and treated with 15 μM hydrogen peroxide for 10 min at 37 °C, followed by centrifugation (1200<i>g</i>, 5 min). The pellet was resuspended in medium, and aliquots of 50 000 cells were removed and diluted to 1 mL with medium containing the drugs of interest for treatment. The assays continued as described.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Statistical Analysis of Comet Assays</h3><div class="NLM_p last">All statistical analyses were performed with SAS v9.3 (SAS Institute, Inc., Cary, NC). Means, standard deviations, and confidence intervals were generated to describe treatment groups for each study and within cell lines when applicable (via the MEANS procedure). Multiple pairwise <i>t</i>-tests accounting for unequal variance were also computed to determine the differences between treatment groups within each study (via the TTEST procedure). For the analysis in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, all pairwise <i>t</i>-tests were computed within each cell line and the same treatment groups were compared across cell lines. In all cases, the Satterthwaite approximation for degrees of freedom was used to account for the possibility of unequal variances. All sample sizes are greater than 60, allowing the use of normal approximations for confidence intervals around the mean of each treatment group. In addition to pairwise <i>t</i>-tests, analyses to support robustness of results were performed with generalized estimating equations (GEE) for analysis of variance (via the GENMOD procedure). These supplemental analyses using GEE methods agreed with the results from the pairwise <i>t</i>-tests. The full statistical report is available in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Restriction Digest Inhibition</h3><div class="NLM_p last">DH5α <i>Escherichia coli</i> cells transformed with pcDNA3.1(−) were received as a gift from Leslie Leinwand (University of Colorado, Boulder, CO). The plasmid DNA was purified by Maxiprep (Qiagen, Inc., Alameda, CA). In order to more clearly see the results of downstream analyses, the DNA was first completely linearized with <i>Sma</i>I (Thermo Fisher Scientific, Lafayette, CO) at 37 °C, with reaction progress monitored by agarose gel electrophoresis. <i>Sma</i>I was then heat-inactivated at 65 °C for 10 min. To determine whether dox and doxaz have differential effects on restriction digests, linearized DNA was digested with either <i>Not</i>I (GC-rich cut sequence) or <i>Nde</i>I (AT-rich cut sequence). Both enzymes were acquired from Thermo Fisher Scientific. For the initial drug–DNA reactions, 1.43 μg of DNA [0.426 pmol (7.8 nM plasmid), 175 pmol (3.2 μM) 5′-GC-3′ sequences] was incubated with 1.5, 5.0, and 8.0 μM dox or doxaz solutions in DMSO (final concentration of 1% DMSO) in a water bath at 37 °C for 30 min. FastDigest reaction buffer (5.5 μL) was then added, followed by 1.6 μL of <i>Nde</i>I or 0.8 μL of <i>Not</i>I (enzyme specific activity not provided by Thermo Fisher). Aliquots (5 μL) of the reaction were removed at various times and quenched with 5 μL of DNA loading buffer [2× Tris–acetate–EDTA (TAE), 12% glycerol, and bromophenol blue] containing 150 mM EDTA. These time points were each electrophoresed twice in 0.5% agarose gels containing 250 ng/mL ethidium bromide to control for variability in gelling, loading, or migration. The gels were run in 1× TAE electrophoresis buffer, also containing ethidium bromide at 250 ng/mL, and visualized by fluorescence on a UVP EC3 imaging system with a BioChemiHR camera and VisionWorksLS 6.7.4 software (UVP LLC, Upland, CA) or a GE ImageQuant LAS 4000 system (GE Inc., Fairfield, CT). Densitometry was performed on uncompressed 16-bit TIFF files in ImageJ (version 1.48v, National Institutes of Health, Bethesda, MD) and the fraction of starting material remaining at each time point was calculated and plotted with GraphPad Prism 5.0.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> NMR Analysis of Synthesis and Hydrolysis</h3><div class="NLM_p">In pilot experiments, either pure doxF or mixtures of doxF and doxaz were synthesized in chloroform as described. The chloroform was evaporated and the material was dissolved in DMSO-<i>d</i><sub>6</sub>. When diluted to 5% DMSO-<i>d</i><sub>6</sub> with D<sub>2</sub>O, the drugs were insoluble. Therefore, stepwise addition of D<sub>2</sub>O to solutions of doxF and/or doxaz was utilized.</div><div class="NLM_p">To initially observe the effects of hydrolysis, 500 μL of 2–5 mM DMSO-<i>d</i><sub>6</sub> solutions of pure doxF or doxF/doxaz mixtures were placed into an oven-dried NMR tube. A high-quality baseline spectrum was taken at 500 MHz, after which D<sub>2</sub>O was added to a final concentration of 1% (v/v) and mixed by vortexing. Room-temperature (20 °C) spectra were taken starting immediately but were of poor quality, as indicated by broad peaks and poor shimming, until approximately 10–15 min, at which point resolution improved. Spectra continued to improve slightly until 30–45 min, after which no further gains in quality were observed. The composition of the sample, monitoring in particular the informative regions of δ 0.8–1.5 ppm (5′-CH<sub>3</sub>) and δ 4–5 ppm (oxazolidine), remained constant at constant concentrations of D<sub>2</sub>O in all interpretable spectra, including those taken after several days of room-temperature incubation. Stepwise addition of D<sub>2</sub>O up to 20% final concentration (v/v) resulted in the establishment of a new equilibrium with each increment. It was observed that, beyond 20% D<sub>2</sub>O in DMSO-<i>d</i><sub>6</sub>, spectral quality decreased significantly and drug precipitation began to occur, which limited our ability to use signal integration as a means of following sample composition. At 35% D<sub>2</sub>O, nearly all the drug precipitated.</div><div class="NLM_p">The analysis was further hindered by the presence of a singlet, initially appearing at δ 1.22 and migrating upfield with each D<sub>2</sub>O addition, complicating integration and pattern identification. Proton–carbon heteronuclear single quantum correlation (HSQC) analysis identified this interloping singlet as a CH<sub>2</sub> group, which led us to hypothesize that it was perhaps a chloroform-soluble, long-chain hydrocarbon impurity in the prilled paraformaldehyde used to synthesize doxaz/doxF. Its association with the paraformaldehyde was confirmed by washing the paraformaldehyde powder with chloroform and analyzing the filtrate by proton NMR in DMSO-<i>d</i><sub>6</sub>. Therefore, paraformaldehyde for further experiments was rinsed three times in deuteriochloroform and filtered through a glass frit.</div><div class="NLM_p">To synthesize doxF in a controlled, observable manner, dox free base was dissolved in DMSO-<i>d</i><sub>6</sub>. To a clean and oven-dried NMR tube, 3.8 μmol was added and diluted with 420 μL of DMSO-<i>d</i><sub>6</sub>, for a final concentration of 9 mM. A baseline 1D <sup>1</sup>H spectrum was acquired, along with homonuclear COSY. To add approximately 1–2 equiv of paraformaldehyde, deuteriochloroform-rinsed paraformaldehyde was suspended in DMSO-<i>d</i><sub>6</sub> at an approximate concentration of 1 mg/mL (94 mM) and mixed until visibly homogeneous. From this suspension, a volume corresponding to 1.0 equiv of paraformaldehyde (40.6 μL) was added to the solution of dox free base. While the DMSO-<i>d</i><sub>6</sub> stock of paraformaldehyde was a visible suspension, there were no observable particulates in the NMR tube. The presence of paraformaldehyde was confirmed by a <sup>1</sup>H NMR spectrum taken at 10 min (DMSO-<i>d</i><sub>6</sub>, 500 MHz): δ 4.68 (d, 2H, <i>J</i> = 8 Hz, penultimate CH<sub>2</sub>), 4.77–4.82 (multiple s, average of 6–8H, internal CH<sub>2</sub> units), 6.46 (t, 2H, <i>J</i> = 8 Hz, terminal OH) ppm. Integration of internal CH<sub>2</sub> protons and penultimate CH<sub>2</sub> protons indicated that approximately 1.5 equiv of paraformaldehyde had been added to the reaction. The progress of the reaction at room temperature was followed by 1D <sup>1</sup>H NMR and homonuclear COSY spectra. Fractional composition of dox, doxaz, doxF, and various intermediates observed was calculated by integration in the 5′-CH<sub>3</sub> resonance region (δ 0.8–1.3 ppm), and identification of oxazolidines was indicated by AX patterns in the δ 4–5 ppm region. After 16 days of reaction, the fractional composition of the sample was approximately 0.4 each for doxF and doxaz and 0.18 for unreacted dox, with a small amount of paraformaldehyde left unreacted.</div><div class="NLM_p last">To hydrolyze the doxF/doxaz/dox sample, small volumes of D<sub>2</sub>O were added to the NMR sample, beginning at 0.5% (v/v) and progressing to 16% (v/v). Mixing of the sample was accomplished by vortexing the tube at an angle, watching for mixing throughout the liquid column. Following mixing, the sample sat at room temperature for 30 min to allow for thermal and chemical equilibration, followed by collection of 1D <sup>1</sup>H NMR and homonuclear COSY spectra at 500 MHz. The regions of observation were the same as previously described. To force the hydrolysis to its end point, TFA was diluted to 10% in 16% D<sub>2</sub>O/84% DMSO-<i>d</i><sub>6</sub> and then was diluted 1:100 into the NMR sample, for a final concentration of 0.1% (v/v, 109 equiv, relative to starting dox free base) and incubated at room temperature.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Dox Free Base NMR Assignments</h3><div class="NLM_p last">Dox free base in DMSO-<i>d</i><sub>6</sub> was characterized by the following spectral data, with assignments made from <sup>1</sup>H NMR and homonuclear COSY spectra of a pure sample (see numbering scheme in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>): <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.13 (d, 3H, <i>J</i> = 7 Hz, 5′-CH<sub>3</sub>), 1.47 (dd, 1H, <i>J</i> = 4, 13 Hz, 2′), 1.61 (td, 1H, <i>J</i> = 4, 13 Hz, 2′), 2.10 (dd, 1H, <i>J</i> = 5, 14 Hz, 8), 2.17 (dd, 1H, <i>J</i> = 3, 14 Hz, 8), 2.87 (dt, 1H, <i>J</i> = 4, 12 Hz, 3′), 2.94 and 2.96 (ABq, 2H, <i>J</i><sub>AB</sub> = 18 Hz, 10), 3.29 (s, 1H, 4′), 3.99 (s, 3H, 4-OCH<sub>3</sub>), 4.07 (q, 1H, <i>J</i> = 6 Hz, 5′), 4.56 (s, 3H, 14), 4.87 (s, 1H, 14-OH), 4.94 (t, 1H, <i>J</i> = 4 Hz, 7), 5.19 (d, 1H, <i>J</i> = 4 Hz, 1′), 5.38 (s, 1H, 9-OH), 7.65 (t, 1H, <i>J</i> = 5 Hz, 2), 7.92 (d, 2H, <i>J</i> = 5 Hz, 1 and 3).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> DoxF NMR Assignments</h3><div class="NLM_p last">DoxF, synthesized in chloroform and solubilized in DMSO-<i>d</i><sub>6</sub>, was characterized by the following spectral data, with assignments made from <sup>1</sup>H NMR and homonuclear COSY spectra of a sample of 90% doxF/10% doxaz: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.22 (d, 3H, <i>J</i> = 7 Hz, 5′-CH<sub>3</sub>), 1.62–1.74 (m, 1H, 2′), 1.89–1.98 (m, 2H, 2′ and 8), 2.33 (app d, 1H, <i>J</i> = 14 Hz, 8), 2.87 and 2.90 (ABq, 2H, <i>J</i><sub>AB</sub> = 18 Hz, 10), 3.28–3.42 (m, 3H, 3′ and N-CH<sub>2</sub>-N), 3.77 (s, 3H, 4-OCH<sub>3</sub>), 3.86 (d, 1H, <i>J</i> = 7 Hz, 4′), 4.02–4.10 (m, 1H, 5′), 4.07 (d, 1H, <i>J</i> = 4 Hz, oxazolidine), 4.52–4.59 (m, 3H, 14 and oxazolidine), 4.85 (br s, 1H, 14-OH), 4.93 (br s, 1H, 7), 5.27 (d, 1H, <i>J</i> = 5 Hz, 1′), 7.40 (d, 1H, <i>J</i> = 8 Hz, 3), 7.61 (d, 1H, <i>J</i> = 8 Hz, 1), 7.74 (t, 1H, <i>J</i> = 8 Hz, 2), 12.96 (s, 1H, phenolic OH), 13.85 (s, 1H, phenolic OH). The region containing the 3′ and N-CH<sub>2</sub>-N protons (3.28–3.42) falls partially underneath the HOD peak. However, it was temporarily resolved for the purposes of characterization by collecting NMR data at 35 °C. At this elevated temperature, no other changes were observed.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Enzymatic Release of Doxaz from Pentyl PABC-Doxaz</h3><div class="NLM_p">Pig liver esterase (PLE) as a lyophilized powder was purchased from Sigma (Milwaukee, WI) and dissolved in phosphate-buffered saline containing 25% glycerol (final concentration 9.38 mg of solid/mL). The solution was clarified by centrifugation at 10000<i>g</i> for 5 min at room temperature, and the supernatant was distributed into small aliquots and stored at −20 °C. The enzymatic activity of the enzyme solutions was quantified by reacting 5 volumes of enzyme solution (1, 2.5, 5, 10, and 20 μL) with 50 μM PPD<a onclick="showRef(event, 'ref35 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref35 ref41 ref42">(35, 41, 42)</a> in 95% PBS/5% DMSO (final volume 200 μL) at 37 °C. Samples of 50 μL were removed at various time points and the production of dox was assessed by HPLC. All reactions eventually proceeded to 100% conversion. Rates of the reaction were taken from the initial rates (<25% conversion), and 1 unit was defined as the amount of enzyme required to convert 1 μM PPD to dox per hour under these conditions. From this assay, the enzyme stock was calculated to contain 2100 units/μL, and this stock was used for subsequent experiments.</div><div class="NLM_p">To determine the cytotoxicity of PPD/PLE cotreatments, the cells were subjected to IC<sub>50</sub> experiments generally as described. Here, pig liver esterase was added to the medium in concentrations of 0, 0.05, 0.1, 0.5, 2.5, 5, and 10 units/mL, followed by PPD in various concentrations. All treatments were performed in complete RPMI medium and a final DMSO concentration of 1%. The cells were treated for 3 h, after which the IC<sub>50</sub> plates were treated identically to the growth inhibition experiments.</div><div class="NLM_p last">Experiments to determine the rates of enzymatic cleavage of PPD under cell culture conditions were conducted by HPLC. Given the limit of detection in the HPLC system, initial experiments were done to determine the lowest concentration of PPD that would give quality and reproducible kinetic measurements. In duplicate, PPD (10.0, 3.2, 1.0, and 0.5 μM) was reacted with 1 unit/mL PLE in complete RPMI medium at 37 °C. Aliquots were removed at 1 and 3 h, quenched by adding an equal volume of isopropyl alcohol, and analyzed by HPLC for formation of dox. The integration parameters were set to a height cutoff of 0.085 milliabsorbance units, which represents approximately 4 times the average baseline noise variation (±0.02 milliabsorbance units). Under these conditions, 1 μM PPD was determined to be the minimum reliable concentration. Therefore, duplicate experiments were performed in which 1 μM PPD was reacted with 1.0, 0.5, and 0.25 unit/mL PLE under the same conditions to determine whether reaction rates at this concentration fit well to a first-order kinetic model and, if so, which enzyme concentration corresponded to approximately 1 h half-life. Integrated peak areas for dox were converted to fractional conversion and plotted in GraphPad Prism 5.0, and the data were fit with a single-exponential model, which resulted in good fits (<i>R</i><sup>2</sup> ≥ 0.993) in all cases.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01956">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01956" class="ext-link">10.1021/acs.jmedchem.5b01956</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Cartoon of the comet assay, full statistical analysis of comet assay data, detailed discussion of the restriction digest, and four figures showing effect of drug treatment on both <i>Nde</i>I and <i>Not</i>I digestion of <i>Sma</i>I-linearized pcDNA3.1(−) and reaction progress versus time for both <i>Nde</i>I and <i>Not</i>I enzymatic digests (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (SMILES) for <b>1</b>–<b>13</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf">jm5b01956_si_001.pdf (1.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_002.csv">jm5b01956_si_002.csv (1.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01956" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tad H. Koch</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Colorado Boulder, Boulder, Colorado 80309, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#453124216b2e2a262d05262a292a3724212a6b202130"><span class="__cf_email__" data-cfemail="4e3a2f2a6025212d260e2d2122213c2f2a21602b2a3b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin L. Barthel</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Colorado Boulder, Boulder, Colorado 80309, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin L. Mooz</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Colorado Boulder, Boulder, Colorado 80309, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Elizabeth Wiener</span> - <span class="hlFld-Affiliation affiliation">Department
of Biostatistics, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary G. Koch</span> - <span class="hlFld-Affiliation affiliation">Department
of Biostatistics, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d52e2094-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Kristen Barthel and Leslie Leinwand for the gift of DH5α cells, as well as Jessica Podoll, Xiang Wang, Wei Wang, the High-Throughput Screening Core Facility at CU Boulder for the use of various pieces of equipment, and Richard Shoemaker for help with NMR. This work was supported by NIH Grants R21CA141101 and R21CA143549, a Bioscience Discovery and Evaluation Grant 11BGF-34 from University of Colorado Technology Transfer Office and the State of Colorado, a grant from the Colorado Center for Drug Discovery. E.L.M. thanks the University of Colorado Cancer Center and the Cancer League of Colorado for funding.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> Abbreviations Used</h2><tr><td class="NLM_term">ADR</td><td class="NLM_def"><p class="first last">NCI/ADR-RES cells</p></td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">combination index</p></td></tr><tr><td class="NLM_term">dau</td><td class="NLM_def"><p class="first last">daunorubicin</p></td></tr><tr><td class="NLM_term">dox</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">doxaz</td><td class="NLM_def"><p class="first last">doxazolidine</p></td></tr><tr><td class="NLM_term">doxF</td><td class="NLM_def"><p class="first last">doxoform</p></td></tr><tr><td class="NLM_term">doxSF</td><td class="NLM_def"><p class="first last">doxsaliform</p></td></tr><tr><td class="NLM_term">ida</td><td class="NLM_def"><p class="first last">idarubicin</p></td></tr><tr><td class="NLM_term">epi</td><td class="NLM_def"><p class="first last">epirubicin</p></td></tr><tr><td class="NLM_term">epiF</td><td class="NLM_def"><p class="first last">epiform</p></td></tr><tr><td class="NLM_term">form</td><td class="NLM_def"><p class="first last">formaldehyde</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibitory concentration 50%</p></td></tr><tr><td class="NLM_term">P170gp</td><td class="NLM_def"><p class="first last">P170 glycoprotein</p></td></tr><tr><td class="NLM_term">PPD</td><td class="NLM_def"><p class="first last">pentyl 4-(<i>N</i>-doxazolidinylcarbonyloxymethyl)phenylcarbamate or pentyl PABC-doxaz</p></td></tr><tr><td class="NLM_term">PLE</td><td class="NLM_def"><p class="first last">pig liver esterase</p></td></tr><tr><td class="NLM_term">SCGE</td><td class="NLM_def"><p class="first last">single-cell gel electrophoresis</p></td></tr><tr><td class="NLM_term">topo II</td><td class="NLM_def"><p class="first last">topoisomerase II</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Young, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span> </span><span class="NLM_article-title">The anthracycline antineoplastic drugs</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1056/NEJM198107163050305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1056%2FNEJM198107163050305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=7017406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL3MXkslartLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1981&pages=139-153&author=R.+C.+Youngauthor=R.+F.+Ozolsauthor=C.+E.+Myers&title=The+anthracycline+antineoplastic+drugs&doi=10.1056%2FNEJM198107163050305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The anthracycline antineoplastic drugs</span></div><div class="casAuthors">Young, Robert C.; Ozols, Robert F.; Myers, Charles E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">139-53</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A review with 166 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojq1MexPtSbrVg90H21EOLACvtfcHk0lhNHOWan6PBNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslartLs%253D&md5=30b792d8c6e1f9d391c520e9385f1f74</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM198107163050305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198107163050305%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BC.%26aulast%3DOzols%26aufirst%3DR.%2BF.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26atitle%3DThe%2520anthracycline%2520antineoplastic%2520drugs%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1981%26volume%3D305%26spage%3D139%26epage%3D153%26doi%3D10.1056%2FNEJM198107163050305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Sordet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, Q. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Apoptosis induced by topoisomerase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span><span class="refDoi"> DOI: 10.2174/1568011033482378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.2174%2F1568011033482378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12769773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Giu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=271-290&author=O.+Sordetauthor=Q.+A.+Khanauthor=K.+W.+Kohnauthor=Y.+Pommier&title=Apoptosis+induced+by+topoisomerase+inhibitors&doi=10.2174%2F1568011033482378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis induced by topoisomerase inhibitors</span></div><div class="casAuthors">Sordet, Olivier; Khan, Qasim A.; Kohn, Kurt W.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-290</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Topoisomerase inhibitors are among the most efficient inducers of apoptosis.  The main pathways leading from topoisomerase-mediated DNA damage to cell death involve activation of caspases in the cytoplasm by proapoptotic mols. released from mitochondria.  In some cells, apoptotic response also involves the death receptor Fas (APO-1/CD95).  The engagement of these apoptotic effector pathways is tightly controlled by upstream regulatory pathways that respond to DNA lesions-induced by topoisomerase inhibitors in cells undergoing apoptosis.  These include the proapoptotic Chk2, c-Abl and SAPK/JNK pathways, the survival PI(3)kinase-Akt-dependent pathway and the transcription factors p53 and NF-κB.  Initiation of cellular responses to DNA lesions-induced by topoisomerase inhibitors is ensured by the protein kinases DNA-PK, ATM and ATR, which bind to DNA breaks.  These kinases commonly called "DNA sensors" mediate their effects (DNA repair, cell cycle arrest and/or apoptosis) by phosphorylating a large no. of substrates, including several downstream kinases such as c-Abl and the checkpoint protein Chk2.  C-Abl induces apoptosis by activating cell death pathways (e.g., SAPK, p53 and p73) and inhibiting cell survival pathways [e.g., PI(3)kinase].  The DNA-damage regulating kinase Chk2, in addn. to its role in cell cycle arrest and/or DNA repair, can induce apoptosis by phosphorylation/activation of the promyelocytic leukemia (PML) protein and p53.  Finally, we will review the recent observations that support a role for topoisomerases in chromatin fragmentation during the execution phase of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKuE3P03H3HLVg90H21EOLACvtfcHk0lhNHOWan6PBNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Giu7g%253D&md5=1ec5acb3cab774a42ef88fff75d1aa7c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1568011033482378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011033482378%26sid%3Dliteratum%253Aachs%26aulast%3DSordet%26aufirst%3DO.%26aulast%3DKhan%26aufirst%3DQ.%2BA.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DApoptosis%2520induced%2520by%2520topoisomerase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2003%26volume%3D3%26spage%3D271%26epage%3D290%26doi%3D10.2174%2F1568011033482378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wilstermann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osheroff, N.</span><span> </span><span class="NLM_article-title">Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.2174/1568026033452519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.2174%2F1568026033452519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12570766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=321-338&author=A.+M.+Wilstermannauthor=N.+Osheroff&title=Stabilization+of+eukaryotic+topoisomerase+II-DNA+cleavage+complexes&doi=10.2174%2F1568026033452519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes</span></div><div class="casAuthors">Wilstermann, Amy M.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-338</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Topoisomerase II is an essential enzyme that plays crit. roles in many DNA processes, including chromosome segregation.  To carry out its important physiol. functions, topoisomerase II creates and rejoins double-stranded breaks in the genetic material.  Thus, while the enzyme is necessary for cell survival, it also has the capacity to fragment the genome.  Topoisomerase II-mediated DNA breaks are sequestered within a covalent enzyme-DNA complex.  Normally, these "cleavage complexes" are present at low levels and are tolerated by the cell.  However, conditions that significantly increase the physiol. concn. or life-time of topoisomerase II-DNA cleavage complexes lead to chromosomal translocations and other mutagenic events, and can induce cell death pathways.  The potentially lethal aspect of enzyme mechanism has been exploited by a no. of highly successful anticancer agents.  Since drugs that increase levels of topoisomerase II-DNA cleavage complexes transform the enzyme into a potent cellular toxin, they are referred to as topoisomerase II "poisons" to distinguish them from compds. that inhibit the catalytic activity of the enzyme.  Recent evidence indicates that many DNA lesions also act as topoisomerase II poisons.  This finding has provided tremendous insight into enzyme and drug action and raises important questions regarding the physiol. interactions of topoisomerase II with DNA damage.  Since the DNA cleavage and ligation reactions of topoisomerase II are fundamental to its physiol. and pharmacol. functions, this review will focus on how the enzyme cuts and rejoins the double helix and how these reactions are altered by topoisomerase II poisons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3iQkF9Pd2rVg90H21EOLACvtfcHk0lhNHOWan6PBNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksw%253D%253D&md5=fc0730783cab33ea45203e215aa6e7d1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026033452519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452519%26sid%3Dliteratum%253Aachs%26aulast%3DWilstermann%26aufirst%3DA.%2BM.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DStabilization%2520of%2520eukaryotic%2520topoisomerase%2520II-DNA%2520cleavage%2520complexes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D321%26epage%3D338%26doi%3D10.2174%2F1568026033452519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Larsen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escargueil, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skladanowski, A.</span><span> </span><span class="NLM_article-title">Catalytic topoisomerase II inhibitors in cancer therapy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/S0163-7258(03)00058-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2FS0163-7258%2803%2900058-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12888111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVWhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=167-181&author=A.+K.+Larsenauthor=A.+E.+Escargueilauthor=A.+Skladanowski&title=Catalytic+topoisomerase+II+inhibitors+in+cancer+therapy&doi=10.1016%2FS0163-7258%2803%2900058-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic topoisomerase II inhibitors in cancer therapy</span></div><div class="casAuthors">Larsen, Annette K.; Escargueil, Alexandre E.; Skladanowski, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-181</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The nuclear enzyme DNA topoisomerase II is a major target for antineoplastic agents.  All topoisomerase II-directed agents are able to interfere with at least one step of the catalytic cycle.  Agents able to stabilize the covalent DNA topoisomerase II complex (also known as the cleavable complex) are traditionally called topoisomerase II poisons, while agents acting on any of the other steps in the catalytic cycle are called catalytic inhibitors.  Thus, catalytic topoisomerase II inhibitors are a heterogeneous group of compds. that might interfere with the binding between DNA and topoisomerase II (aclarubicin and suramin), stabilize noncovalent DNA topoisomerase II complexes (merbarone, ICRF-187, and structurally related bisdioxopiperazine derivs.), or inhibit ATP binding (novobiocin).  Some, such as fostriecin, may also have alternative biol. targets.  Whereas topoisomerase II poisons are used solely for their antitumor activities, catalytic inhibitors are utilized for a variety of reasons, including their activity as antineoplastic agents (aclarubicin and MST-16), cardioprotectors (ICRF-187), or modulators in order to increase the efficacy of other agents (suramin and novobiocin).  In this review, the mechanism and biol. activity of different catalytic inhibitors is described, with emphasis on therapeutically used compds.  We will then discuss future development and applications of this interesting class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGote2bOTWP17bVg90H21EOLACvtfcHk0li7ez5opzbFwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVWhtL0%253D&md5=4207fb899e2b98345f97e91983514913</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900058-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900058-5%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BK.%26aulast%3DEscargueil%26aufirst%3DA.%2BE.%26aulast%3DSkladanowski%26aufirst%3DA.%26atitle%3DCatalytic%2520topoisomerase%2520II%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D99%26spage%3D167%26epage%3D181%26doi%3D10.1016%2FS0163-7258%2803%2900058-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Goormaghtigh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasseur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruysschaert, J. M.</span><span> </span><span class="NLM_article-title">Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity</span> <span class="citation_source-journal">Biophys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1016/0301-4622(90)80012-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0301-4622%2890%2980012-V" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1990&pages=247-257&author=E.+Goormaghtighauthor=P.+Huartauthor=M.+Praetauthor=R.+Brasseurauthor=J.+M.+Ruysschaert&title=Structure+of+the+adriamycin-cardiolipin+complex.+Role+in+mitochondrial+toxicity&doi=10.1016%2F0301-4622%2890%2980012-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0301-4622%2890%2980012-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-4622%252890%252980012-V%26sid%3Dliteratum%253Aachs%26aulast%3DGoormaghtigh%26aufirst%3DE.%26aulast%3DHuart%26aufirst%3DP.%26aulast%3DPraet%26aufirst%3DM.%26aulast%3DBrasseur%26aufirst%3DR.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520of%2520the%2520adriamycin-cardiolipin%2520complex.%2520Role%2520in%2520mitochondrial%2520toxicity%26jtitle%3DBiophys.%2520Chem.%26date%3D1990%26volume%3D35%26spage%3D247%26epage%3D257%26doi%3D10.1016%2F0301-4622%2890%2980012-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Keizer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinedo, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurhuis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joenje, H.</span><span> </span><span class="NLM_article-title">Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/0163-7258(90)90088-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0163-7258%2890%2990088-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=2203071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=219-231&author=H.+G.+Keizerauthor=H.+M.+Pinedoauthor=G.+J.+Schuurhuisauthor=H.+Joenje&title=Doxorubicin+%28adriamycin%29%3A+a+critical+review+of+free+radical-dependent+mechanisms+of+cytotoxicity&doi=10.1016%2F0163-7258%2890%2990088-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin (adriamycin):  a critical review of free radical-dependent mechanisms of cytotoxicity</span></div><div class="casAuthors">Keizer, H. G.; Pinedo, H. M.; Schuurhuis, G. J.; Joenje, H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-31</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼130 refs.  The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered crit. for its antitumor action.  However, for most tumor cell lines, this mechanism of cytotoxicity does not appear to play a major role.  Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh7SgS1hAtL7Vg90H21EOLACvtfcHk0li7ez5opzbFwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D&md5=4dd568ea3172c73030b58b6822f9477f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2890%2990088-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252890%252990088-J%26sid%3Dliteratum%253Aachs%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DSchuurhuis%26aufirst%3DG.%2BJ.%26aulast%3DJoenje%26aufirst%3DH.%26atitle%3DDoxorubicin%2520%2528adriamycin%2529%253A%2520a%2520critical%2520review%2520of%2520free%2520radical-dependent%2520mechanisms%2520of%2520cytotoxicity%26jtitle%3DPharmacol.%2520Ther.%26date%3D1990%26volume%3D47%26spage%3D219%26epage%3D231%26doi%3D10.1016%2F0163-7258%2890%2990088-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Maestre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffrezou, J. P.</span><span> </span><span class="NLM_article-title">Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2558</span><span class="NLM_x">–</span> <span class="NLM_lpage">2561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2558-2561&author=N.+Maestreauthor=T.+R.+Trittonauthor=G.+Laurentauthor=J.+P.+Jaffrezou&title=Cell+surface-directed+interaction+of+anthracyclines+leads+to+cytotoxicity+and+nuclear+factor+kappaB+activation+but+not+apoptosis+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaestre%26aufirst%3DN.%26aulast%3DTritton%26aufirst%3DT.%2BR.%26aulast%3DLaurent%26aufirst%3DG.%26aulast%3DJaffrezou%26aufirst%3DJ.%2BP.%26atitle%3DCell%2520surface-directed%2520interaction%2520of%2520anthracyclines%2520leads%2520to%2520cytotoxicity%2520and%2520nuclear%2520factor%2520kappaB%2520activation%2520but%2520not%2520apoptosis%2520signaling%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2558%26epage%3D2561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velds, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groothuis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huijgens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neefjes, J.</span><span> </span><span class="NLM_article-title">Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="refDoi"> DOI: 10.1038/ncomms2921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1038%2Fncomms2921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=23715267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A280%3ADC%252BC3snnsFWqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1908&author=B.+Pangauthor=X.+Qiaoauthor=L.+Janssenauthor=A.+Veldsauthor=T.+Groothuisauthor=R.+Kerkhovenauthor=M.+Nieuwlandauthor=H.+Ovaaauthor=S.+Rottenbergauthor=O.+van+Tellingenauthor=J.+Janssenauthor=P.+Huijgensauthor=W.+Zwartauthor=J.+Neefjes&title=Drug-induced+histone+eviction+from+open+chromatin+contributes+to+the+chemotherapeutic+effects+of+doxorubicin&doi=10.1038%2Fncomms2921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin</span></div><div class="casAuthors">Pang Baoxu; Qiao Xiaohang; Janssen Lennert; Velds Arno; Groothuis Tom; Kerkhoven Ron; Nieuwland Marja; Ovaa Huib; Rottenberg Sven; van Tellingen Olaf; Janssen Jeroen; Huijgens Peter; Zwart Wilbert; Neefjes Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1908</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DNA topoisomerase II inhibitors are a major class of cancer chemotherapeutics, which are thought to eliminate cancer cells by inducing DNA double-strand breaks.  Here we identify a novel activity for the anthracycline class of DNA topoisomerase II inhibitors: histone eviction from open chromosomal areas.  We show that anthracyclines promote histone eviction irrespective of their ability to induce DNA double-strand breaks.  The histone variant H2AX, which is a key component of the DNA damage response, is also evicted by anthracyclines, and H2AX eviction is associated with attenuated DNA repair.  Histone eviction deregulates the transcriptome in cancer cells and organs such as the heart, and can drive apoptosis of topoisomerase-negative acute myeloid leukaemia blasts in patients.  We define a novel mechanism of action of anthracycline anticancer drugs doxorubicin and daunorubicin on chromatin biology, with important consequences for DNA damage responses, epigenetics, transcription, side effects and cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7JMlDyqgCydy3lHz94U-GfW6udTcc2ea6oqjoE6K8DLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snnsFWqsw%253D%253D&md5=035068cc31bb3817945d8b407d5ff89f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fncomms2921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2921%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DB.%26aulast%3DQiao%26aufirst%3DX.%26aulast%3DJanssen%26aufirst%3DL.%26aulast%3DVelds%26aufirst%3DA.%26aulast%3DGroothuis%26aufirst%3DT.%26aulast%3DKerkhoven%26aufirst%3DR.%26aulast%3DNieuwland%26aufirst%3DM.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DRottenberg%26aufirst%3DS.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DJanssen%26aufirst%3DJ.%26aulast%3DHuijgens%26aufirst%3DP.%26aulast%3DZwart%26aufirst%3DW.%26aulast%3DNeefjes%26aufirst%3DJ.%26atitle%3DDrug-induced%2520histone%2520eviction%2520from%2520open%2520chromatin%2520contributes%2520to%2520the%2520chemotherapeutic%2520effects%2520of%2520doxorubicin%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1908%26doi%3D10.1038%2Fncomms2921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Olson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mushlin, P. S.</span><span> </span><span class="NLM_article-title">Doxorubicin cardiotoxicity: analyses of prevailing hypotheses</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=3076-3086&author=R.+D.+Olsonauthor=P.+S.+Mushlin&title=Doxorubicin+cardiotoxicity%3A+analyses+of+prevailing+hypotheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DR.%2BD.%26aulast%3DMushlin%26aufirst%3DP.%2BS.%26atitle%3DDoxorubicin%2520cardiotoxicity%253A%2520analyses%2520of%2520prevailing%2520hypotheses%26jtitle%3DFASEB%2520J.%26date%3D1990%26volume%3D4%26spage%3D3076%26epage%3D3086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Weiss, R. B.</span><span> </span><span class="NLM_article-title">The anthracyclines: will we ever find a better doxorubicin?</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1462166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1992&pages=670-686&author=R.+B.+Weiss&title=The+anthracyclines%3A+will+we+ever+find+a+better+doxorubicin%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The anthracyclines:  will we even find a better doxorubicin?</span></div><div class="casAuthors">Weiss, Raymond B.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">670-86</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">A review with 105 refs.  The anthracyclines are the class of antitumor drugs with the widest spectrum of activity in human cancers, and only a few cancers (eg., colon cancer) are unresponsive to them.  The first two anthracyclines were developed in the 1960s.  Doxorubicin (DOX) differs from daunorubicin (DNR) only by a single hydroxyl group.  This fact has spurred researchers worldwide to find analogs of DOX that have less acute toxicity, cause less cardiomyopathy, can be administered orally, and/or have different, or greater, antitumor efficacy.  Five DOX/DNR analogs are marketed in other countries, and one (idarubicin) is available in the United States.  None of these analogs have stronger antitumor efficacy than the original two anthracycline, but there are some differences in toxicity.  Methods have been fashioned to keep the peak plasma level of DOX muted to minimize cardiotoxicity, but the only apparently effective method available so far (prolonged drug infusion) is cumbersome.  The bisoxopiperazine class of drugs (esp. dexrazoxane) provides protection against anthracycline-induced cardiomyopathy and has much promise for helping mitigate this major obstacle to prolonged use of the anthracyclines.  The DOX analogs being evaluated in the 1990s have been selected for their ability to overcome multidrug resistance in cancer cells.  Thirty years after discovery of the anticancer activity of the first anthracycline, some means of reducing anthracycline toxicity have been devised.  Current studies are evaluating increased doses of epirubicin to improve anthracycline cytotoxicity, while limiting cardiotoxicity, but at present DOX still reigns in this drug class as the one having the most proven cancerocidal effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs1ERdJDycw7Vg90H21EOLACvtfcHk0lg3IxlhqbVwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2jsbo%253D&md5=62df8a9f6a9bb52567b34c90c677dd26</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DR.%2BB.%26atitle%3DThe%2520anthracyclines%253A%2520will%2520we%2520ever%2520find%2520a%2520better%2520doxorubicin%253F%26jtitle%3DSemin.%2520Oncol.%26date%3D1992%26volume%3D19%26spage%3D670%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Julka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, K. D.</span><span> </span><span class="NLM_article-title">A possible mechanism for adriamycin induced cardiotoxicity</span> <span class="citation_source-journal">Indian J. Exp. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1994&pages=146-148&author=D.+Julkaauthor=S.+Sarinauthor=K.+D.+Gill&title=A+possible+mechanism+for+adriamycin+induced+cardiotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJulka%26aufirst%3DD.%26aulast%3DSarin%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DK.%2BD.%26atitle%3DA%2520possible%2520mechanism%2520for%2520adriamycin%2520induced%2520cardiotoxicity%26jtitle%3DIndian%2520J.%2520Exp.%2520Biol.%26date%3D1994%26volume%3D32%26spage%3D146%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kartner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span><span class="refDoi"> DOI: 10.1126/science.6137059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1126%2Fscience.6137059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=6137059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL3sXlsFWku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1983&pages=1285-1288&author=N.+Kartnerauthor=J.+R.+Riordanauthor=V.+Ling&title=Cell+surface+P-glycoprotein+associated+with+multidrug+resistance+in+mammalian+cell+lines&doi=10.1126%2Fscience.6137059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines</span></div><div class="casAuthors">Kartner, Norbert; Riordan, John R.; Ling, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">4617</span>),
    <span class="NLM_cas:pages">1285-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The plasma membranes of hamster, mouse, and human tumor cell lines that display multiple resistance to drugs were examd. by gel electrophoresis and immunoblotting.  In every case, increased expression of a 170,000-dalton surface antigen was found to be correlated with multidrug resistance.  This membrane component is of identical mol. size and shares some immunogenic homol. with the previously characterized P-glycoprotein of colchicine-resistant Chinese hamster ovary cells.  This finding may have application to cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGxMo45kJlOLVg90H21EOLACvtfcHk0lhEBR4rxguNCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlsFWku7c%253D&md5=36b4cbc533fedb47e14ae9cc064682e3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.6137059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6137059%26sid%3Dliteratum%253Aachs%26aulast%3DKartner%26aufirst%3DN.%26aulast%3DRiordan%26aufirst%3DJ.%2BR.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DCell%2520surface%2520P-glycoprotein%2520associated%2520with%2520multidrug%2520resistance%2520in%2520mammalian%2520cell%2520lines%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1983%26volume%3D221%26spage%3D1285%26epage%3D1288%26doi%3D10.1126%2Fscience.6137059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kartner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer</span> <span class="citation_source-journal">Sci. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1038/scientificamerican0389-44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1038%2Fscientificamerican0389-44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=2564696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL1MXhsVKqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1989&pages=44-51&author=N.+Kartnerauthor=V.+Ling&title=Multidrug+resistance+in+cancer&doi=10.1038%2Fscientificamerican0389-44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer</span></div><div class="casAuthors">Kartner, Norbert; Ling, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Scientific American</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">44-51</span>CODEN:
                <span class="NLM_cas:coden">SCAMAC</span>;
        ISSN:<span class="NLM_cas:issn">0036-8733</span>.
    </div><div class="casAbstract">A review with 4 refs. of historical perspectives in the study of the mol. mechanism of cancer cell multidrug resistance.  The discovery of P-glycoprotein, its function as a pump protein which removes toxins from the cells, and its implications for therapeutic strategies are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8IUyZ73wjLVg90H21EOLACvtfcHk0lhEBR4rxguNCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsVKqt74%253D&md5=5be9d9b59a2c9918636e1f2ef17147a4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fscientificamerican0389-44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fscientificamerican0389-44%26sid%3Dliteratum%253Aachs%26aulast%3DKartner%26aufirst%3DN.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%26jtitle%3DSci.%2520Am.%26date%3D1989%26volume%3D260%26spage%3D44%26epage%3D51%26doi%3D10.1038%2Fscientificamerican0389-44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nielsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovsgaard, T.</span><span> </span><span class="NLM_article-title">Cellular resistance to anthracyclines</span> <span class="citation_source-journal">Gen. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/0306-3623(95)02013-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0306-3623%2895%2902013-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=8919638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK28XisVKgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=251-255&author=D.+Nielsenauthor=C.+Maareauthor=T.+Skovsgaard&title=Cellular+resistance+to+anthracyclines&doi=10.1016%2F0306-3623%2895%2902013-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular resistance to anthracyclines</span></div><div class="casAuthors">Nielsen, Dorte; Maare, Christian; Skovsgaard, Torben</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-5</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 30 refs.  The antracyclines induce multiple intracellular effects; however, inhibition of the nuclear enzyme topoisomerase II (TOPO II) is the main mechanisms of action.  Resistance to anthracyclines in tumor cells is multifactorial.  The main mechanisms are: (1) the classic multidrug resistance (MDR) phenotype, which is due to the presence of P-glycoprotein (PGP) in plasma membrane, i.e., a "pump" that can extrude a wide range of anticaner drugs.  Membrane-active drugs (e.g., verapamil) have been found in vitro to reverse this phenotype.  Most clin. studies including chemosensitizers have, however, been disappointing.  (2) Non-PGP-mediated MDR: this phenotype is characterized by expression of other proteins in the plasma membrane which are also able to extrude anticancer drugs.  (3) Changes in the intracellular distribution of drug: this mechanism has been demonstrated in several cell lines, most often in combination with PGP or non-PGP-mediated resistance.  (4) Glutathione transferases (GST) and detoxification mechanisms: these represent a multigene family of enzymes that conjugate glutathione to chem. reactive groups.  Direct evidence for a causative role of GST in antracycline resistance is missing.  (5) Alterations in TOPO II (at-MDR): DNA topoisomerases are involved in several aspects of DNA metab., in particular genetic recombination, DNA transcription , and chromosome segregation.  Low levels of expression or alterations in TOPO II are assocd. in vitro with resistance.  (5) Alterations in TOPO II (at-MDR): DNA topoisomerases are involved in several aspects of DNA metab., in particular genetic recombinations, DNA transcription, and chromosome segregation.  Low levels of expression or alterations in TOPO II are assocd. in vitro with resistance.  (6) Increased DNA repair: in several cell lines, an increase in the efficacy of DNA repair has been assocd. with resistance to doxorubicin (DOX).  So far, only classic MDR has been shown to contribute to resistance in clin. conditions, whereas evidence for the other mechanisms of resistance is still missing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVm6blGZnXu7Vg90H21EOLACvtfcHk0ljgiUXOTQZtRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVKgtrc%253D&md5=24b13b0dcd7f0e9dcf3a30013de091be</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2895%2902013-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252895%252902013-6%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DD.%26aulast%3DMaare%26aufirst%3DC.%26aulast%3DSkovsgaard%26aufirst%3DT.%26atitle%3DCellular%2520resistance%2520to%2520anthracyclines%26jtitle%3DGen.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D251%26epage%3D255%26doi%3D10.1016%2F0306-3623%2895%2902013-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Post, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagadorn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7648</span><span class="NLM_x">–</span> <span class="NLM_lpage">7657</span><span class="refDoi"> DOI: 10.1021/jm050678v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050678v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOisL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7648-7657&author=G.+C.+Postauthor=B.+L.+Barthelauthor=D.+J.+Burkhartauthor=J.+R.+Hagadornauthor=T.+H.+Koch&title=Doxazolidine%2C+a+proposed+active+metabolite+of+doxorubicin+that+cross-links+DNA&doi=10.1021%2Fjm050678v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Doxazolidine, a Proposed Active Metabolite of Doxorubicin That Cross-links DNA</span></div><div class="casAuthors">Post, Glen C.; Barthel, Benjamin L.; Burkhart, David J.; Hagadorn, John R.; Koch, Tad H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7648-7657</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A crystal structure establishes doxoform as a dimeric formaldehyde conjugate of the oxazolidine of doxorubicin.  Doxoform is a prodrug of doxazolidine, a monomeric doxorubicin formaldehyde-oxazolidine.  Both doxoform and doxazolidine inhibit the growth of cancer cells at 1-4 orders of magnitude lower concn. than doxorubicin.  They also inhibit the growth of cancer cells better than doxsaliform, a prodrug for an acyclic doxorubicin-formaldehyde conjugate.  Doxoform rapidly hydrolyzes to doxazolidine, which then hydrolyzes to doxorubicin with a half-life of 3 min in human serum at 37 °C.  Both doxoform and doxazolidine are taken up by multidrug-resistant MCF-7/Adr cells 3- to 4-fold better than doxorubicin.  A mol. model suggests that doxazolidine can cross-link DNA by direct reaction with a G-base in a tautomeric form with synchronous ring opening of the oxazolidine.  These results point to doxoform being a prodrug for doxazolidine that is the reactive species that directly cross-links DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLpgrk9qR0drVg90H21EOLACvtfcHk0ljGdBWxMKZwjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOisL3P&md5=a169e59558dcb2bd3eb775c004ff7f91</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm050678v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050678v%26sid%3Dliteratum%253Aachs%26aulast%3DPost%26aufirst%3DG.%2BC.%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DBurkhart%26aufirst%3DD.%2BJ.%26aulast%3DHagadorn%26aufirst%3DJ.%2BR.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxazolidine%252C%2520a%2520proposed%2520active%2520metabolite%2520of%2520doxorubicin%2520that%2520cross-links%2520DNA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7648%26epage%3D7657%26doi%3D10.1021%2Fjm050678v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kalet, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBryde, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4493</span><span class="NLM_x">–</span> <span class="NLM_lpage">4500</span><span class="refDoi"> DOI: 10.1021/jm070569b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070569b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4493-4500&author=B.+T.+Kaletauthor=M.+B.+McBrydeauthor=J.+M.+Espinosaauthor=T.+H.+Koch&title=Doxazolidine+induction+of+apoptosis+by+a+topoisomerase+II+independent+mechanism&doi=10.1021%2Fjm070569b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm070569b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070569b%26sid%3Dliteratum%253Aachs%26aulast%3DKalet%26aufirst%3DB.%2BT.%26aulast%3DMcBryde%26aufirst%3DM.%2BB.%26aulast%3DEspinosa%26aufirst%3DJ.%2BM.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxazolidine%2520induction%2520of%2520apoptosis%2520by%2520a%2520topoisomerase%2520II%2520independent%2520mechanism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4493%26epage%3D4500%26doi%3D10.1021%2Fjm070569b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fenick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2461</span><span class="refDoi"> DOI: 10.1021/jm970237e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970237e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2452-2461&author=D.+J.+Fenickauthor=D.+J.+Taatjesauthor=T.+H.+Koch&title=Doxoform+and+Daunoform%3A+anthracycline-formaldehyde+conjugates+toxic+to+resistant+tumor+cells&doi=10.1021%2Fjm970237e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm970237e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970237e%26sid%3Dliteratum%253Aachs%26aulast%3DFenick%26aufirst%3DD.%2BJ.%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxoform%2520and%2520Daunoform%253A%2520anthracycline-formaldehyde%2520conjugates%2520toxic%2520to%2520resistant%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2452%26epage%3D2461%26doi%3D10.1021%2Fjm970237e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Crabb, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. O.</span><span> </span><span class="NLM_article-title">The Reaction of trans-2-Aminocyclohexanol with Formaldehyde</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1002/jhet.5570040201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1002%2Fjhet.5570040201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1967&pages=169-170&author=T.+A.+Crabbauthor=R.+O.+Williams&title=The+Reaction+of+trans-2-Aminocyclohexanol+with+Formaldehyde&doi=10.1002%2Fjhet.5570040201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570040201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570040201%26sid%3Dliteratum%253Aachs%26aulast%3DCrabb%26aufirst%3DT.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26atitle%3DThe%2520Reaction%2520of%2520trans-2-Aminocyclohexanol%2520with%2520Formaldehyde%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1967%26volume%3D4%26spage%3D169%26epage%3D170%26doi%3D10.1002%2Fjhet.5570040201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Barkworth, P. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crabb, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, P.</span><span> </span><span class="NLM_article-title">Compounds with Bridgehead Nitrogen. Part 47. The Reaction between trans-1-Aminobenzocycloalkan-2-ols and Formaldehyde</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_fpage">2807</span><span class="NLM_x">–</span> <span class="NLM_lpage">2810</span><span class="refDoi"> DOI: 10.1039/p19830002807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1039%2Fp19830002807" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=2807-2810&author=P.+M.+R.+Barkworthauthor=T.+A.+Crabbauthor=P.+Robinson&title=Compounds+with+Bridgehead+Nitrogen.+Part+47.+The+Reaction+between+trans-1-Aminobenzocycloalkan-2-ols+and+Formaldehyde&doi=10.1039%2Fp19830002807"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2Fp19830002807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19830002807%26sid%3Dliteratum%253Aachs%26aulast%3DBarkworth%26aufirst%3DP.%2BM.%2BR.%26aulast%3DCrabb%26aufirst%3DT.%2BA.%26aulast%3DRobinson%26aufirst%3DP.%26atitle%3DCompounds%2520with%2520Bridgehead%2520Nitrogen.%2520Part%252047.%2520The%2520Reaction%2520between%2520trans-1-Aminobenzocycloalkan-2-ols%2520and%2520Formaldehyde%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1983%26spage%3D2807%26epage%3D2810%26doi%3D10.1039%2Fp19830002807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1314</span><span class="refDoi"> DOI: 10.1021/jm970739s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970739s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1306-1314&author=D.+J.+Taatjesauthor=D.+J.+Fenickauthor=T.+H.+Koch&title=Epidoxoform%3A+a+hydrolytically+more+stable+anthracycline-formaldehyde+conjugate+toxic+to+resistant+tumor+cells&doi=10.1021%2Fjm970739s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm970739s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970739s%26sid%3Dliteratum%253Aachs%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DFenick%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DEpidoxoform%253A%2520a%2520hydrolytically%2520more%2520stable%2520anthracycline-formaldehyde%2520conjugate%2520toxic%2520to%2520resistant%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1306%26epage%3D1314%26doi%3D10.1021%2Fjm970739s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.-g.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Marel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Boom, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.-J.</span><span> </span><span class="NLM_article-title">Simultaneous incorporations of two anticancer drugs into DNA. The structures of formaldehyde-cross-linked adducts of daunorubicin-d(CG(araC)GCG) and doxorubicin-d(CA(araC)GTG) complexes at high resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">10095</span><span class="NLM_x">–</span> <span class="NLM_lpage">10101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=10095-10101&author=H.+Zhangauthor=Y.-g.+Gaoauthor=G.+A.+van+der+Marelauthor=J.+H.+van+Boomauthor=A.+H.-J.+Wang&title=Simultaneous+incorporations+of+two+anticancer+drugs+into+DNA.+The+structures+of+formaldehyde-cross-linked+adducts+of+daunorubicin-d%28CG%28araC%29GCG%29+and+doxorubicin-d%28CA%28araC%29GTG%29+complexes+at+high+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DY.-g.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3Dvan%2BBoom%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DA.%2BH.-J.%26atitle%3DSimultaneous%2520incorporations%2520of%2520two%2520anticancer%2520drugs%2520into%2520DNA.%2520The%2520structures%2520of%2520formaldehyde-cross-linked%2520adducts%2520of%2520daunorubicin-d%2528CG%2528araC%2529GCG%2529%2520and%2520doxorubicin-d%2528CA%2528araC%2529GTG%2529%2520complexes%2520at%2520high%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D10095%26epage%3D10101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rephaeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Sequence specificity of adriamycin-DNA adducts in human tumor cells</span> <span class="citation_source-journal">Mol. Cancer Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12883039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=661-670&author=S.+M.+Cuttsauthor=L.+P.+Swiftauthor=A.+Rephaeliauthor=A.+Nudelmanauthor=D.+R.+Phillips&title=Sequence+specificity+of+adriamycin-DNA+adducts+in+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence specificity of adriamycin-DNA adducts in human tumor cells</span></div><div class="casAuthors">Cutts, Suzanne M.; Swift, Lonnie P.; Rephaeli, Ada; Nudelman, Abraham; Phillips, Don R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-670</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The anticancer anthracycline compd. Adriamycin is a known topoisomerase II inhibitor but is also capable of exerting other cellular consequences.  After intercalation, Adriamycin can form covalent adducts with DNA, and the magnitude of these adducts appears to be limited by the cellular availability of formaldehyde.  Adducts produced by Adriamycin in the presence of formaldehyde have been well characterized in cell-free systems but not in cells.  In this study, we show that when Adriamycin is used in conjunction with the formaldehyde-releasing prodrug AN-9 in IMR-32 tumor cells, this allows the formation of sufficiently high levels of adducts in genomic DNA to enable detection of their DNA sequence specificity for the first time.  The 340-bp α-satellite EcoRI repeat sequence was isolated from drug-treated cells and digested with λ-exonuclease to det. adduct sites at which exonuclease digestion was blocked.  The Adriamycin adducts were formed predominantly at 5'-GC and GG sequences and unstable with respect to elevated temps. and extended times at 37°.  The use of three anthracycline derivs. lacking a 3'amino group demonstrated that this amino portion is crit. for the formation of anthracycline adducts in cells.  The structure of these drug-DNA adducts can therefore be considered to be identical to the Adriamycin adducts, which have been characterized rigorously in cell-free systems by x-ray crystallog., two-dimensional NMR, and mass spectrometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhW8JtuTHzLVg90H21EOLACvtfcHk0liP-HEDsAd20Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFGktrw%253D&md5=91077435f5095086a18025692c0b79a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DSwift%26aufirst%3DL.%2BP.%26aulast%3DRephaeli%26aufirst%3DA.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DSequence%2520specificity%2520of%2520adriamycin-DNA%2520adducts%2520in%2520human%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther%26date%3D2003%26volume%3D2%26spage%3D661%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. K.</span><span> </span><span class="NLM_article-title">Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3812</span><span class="NLM_x">–</span> <span class="NLM_lpage">3815</span><span class="refDoi"> DOI: 10.1021/bi00230a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00230a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=3812-3815&author=A.+H.+Wangauthor=Y.+G.+Gaoauthor=Y.+C.+Liawauthor=Y.+K.+Li&title=Formaldehyde+cross-links+daunorubicin+and+DNA+efficiently%3A+HPLC+and+X-ray+diffraction+studies&doi=10.1021%2Fbi00230a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi00230a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00230a002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DA.%2BH.%26aulast%3DGao%26aufirst%3DY.%2BG.%26aulast%3DLiaw%26aufirst%3DY.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BK.%26atitle%3DFormaldehyde%2520cross-links%2520daunorubicin%2520and%2520DNA%2520efficiently%253A%2520HPLC%2520and%2520X-ray%2520diffraction%2520studies%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26spage%3D3812%26epage%3D3815%26doi%3D10.1021%2Fbi00230a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Podell, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Crystal structure of epidoxorubicin-formaldehyde virtual crosslink of DNA and evidence for its formation in human breast-cancer cells</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1516</span><span class="NLM_x">–</span> <span class="NLM_lpage">1523</span><span class="refDoi"> DOI: 10.1107/S0907444999008161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1107%2FS0907444999008161" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=1516-1523&author=E.+R.+Podellauthor=D.+J.+Harringtonauthor=D.+J.+Taatjesauthor=T.+H.+Koch&title=Crystal+structure+of+epidoxorubicin-formaldehyde+virtual+crosslink+of+DNA+and+evidence+for+its+formation+in+human+breast-cancer+cells&doi=10.1107%2FS0907444999008161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0907444999008161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444999008161%26sid%3Dliteratum%253Aachs%26aulast%3DPodell%26aufirst%3DE.%2BR.%26aulast%3DHarrington%26aufirst%3DD.%2BJ.%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520epidoxorubicin-formaldehyde%2520virtual%2520crosslink%2520of%2520DNA%2520and%2520evidence%2520for%2520its%2520formation%2520in%2520human%2520breast-cancer%2520cells%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1999%26volume%3D55%26spage%3D1516%26epage%3D1523%26doi%3D10.1107%2FS0907444999008161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Forrest, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evison, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rephaeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutts, S. M.</span><span> </span><span class="NLM_article-title">The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1007/s00280-012-2049-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1007%2Fs00280-012-2049-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=23263186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Wmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=809-816&author=R.+A.+Forrestauthor=L.+P.+Swiftauthor=B.+J.+Evisonauthor=A.+Rephaeliauthor=A.+Nudelmanauthor=D.+R.+Phillipsauthor=S.+M.+Cutts&title=The+hydroxyl+epimer+of+doxorubicin+controls+the+rate+of+formation+of+cytotoxic+anthracycline-DNA+adducts&doi=10.1007%2Fs00280-012-2049-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts</span></div><div class="casAuthors">Forrest, Robert A.; Swift, Lonnie P.; Evison, Benny J.; Rephaeli, Ada; Nudelman, Abraham; Phillips, Don R.; Cutts, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">809-816</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Epirubicin was developed as a semi-synthetic anthracycline deriv. to circumvent the cardiotoxic limitations assocd. with the use of doxorubicin in the clinic.  Anthracycline compds. have been demonstrated to form covalent drug-DNA adducts utilizing endogenous and exogenous sources of formaldehyde; however, previous investigations of the formation of epirubicin-DNA adducts provide conflicting evidence for adduct formation.  This work provides evidence that epirubicin acts to form drug-DNA adducts at physiol. relevant concns. and demonstrates that the rate of formation of epirubicin-DNA adducts is slower than that obsd. for other anthracycline compds., explaining why they are only detectable under defined exptl. conditions.  Formation of covalent epirubicin-DNA adducts improves the apoptotic profile of epirubicin and provides opportunities to overcome drug resistance and cardiotoxic limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra55L5WAn6v7Vg90H21EOLACvtfcHk0liBOf4FqDSZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Wmt70%253D&md5=596311d7af909b6b6a907591aeae6cd7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00280-012-2049-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-012-2049-x%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DR.%2BA.%26aulast%3DSwift%26aufirst%3DL.%2BP.%26aulast%3DEvison%26aufirst%3DB.%2BJ.%26aulast%3DRephaeli%26aufirst%3DA.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DCutts%26aufirst%3DS.%2BM.%26atitle%3DThe%2520hydroxyl%2520epimer%2520of%2520doxorubicin%2520controls%2520the%2520rate%2520of%2520formation%2520of%2520cytotoxic%2520anthracycline-DNA%2520adducts%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D71%26spage%3D809%26epage%3D816%26doi%3D10.1007%2Fs00280-012-2049-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Coldwell, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ognibene, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">e100</span><span class="refDoi"> DOI: 10.1093/nar/gkn439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1093%2Fnar%2Fgkn439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=e100&author=K.+E.+Coldwellauthor=S.+M.+Cuttsauthor=T.+J.+Ognibeneauthor=P.+T.+Hendersonauthor=D.+R.+Phillips&title=Detection+of+Adriamycin-DNA+adducts+by+accelerator+mass+spectrometry+at+clinically+relevant+Adriamycin+concentrations&doi=10.1093%2Fnar%2Fgkn439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn439%26sid%3Dliteratum%253Aachs%26aulast%3DColdwell%26aufirst%3DK.%2BE.%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DOgnibene%26aufirst%3DT.%2BJ.%26aulast%3DHenderson%26aufirst%3DP.%2BT.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DDetection%2520of%2520Adriamycin-DNA%2520adducts%2520by%2520accelerator%2520mass%2520spectrometry%2520at%2520clinically%2520relevant%2520Adriamycin%2520concentrations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3De100%26doi%3D10.1093%2Fnar%2Fgkn439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudiano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4138</span><span class="refDoi"> DOI: 10.1021/jm960519z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960519z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4135-4138&author=D.+J.+Taatjesauthor=G.+Gaudianoauthor=K.+Resingauthor=T.+H.+Koch&title=Alkylation+of+DNA+by+the+anthracycline%2C+antitumor+drugs+adriamycin+and+daunomycin&doi=10.1021%2Fjm960519z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm960519z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960519z%26sid%3Dliteratum%253Aachs%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DGaudiano%26aufirst%3DG.%26aulast%3DResing%26aufirst%3DK.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DAlkylation%2520of%2520DNA%2520by%2520the%2520anthracycline%252C%2520antitumor%2520drugs%2520adriamycin%2520and%2520daunomycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4135%26epage%3D4138%26doi%3D10.1021%2Fjm960519z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudiano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1276</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span><span class="refDoi"> DOI: 10.1021/jm960835d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960835d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1276-1286&author=D.+J.+Taatjesauthor=G.+Gaudianoauthor=K.+Resingauthor=T.+H.+Koch&title=Redox+pathway+leading+to+the+alkylation+of+DNA+by+the+anthracycline%2C+antitumor+drugs+adriamycin+and+daunomycin&doi=10.1021%2Fjm960835d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm960835d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960835d%26sid%3Dliteratum%253Aachs%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DGaudiano%26aufirst%3DG.%26aulast%3DResing%26aufirst%3DK.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DRedox%2520pathway%2520leading%2520to%2520the%2520alkylation%2520of%2520DNA%2520by%2520the%2520anthracycline%252C%2520antitumor%2520drugs%2520adriamycin%2520and%2520daunomycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1276%26epage%3D1286%26doi%3D10.1021%2Fjm960835d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zeman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crothers, D. M.</span><span> </span><span class="NLM_article-title">Characterization of covalent adriamycin-DNA adducts</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">11561</span><span class="NLM_x">–</span> <span class="NLM_lpage">11565</span><span class="refDoi"> DOI: 10.1073/pnas.95.20.11561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1073%2Fpnas.95.20.11561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=9751705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK1cXmsV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=11561-11565&author=S.+M.+Zemanauthor=D.+R.+Phillipsauthor=D.+M.+Crothers&title=Characterization+of+covalent+adriamycin-DNA+adducts&doi=10.1073%2Fpnas.95.20.11561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of covalent Adriamycin-DNA adducts</span></div><div class="casAuthors">Zeman, Steven M.; Phillips, Don R.; Crothers, Donald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11561-11565</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Adriamycin is a popular antineoplastic agent whose ability to form covalent adducts with DNA has been correlated to cellular apoptosis (programmed cell death) in tumor models.  We have isolated and purified this adduct formed under oxido-reductive (Fenton) conditions in Tris buffer.  We show by homo- and heteronuclear NMR spectroscopy that the covalent Adriamycin-DNA adduct is structurally equiv. to that resulting from direct reaction with formaldehyde.  Covalent linkage of the drug to one of the DNA strands confers remarkable stability to the duplex, indicated by a 162-fold redn. in the rate of strand displacement compared with the complex with noncovalently bound drug.  Glyceraldehyde also engenders covalent Adriamycin-DNA complexes, providing a possible relevant biol. context for in vivo adduct formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnMVATKt9Ry7Vg90H21EOLACvtfcHk0lj9zXtYvRqxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsV2itbY%253D&md5=f222d0b71e69aae4fcf19575af419e60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.20.11561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.20.11561%26sid%3Dliteratum%253Aachs%26aulast%3DZeman%26aufirst%3DS.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DCrothers%26aufirst%3DD.%2BM.%26atitle%3DCharacterization%2520of%2520covalent%2520adriamycin-DNA%2520adducts%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D11561%26epage%3D11565%26doi%3D10.1073%2Fpnas.95.20.11561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pfuhler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, H. U.</span><span> </span><span class="NLM_article-title">Detection of DNA-crosslinking agents with the alkaline comet assay</span> <span class="citation_source-journal">Environ. Mol. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1002/(SICI)1098-2280(1996)27:3<196::AID-EM4>3.0.CO;2-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=8625955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK28XivFGqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=196-201&author=S.+Pfuhlerauthor=H.+U.+Wolf&title=Detection+of+DNA-crosslinking+agents+with+the+alkaline+comet+assay&doi=10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of DNA-crosslinking agents with the alkaline comet assay</span></div><div class="casAuthors">Pfuhler, Stefan; Wolf, Hans Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Environmental and Molecular Mutagenesis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">196-201</span>CODEN:
                <span class="NLM_cas:coden">EMMUEG</span>;
        ISSN:<span class="NLM_cas:issn">0893-6692</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">The single cell gel electrophoresis, or comet assay, under alk. conditions is a sensitive, simple and rapid method for the detection of DNA damage at the individual cell level.  Its applicability as an indicator for the DNA crosslinking potency of a test substance was investigated in human white blood cells by combined treatment with the DNA damaging agent Me methanesulfonate (MMS) for 2 h at 37°.  The known crosslinking agents cis-platinum, mitomycin C and formaldehyde, and the formaldehyde releasers diazolidinyl urea and dimethylol urea, were shown to reduce MMS-induced DNA migration in the comet assay in a concn.-dependent manner.  Two other protocols, adding MMS to the cells before or after treatment with a crosslinking agent, were carried out and achieved similar results.  The results of this study indicate that the comet assay is a useful tool for the detection of crosslinking agents.  Advantages and limitations of this method compared to the alk. elution technique are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpEnpUXLBj9bVg90H21EOLACvtfcHk0lheWaKxGBhfXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFGqtb4%253D&md5=451732b43e81173500c44963b5fa1d2c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-2280%25281996%252927%253A3%253C196%253A%253AAID-EM4%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DPfuhler%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DH.%2BU.%26atitle%3DDetection%2520of%2520DNA-crosslinking%2520agents%2520with%2520the%2520alkaline%2520comet%2520assay%26jtitle%3DEnviron.%2520Mol.%2520Mutagen.%26date%3D1996%26volume%3D27%26spage%3D196%26epage%3D201%26doi%3D10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cullinane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panousis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span><span class="refDoi"> DOI: 10.1093/nar/28.4.1019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1093%2Fnar%2F28.4.1019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1019-1025&author=C.+Cullinaneauthor=S.+M.+Cuttsauthor=C.+Panousisauthor=D.+R.+Phillips&title=Interstrand+cross-linking+by+adriamycin+in+nuclear+and+mitochondrial+DNA+of+MCF-7+cells&doi=10.1093%2Fnar%2F28.4.1019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.4.1019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.4.1019%26sid%3Dliteratum%253Aachs%26aulast%3DCullinane%26aufirst%3DC.%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DPanousis%26aufirst%3DC.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DInterstrand%2520cross-linking%2520by%2520adriamycin%2520in%2520nuclear%2520and%2520mitochondrial%2520DNA%2520of%2520MCF-7%2520cells%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D1019%26epage%3D1025%26doi%3D10.1093%2Fnar%2F28.4.1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levovich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rephaeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance</span> <span class="citation_source-journal">Oncol Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.3727/096504005776382305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.3727%2F096504005776382305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=17822280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVeqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=199-213&author=S.+M.+Cuttsauthor=A.+Nudelmanauthor=V.+Pillayauthor=D.+M.+Spencerauthor=I.+Levovichauthor=A.+Rephaeliauthor=D.+R.+Phillips&title=Formaldehyde-releasing+prodrugs+in+combination+with+adriamycin+can+overcome+cellular+drug+resistance&doi=10.3727%2F096504005776382305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance</span></div><div class="casAuthors">Cutts, Suzanne M.; Nudelman, Abraham; Pillay, Vinochani; Spencer, Damian M. S.; Levovich, Inesa; Rephaeli, Ada; Phillips, Don R.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-213</span>CODEN:
                <span class="NLM_cas:coden">ONREE8</span>;
        ISSN:<span class="NLM_cas:issn">0965-0407</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">The anticancer drug Adriamycin is widely used in cancer chemotherapy and is classified as a topoisomerase II inhibitor.  However, in the presence of formaldehyde, Adriamycin also forms high levels of DNA adducts.  In this study, a new series of butyric acid and formaldehyde-releasing drugs related to AN9 (pivaloyloxymethyl butyrate) was assessed for their ability to facilitate Adriamycin-DNA adduct formation in Adriamycin-sensitive and -resistant cell lines (HL60 and HL60/MX2; MES-SA and MES-SA/Dx5).  Drugs that released two molar equivalents of formaldehyde per mol of prodrug were superior in their ability to enhance adduct formation compared to those that released one molar equivalent.  Adduct formation (as assessed by binding of radiolabeled Adriamycin to genomic DNA) was always lower in the resistant cell lines compared to the sensitive cell lines.  However, in growth inhibition expts., prodrug combinations were able to overcome Adriamycin resistance to varying degrees, and the combination of Adriamycin with selected prodrugs that release two moles of formaldehyde totally overcame resistance in HL60/MX2 cells.  These HL60-derived cells express altered levels of topoisomerase II and also express a mutant form of the enzyme.  Combinations of Adriamycin with selected prodrugs that release one or two moles of formaldehyde partially overcame P-glycoprotein-mediated resistance in MES-SA/Dx5 cells.  Formaldehyde-releasing prodrugs (as single agents) overcame both forms of resistance in the two resistant cell lines, demonstrating that they were not substrates of these resistance mechanisms.  Collectively, these results suggest that changing the mechanism via which Adriamycin exerts its anticancer effect by dramatically increasing adduct levels (requiring coadministration of formaldehyde-releasing prodrugs) may be a useful means of cancer treatment, as well as for overcoming Adriamycin-induced resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEtFlRlo9Md7Vg90H21EOLACvtfcHk0lj1NJAYY95E7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVeqtbw%253D&md5=8c74ee15f77d2fcfa7af1d8de24c54d7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3727%2F096504005776382305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096504005776382305%26sid%3Dliteratum%253Aachs%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DPillay%26aufirst%3DV.%26aulast%3DSpencer%26aufirst%3DD.%2BM.%26aulast%3DLevovich%26aufirst%3DI.%26aulast%3DRephaeli%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DFormaldehyde-releasing%2520prodrugs%2520in%2520combination%2520with%2520adriamycin%2520can%2520overcome%2520cellular%2520drug%2520resistance%26jtitle%3DOncol%2520Res.%26date%3D2005%26volume%3D15%26spage%3D199%26epage%3D213%26doi%3D10.3727%2F096504005776382305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lambert, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. W.</span><span> </span><span class="NLM_article-title">Ring-Chain Tautomerism in 1,3-Diaza and 1,3-Oxaza Heterocycles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3588</span><span class="NLM_x">–</span> <span class="NLM_lpage">3591</span><span class="refDoi"> DOI: 10.1021/ja00530a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00530a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=3588-3591&author=J.+B.+Lambertauthor=M.+W.+Majchrzak&title=Ring-Chain+Tautomerism+in+1%2C3-Diaza+and+1%2C3-Oxaza+Heterocycles&doi=10.1021%2Fja00530a045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja00530a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00530a045%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BB.%26aulast%3DMajchrzak%26aufirst%3DM.%2BW.%26atitle%3DRing-Chain%2520Tautomerism%2520in%25201%252C3-Diaza%2520and%25201%252C3-Oxaza%2520Heterocycles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D3588%26epage%3D3591%26doi%3D10.1021%2Fja00530a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Cogan, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxsaliform: a novel N-Mannich base prodrug of a doxorubicin formaldehyde conjugate</span> <span class="citation_source-journal">Letters in Drug Design and Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.2174/1570180043399000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.2174%2F1570180043399000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFWltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=247-255&author=P.+S.+Coganauthor=C.+R.+Fowlerauthor=G.+C.+Postauthor=T.+H.+Koch&title=Doxsaliform%3A+a+novel+N-Mannich+base+prodrug+of+a+doxorubicin+formaldehyde+conjugate&doi=10.2174%2F1570180043399000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Doxsaliform: A novel N-Mannich base prodrug of a doxorubicin formaldehyde conjugate</span></div><div class="casAuthors">Cogan, P. S.; Fowler, C. R.; Post, G. C.; Koch, T. H.</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Drug Design & Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-255</span>CODEN:
                <span class="NLM_cas:coden">LDDDAW</span>;
        ISSN:<span class="NLM_cas:issn">1570-1808</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Development of a water-sol. prodrug of doxorubicin-formaldehyde conjugate, a labile, active metabolite of doxorubicin, was described.  The lead compd. was the doxorubicin-salicylamide N-Mannich base, N-(2-hydroxybenzamidomethyl)-doxorubicin (doxsaliform), prepd. in 72% yield from reaction of salicylamide with doxorubicin in the presence of formaldehyde.  Doxsaliform releases doxorubicin-formaldehyde conjugate under physiol. conditions with a half-life of 57 min.  The stability of the prodrug is augmented both by salt formation in acidic media and by covalent modification of the 2-hydroxyl of the salicylamide moiety.  Doxsaliform is 4 fold more active than doxorubicin against MCF-7 breast and PC-3 prostate cancer cell lines and 10 fold more active against the doxorubicin resistant MCF-7/ADR cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzxrxeka4WcLVg90H21EOLACvtfcHk0ljltTwjA2Nl_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFWltrc%253D&md5=c65291654545f3306879adf494040b16</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F1570180043399000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180043399000%26sid%3Dliteratum%253Aachs%26aulast%3DCogan%26aufirst%3DP.%2BS.%26aulast%3DFowler%26aufirst%3DC.%2BR.%26aulast%3DPost%26aufirst%3DG.%2BC.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxsaliform%253A%2520a%2520novel%2520N-Mannich%2520base%2520prodrug%2520of%2520a%2520doxorubicin%2520formaldehyde%2520conjugate%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520and%2520Discovery%26date%3D2004%26volume%3D1%26spage%3D247%26epage%3D255%26doi%3D10.2174%2F1570180043399000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyatt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrug</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1021/jm7011479</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7011479" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=298-304&author=B.+L.+Barthelauthor=R.+C.+Torresauthor=J.+L.+Hyattauthor=C.+C.+Edwardsauthor=M.+J.+Hatfieldauthor=P.+M.+Potterauthor=T.+H.+Koch&title=Identification+of+human+intestinal+carboxylesterase+as+the+primary+enzyme+for+activation+of+a+doxazolidine+carbamate+prodrug&doi=10.1021%2Fjm7011479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm7011479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7011479%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DTorres%26aufirst%3DR.%2BC.%26aulast%3DHyatt%26aufirst%3DJ.%2BL.%26aulast%3DEdwards%26aufirst%3DC.%2BC.%26aulast%3DHatfield%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DIdentification%2520of%2520human%2520intestinal%2520carboxylesterase%2520as%2520the%2520primary%2520enzyme%2520for%2520activation%2520of%2520a%2520doxazolidine%2520carbamate%2520prodrug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D298%26epage%3D304%26doi%3D10.1021%2Fjm7011479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Espenson, J. H.</span> <span class="citation_source-book">Chemical Kinetics and Reaction Mechanisms</span>. <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1981</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&author=J.+H.+Espenson&title=Chemical+Kinetics+and+Reaction+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEspenson%26aufirst%3DJ.%2BH.%26btitle%3DChemical%2520Kinetics%2520and%2520Reaction%2520Mechanisms%26pub%3DMcGraw-Hill%26date%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Crabb, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roch, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, P.</span><span> </span><span class="NLM_article-title">Compounds with Bridgehead Nitrogen. 50—<sup>1</sup>H NMR spectra and structures of the products derived from the reaction between trans-3-aminotetralin-2-ol and formaldehyde</span> <span class="citation_source-journal">Magn. Reson. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span><span class="refDoi"> DOI: 10.1002/mrc.1260241209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1002%2Fmrc.1260241209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL2sXkslOktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1986&pages=1069-1072&author=T.+A.+Crabbauthor=O.+G.+Rochauthor=P.+Robinson&title=Compounds+with+Bridgehead+Nitrogen.+50%E2%80%941H+NMR+spectra+and+structures+of+the+products+derived+from+the+reaction+between+trans-3-aminotetralin-2-ol+and+formaldehyde&doi=10.1002%2Fmrc.1260241209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds with bridgehead nitrogen.  50.  Proton NMR spectra and structures of the products derived from the reaction between trans-3-aminotetralin-2-ol and formaldehyde</span></div><div class="casAuthors">Crabb, Trevor A.; Roch, Olive G.; Robinson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Magnetic Resonance in Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1069-72</span>CODEN:
                <span class="NLM_cas:coden">MRCHEG</span>;
        ISSN:<span class="NLM_cas:issn">0749-1581</span>.
    </div><div class="casAbstract">In contrast to the reported reaction between trans-1-aminotetralin-2-ol and formaldehyde, which gives octahydro-9,18-methanodinaphtho[1,2-d:1',2'-i][1,6,3,8]dioxadiazecine (I), an examn. of the δ 4.0-5.0 region of the 1H NMR spectra of the products of the reaction between trans-3-aminotetralin-2-ol and formaldehyde showed these to be a 50:50 mixt. of II and III.  In a similar way, the reaction between trans-2-aminocyclohexanol and formaldehyde was reexamd. and found to produce initially a ca. 80:20 mixt. of IV and V.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrka3araVnKnbVg90H21EOLACvtfcHk0ljltTwjA2Nl_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkslOktb0%253D&md5=9c215d51de575e62d5f767dd81648b6c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fmrc.1260241209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmrc.1260241209%26sid%3Dliteratum%253Aachs%26aulast%3DCrabb%26aufirst%3DT.%2BA.%26aulast%3DRoch%26aufirst%3DO.%2BG.%26aulast%3DRobinson%26aufirst%3DP.%26atitle%3DCompounds%2520with%2520Bridgehead%2520Nitrogen.%252050%25E2%2580%25941H%2520NMR%2520spectra%2520and%2520structures%2520of%2520the%2520products%2520derived%2520from%2520the%2520reaction%2520between%2520trans-3-aminotetralin-2-ol%2520and%2520formaldehyde%26jtitle%3DMagn.%2520Reson.%2520Chem.%26date%3D1986%26volume%3D24%26spage%3D1069%26epage%3D1072%26doi%3D10.1002%2Fmrc.1260241209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudnicki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Synthesis and biological characterization of protease-activated prodrugs of doxazolidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6595</span><span class="NLM_x">–</span> <span class="NLM_lpage">6607</span><span class="refDoi"> DOI: 10.1021/jm300714p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300714p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6595-6607&author=B.+L.+Barthelauthor=D.+L.+Rudnickiauthor=T.+P.+Kirbyauthor=S.+M.+Colvinauthor=D.+J.+Burkhartauthor=T.+H.+Koch&title=Synthesis+and+biological+characterization+of+protease-activated+prodrugs+of+doxazolidine&doi=10.1021%2Fjm300714p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm300714p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300714p%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DRudnicki%26aufirst%3DD.%2BL.%26aulast%3DKirby%26aufirst%3DT.%2BP.%26aulast%3DColvin%26aufirst%3DS.%2BM.%26aulast%3DBurkhart%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DSynthesis%2520and%2520biological%2520characterization%2520of%2520protease-activated%2520prodrugs%2520of%2520doxazolidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6595%26epage%3D6607%26doi%3D10.1021%2Fjm300714p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chou, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Analysis of combined drug effects: a new look at a very old problem</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1016/0165-6147(83)90490-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0165-6147%2883%2990490-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=450-454&author=T.+C.+Chouauthor=P.+Talalay&title=Analysis+of+combined+drug+effects%3A+a+new+look+at+a+very+old+problem&doi=10.1016%2F0165-6147%2883%2990490-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of combined drug effects:  a new look at a very old problem</span></div><div class="casAuthors">Chou, Ting Chao; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">450-4</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A simple, general and novel method for the quant. anal. of combined drug effects is presented.  The procedure dets. if the drug combinations are additive, synergistic or antagonistic, regardless of whether the dose-effect curves are hyperbolic (first order) or sigmoidal (higher order), or whether the effects of the drugs are totally independent or not.  The proposed method (median-effect plot) suffers from fewer restrictions and is more widely applicable than the isobologram or the fractional product method.  It provides insight into the nature of the dose-effect relationship with relatively few measurements.  The procedure is illustrated by analyzing the combined lethal effects of 2 insecticides on house-flies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObQzLgU9z07Vg90H21EOLACvtfcHk0ljmE5L45kqZDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D&md5=af5698ed81a74924a1a296dacc8ce691</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2883%2990490-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252883%252990490-X%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DAnalysis%2520of%2520combined%2520drug%2520effects%253A%2520a%2520new%2520look%2520at%2520a%2520very%2520old%2520problem%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1983%26volume%3D4%26spage%3D450%26epage%3D454%26doi%3D10.1016%2F0165-6147%2883%2990490-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Nadin, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas-Roig, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciocca, D. R.</span><span> </span><span class="NLM_article-title">A silver staining method for single-cell gel assay</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.1177/002215540104900912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1177%2F002215540104900912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=11511687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFyltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=1183-1186&author=S.+B.+Nadinauthor=L.+M.+Vargas-Roigauthor=D.+R.+Ciocca&title=A+silver+staining+method+for+single-cell+gel+assay&doi=10.1177%2F002215540104900912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A silver staining method for single-cell gel assay</span></div><div class="casAuthors">Nadin, Silvina B.; Vargas-Roig, Laura M.; Ciocca, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1183-1186</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">The single-cell gel assay (comet assay) is a very useful microelectrophoretic technique for evaluation of DNA damage and repair in individual cells.  Usually, the comets are visualized and evaluated with fluorescent DNA stains.  This staining requires specific equipment (e.g., a high-quality fluorescence microscope), the slides must be analyzed immediately, and they cannot be stored for long periods of time.  Here the authors describe, using human lymphocytes, some modifications of the silver staining for comets that significantly increase the sensitivity/reproducibility of the assay.  This silver staining was compared with fluorescence staining and com. silver stains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH9rpku5Qf3LVg90H21EOLACvtfcHk0li0_-YmBaC9OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFyltLk%253D&md5=3d57cfdcbec34d2a08bec89ee85debf7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1177%2F002215540104900912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215540104900912%26sid%3Dliteratum%253Aachs%26aulast%3DNadin%26aufirst%3DS.%2BB.%26aulast%3DVargas-Roig%26aufirst%3DL.%2BM.%26aulast%3DCiocca%26aufirst%3DD.%2BR.%26atitle%3DA%2520silver%2520staining%2520method%2520for%2520single-cell%2520gel%2520assay%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2001%26volume%3D49%26spage%3D1183%26epage%3D1186%26doi%3D10.1177%2F002215540104900912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Burkhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalet, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nafie, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7002</span><span class="NLM_x">–</span> <span class="NLM_lpage">7012</span><span class="refDoi"> DOI: 10.1021/jm060597e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060597e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7002-7012&author=D.+J.+Burkhartauthor=B.+L.+Barthelauthor=G.+C.+Postauthor=B.+T.+Kaletauthor=J.+W.+Nafieauthor=R.+K.+Shoemakerauthor=T.+H.+Koch&title=Design%2C+synthesis%2C+and+preliminary+evaluation+of+doxazolidine+carbamates+as+prodrugs+activated+by+carboxylesterases&doi=10.1021%2Fjm060597e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060597e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060597e%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhart%26aufirst%3DD.%2BJ.%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DPost%26aufirst%3DG.%2BC.%26aulast%3DKalet%26aufirst%3DB.%2BT.%26aulast%3DNafie%26aufirst%3DJ.%2BW.%26aulast%3DShoemaker%26aufirst%3DR.%2BK.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preliminary%2520evaluation%2520of%2520doxazolidine%2520carbamates%2520as%2520prodrugs%2520activated%2520by%2520carboxylesterases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7002%26epage%3D7012%26doi%3D10.1021%2Fjm060597e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudnicki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coldren, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinkovsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7678</span><span class="NLM_x">–</span> <span class="NLM_lpage">7688</span><span class="refDoi"> DOI: 10.1021/jm900694z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900694z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7678-7688&author=B.+L.+Barthelauthor=Z.+Zhangauthor=D.+L.+Rudnickiauthor=C.+D.+Coldrenauthor=M.+Polinkovskyauthor=H.+Sunauthor=G.+G.+Kochauthor=D.+C.+Chanauthor=T.+H.+Koch&title=Preclinical+efficacy+of+a+carboxylesterase+2-activated+prodrug+of+doxazolidine&doi=10.1021%2Fjm900694z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm900694z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900694z%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRudnicki%26aufirst%3DD.%2BL.%26aulast%3DColdren%26aufirst%3DC.%2BD.%26aulast%3DPolinkovsky%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DG.%2BG.%26aulast%3DChan%26aufirst%3DD.%2BC.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DPreclinical%2520efficacy%2520of%2520a%2520carboxylesterase%25202-activated%2520prodrug%2520of%2520doxazolidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7678%26epage%3D7688%26doi%3D10.1021%2Fjm900694z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhenlei Zhang, Juzheng Zhang, Ming Jiang, Lei Zhao, Shanhe Li, Hongbin Sun, Feng Yang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (4)
                                     , 1405-1414. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c00133" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c00133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c00133%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DHuman%252BSerum%252BAlbumin-Based%252BDual-Agent%252BDelivery%252BSystems%252Bfor%252BCombination%252BTherapy%25253A%252BActing%252Bagainst%252BCancer%252BCells%252Band%252BInhibiting%252BNeovascularization%252Bin%252Bthe%252BTumor%252BMicroenvironment%26aulast%3DZhang%26aufirst%3DZhenlei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09022020%26date%3D25022020%26date%3D24022020%26date%3D04032020%26date%3D25022020%26volume%3D17%26issue%3D4%26spage%3D1405%26epage%3D1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiagen Li, Xinming Li, <span class="NLM_string-name hlFld-ContribAuthor">Peng Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Acid-Labile Poly(Doxazolidine) as a Polyprodrug with an Ultra-High Drug Content for Self-Delivery of High-Performance Chemotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (2)
                                     , 710-716. <a href="https://doi.org/10.1021/acs.molpharmaceut.9b00972" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.9b00972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.9b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.9b00972%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSynthesis%252Bof%252BAcid-Labile%252BPoly%252528Doxazolidine%252529%252Bas%252Ba%252BPolyprodrug%252Bwith%252Ban%252BUltra-High%252BDrug%252BContent%252Bfor%252BSelf-Delivery%252Bof%252BHigh-Performance%252BChemotherapeutics%26aulast%3DLi%26aufirst%3DJiagen%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2020%26date%3D17092019%26date%3D07012020%26date%3D02012020%26date%3D21012020%26date%3D07012020%26volume%3D17%26issue%3D2%26spage%3D710%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinming  Li</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-triggered degradable polyprodrug with drug as unique repeating unit for long-acting drug delivery with minimal leakage. </span><span class="cited-content_cbyCitation_journal-name">Materials Science and Engineering: C</span><span> <strong>2021,</strong> <em>128 </em>, 112317. <a href="https://doi.org/10.1016/j.msec.2021.112317" title="DOI URL">https://doi.org/10.1016/j.msec.2021.112317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.msec.2021.112317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.msec.2021.112317%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Science%2520and%2520Engineering%253A%2520C%26atitle%3DAcid-triggered%252Bdegradable%252Bpolyprodrug%252Bwith%252Bdrug%252Bas%252Bunique%252Brepeating%252Bunit%252Bfor%252Blong-acting%252Bdrug%252Bdelivery%252Bwith%252Bminimal%252Bleakage%26aulast%3DLi%26aufirst%3DXinming%26date%3D2021%26volume%3D128%26spage%3D112317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Estela  Ordonez</span>, <span class="hlFld-ContribAuthor ">Laken L.  Kendrick-Williams</span>, <span class="hlFld-ContribAuthor ">Eva  Harth</span>. </span><span class="cited-content_cbyCitation_article-title">Formaldehyde-doxorubicin dual polymeric drug delivery system for higher efficacy and limited cardiotoxicity of anthracyclines. </span><span class="cited-content_cbyCitation_journal-name">European Polymer Journal</span><span> <strong>2021,</strong> <em>143 </em>, 110210. <a href="https://doi.org/10.1016/j.eurpolymj.2020.110210" title="DOI URL">https://doi.org/10.1016/j.eurpolymj.2020.110210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.eurpolymj.2020.110210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.eurpolymj.2020.110210%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Polymer%2520Journal%26atitle%3DFormaldehyde-doxorubicin%252Bdual%252Bpolymeric%252Bdrug%252Bdelivery%252Bsystem%252Bfor%252Bhigher%252Befficacy%252Band%252Blimited%252Bcardiotoxicity%252Bof%252Banthracyclines%26aulast%3DOrdonez%26aufirst%3DEstela%26date%3D2021%26volume%3D143%26spage%3D110210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sayantani  Roychoudhury</span>, <span class="hlFld-ContribAuthor ">Ajay  Kumar</span>, <span class="hlFld-ContribAuthor ">Devyani  Bhatkar</span>, <span class="hlFld-ContribAuthor ">Nilesh Kumar  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular avenues in targeted doxorubicin cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (11)
                                     , 687-700. <a href="https://doi.org/10.2217/fon-2019-0458" title="DOI URL">https://doi.org/10.2217/fon-2019-0458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2019-0458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2019-0458%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DMolecular%252Bavenues%252Bin%252Btargeted%252Bdoxorubicin%252Bcancer%252Btherapy%26aulast%3DRoychoudhury%26aufirst%3DSayantani%26date%3D2020%26volume%3D16%26issue%3D11%26spage%3D687%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kinga  Piorecka</span>, <span class="hlFld-ContribAuthor ">David  Smith</span>, <span class="hlFld-ContribAuthor ">Jan  Kurjata</span>, <span class="hlFld-ContribAuthor ">Maciej  Stanczyk</span>, <span class="hlFld-ContribAuthor ">Wlodzimierz A.  Stanczyk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic routes to nanoconjugates of anthracyclines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>96 </em>, 103617. <a href="https://doi.org/10.1016/j.bioorg.2020.103617" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103617%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthetic%252Broutes%252Bto%252Bnanoconjugates%252Bof%252Banthracyclines%26aulast%3DPiorecka%26aufirst%3DKinga%26date%3D2020%26volume%3D96%26spage%3D103617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric G.  Fuller</span>, <span class="hlFld-ContribAuthor ">Georg M.  Scheutz</span>, <span class="hlFld-ContribAuthor ">Angela  Jimenez</span>, <span class="hlFld-ContribAuthor ">Parker  Lewis</span>, <span class="hlFld-ContribAuthor ">Shehaab  Savliwala</span>, <span class="hlFld-ContribAuthor ">Sitong  Liu</span>, <span class="hlFld-ContribAuthor ">Brent S.  Sumerlin</span>, <span class="hlFld-ContribAuthor ">Carlos  Rinaldi</span>. </span><span class="cited-content_cbyCitation_article-title">Theranostic nanocarriers combining high drug loading and magnetic particle imaging. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2019,</strong> <em>572 </em>, 118796. <a href="https://doi.org/10.1016/j.ijpharm.2019.118796" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2019.118796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2019.118796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2019.118796%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DTheranostic%252Bnanocarriers%252Bcombining%252Bhigh%252Bdrug%252Bloading%252Band%252Bmagnetic%252Bparticle%252Bimaging%26aulast%3DFuller%26aufirst%3DEric%2BG.%26date%3D2019%26volume%3D572%26spage%3D118796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanaparthi  Satheesh</span>, <span class="hlFld-ContribAuthor ">Sundaravel  Vivek Kumar</span>, <span class="hlFld-ContribAuthor ">Tharmalingam  Punniyamurthy</span>. </span><span class="cited-content_cbyCitation_article-title">Expedient stereospecific Co-catalyzed tandem C–N and C–O bond formation of
              N
              -methylanilines with styrene oxides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (83)
                                     , 11813-11816. <a href="https://doi.org/10.1039/C8CC06223D" title="DOI URL">https://doi.org/10.1039/C8CC06223D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC06223D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC06223D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DExpedient%252Bstereospecific%252BCo-catalyzed%252Btandem%252BC%2525E2%252580%252593N%252Band%252BC%2525E2%252580%252593O%252Bbond%252Bformation%252Bof%252BN%252B-methylanilines%252Bwith%252Bstyrene%252Boxides%26aulast%3DSatheesh%26aufirst%3DVanaparthi%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D83%26spage%3D11813%26epage%3D11816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahman  Bikas</span>, <span class="hlFld-ContribAuthor ">Fatemeh  Ajormal</span>, <span class="hlFld-ContribAuthor ">Marzieh  Emami</span>, <span class="hlFld-ContribAuthor ">Nader  Noshiranzadeh</span>, <span class="hlFld-ContribAuthor ">Anna  Kozakiewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic oxidation of benzyl alcohols by new Cu(II) complexes of 1,3-oxazolidine based ligand obtained from a solvent free reaction. </span><span class="cited-content_cbyCitation_journal-name">Inorganica Chimica Acta</span><span> <strong>2018,</strong> <em>478 </em>, 77-87. <a href="https://doi.org/10.1016/j.ica.2018.03.038" title="DOI URL">https://doi.org/10.1016/j.ica.2018.03.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ica.2018.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ica.2018.03.038%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganica%2520Chimica%2520Acta%26atitle%3DCatalytic%252Boxidation%252Bof%252Bbenzyl%252Balcohols%252Bby%252Bnew%252BCu%252528II%252529%252Bcomplexes%252Bof%252B1%25252C3-oxazolidine%252Bbased%252Bligand%252Bobtained%252Bfrom%252Ba%252Bsolvent%252Bfree%252Breaction%26aulast%3DBikas%26aufirst%3DRahman%26date%3D2018%26volume%3D478%26spage%3D77%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weichuan  Mo</span>, <span class="hlFld-ContribAuthor ">Rongqiao  He</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Formaldehyde in Cell Proliferation and Death. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 79-97. <a href="https://doi.org/10.1007/978-94-024-1177-5_5" title="DOI URL">https://doi.org/10.1007/978-94-024-1177-5_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-024-1177-5_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-024-1177-5_5%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BFormaldehyde%252Bin%252BCell%252BProliferation%252Band%252BDeath%26aulast%3DMo%26aufirst%3DWeichuan%26date%3D2017%26date%3D2017%26spage%3D79%26epage%3D97%26pub%3DSpringer%2520Netherlands%26atitle%3DFormaldehyde%252Band%252BCognition%26aulast%3DHe%26aufirst%3DRongqiao%26date%3D2017%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Clinical Anthracyclines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Structures are shown for doxorubicin, daunorubicin, idarubicin, and epirubicin as well as for the oxazolidine derivative of doxorubicin, doxazolidine.</p></p></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Reaction of Dox (top) and Epi (bottom) with Formaldehyde<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(Top) Dox (<b>1</b>) reacts with formaldehyde to form aminol (<b>6a</b>) and Schiff base (<b>6b</b>) in equilibrium. The ring then closes to form doxaz (<b>5</b>). With excess formaldehyde, doxaz pseudodimerizes to form doxoform (<b>7</b>). (Bottom) Epi (<b>4</b>) reacts to form the aminol (<b>8a</b>), which is also likely in equilibrium with a Schiff base (<b>8b</b>). Another equivalent of formaldehyde can react to form the bisaminol (<b>9</b>), which can combine with <b>8a/8b</b> to form epiform (<b>10</b>). In the case of epi, no stable oxazolidine product is formed. Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. DNA–Drug Adduct Formation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>We believe that tautomerization of guanine results in an attack by the exocyclic amine on the formaldehyde carbon (shown with asterisks) of the oxazolidine, Schiff base, and/or aminol. At 5′-GC-3′ sequences, the result is a virtual cross-link, in which the drug is covalently bonded to guanine on one strand while hydrogen-bonded to guanine on the opposite strand. Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lack of DNA strand cleavage from doxaz treatment. NCI/ADR-RES ovarian cancer cells and MIA PaCa-2 pancreatic cells were treated with either vehicle, dox, epi, or doxaz in suspension for 90 min and then analyzed for DNA damage by the comet assay and silver staining. Individual comets were scored by CometScore software, and the fraction of the cellular DNA in the tail was plotted (A). Each point represents the comet derived from a single cell, and the bars are the population mean ± standard deviation. The gray boxes about the mean represent the 95% confidence interval. Sample images of each of the treated populations are shown for (B–F) NCI/ADR-RES and (G–K) MIA PaCa-2 cells: control (B and G), 100 μM dox (C and H), 100 μM epi (D and I), 10 μM doxaz (E and J), and 250 nM doxaz (F and K). Each image is shown on the same scale, and the bar below panel D represents 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Sample comets for dox, epi, and doxaz. A suspension of NCI/ADR-RES cells was treated with either (top row) phosphate-buffered saline (PBS) or (second row)15 mM hydrogen peroxide for 10 min to induce DNA damage. The cells were pelleted, and the medium was replaced with medium containing no drug (left column), 100 μM dox (second column), 100 μM epi (third column), or 10 μM doxaz (last column) and analyzed as described in the text. All images are representative of the population as a whole and are shown at the same scale (black scale bar indicates 50 μm). The separation between 10 μM doxaz and the rest of the panels is to indicate that the rest of the panels belong to the same experiment, while the doxaz micrographs came from a second experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Doxaz cross-linking activity by comet assay. Hydrogen peroxide (15 mM, 10 min) to introduce DNA damage was followed by a 90-min treatment of ADR cells with either 100 μM dox or epi (A) or 10 μM doxaz (B) and analyzed by the comet assay. Sample images for some conditions are shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> (bottom row). Each data point represents the comet derived from a single cell, and the bars are the population means and standard deviations. Gray boxes surrounding the means represent the 95% confidence interval of the means. A full statistical analysis of panel A is discussed in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>. For panel B, the <i>p</i>-values relating to pairwise <i>t</i>-tests with the Satterthwaite approximation for degrees of freedom were all less than 0.001 and thereby statistically significant at the 0.05 level via the Bonferroni–Holm method to adjust for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Synergy between formaldehyde and dox. MIA PaCa-2 (A, B) and NCI/ADR-RES (C, D) cells were treated with dox, formaldehyde (form), doxaz, or combinations of dox and formaldehyde for 30 min (black bars) or 90 min (gray bars), and IC<sub>50</sub> values were determined (A, C). The arrow in part A indicates that IC<sub>50</sub> was beyond the scope of the experiment. In part C, all combinations were tested at 90 min but not all were tested at 30 min; conditions not tested are shown by asterisks. The resulting 90-min IC<sub>50</sub> values were then plotted as isobolograms (B, D), where the IC<sub>50</sub> concentrations of dox (<i>y</i>-axis) and formaldehyde (<i>x</i>-axis) alone are shown as gray circles and the IC<sub>50</sub> concentrations of combinations are shown as open diamonds. The points in all panels represent the mean ± standard deviation of at least two independent measurements performed in triplicate. In part D, all points have error bars, but in many cases, they are smaller than the size of the points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Lack of synergy between epi and formaldehyde. MIA PaCa-2 cells were treated with epi for 90 min, as well as with combinations of epi and formaldehyde. IC<sub>50</sub> values were determined (A), and those values were then plotted as an isobologram with IC<sub>50</sub> values for epi and formaldehyde alone (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Micrographs for evidence of cross-linking activity from cotreatments with formaldehyde and anthracyclines. ADR cells were treated with nothing (control) or hydrogen peroxide (15 mM for 10 min) followed by formaldehyde (form) alone or in combination with either dox or epi. Anthracyclines were added at 100 μM (top panels) or 5 μM (bottom panels). In each panel, the black scale bar equals 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comet assay for evidence of cross-linking activity from anthracycline–formaldehyde cotreatments. Cells were treated under the conditions described (peroxide, 15 mM, 10 min; drugs/formaldehyde, 90 min). Formaldehyde was always added at 100 μM, while dox and epi were either 100 or 5 μM as shown below the plot. Columns 1, 2, 4, and 7 are reproduced from <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, as they are all part of the same experiment. Each data point represents the comet resulting from a single cell. The population mean and standard deviations are shown by the line and error bars, while the gray box surrounding the mean indicates the 95% confidence interval about the mean. All <i>p</i>-values for pairwise <i>t</i>-tests with the Satterthwaite approximation for degrees of freedom are less than 0.001 for each comparison, with the exception of groups 3 (H<sub>2</sub>O<sub>2</sub> + form) versus 9 (H<sub>2</sub>O<sub>2</sub> + form + 5 μM epi; <i>p</i> = 0.0258), and groups 6 (H<sub>2</sub>O<sub>2</sub> + form + 5 μM dox) versus 8 (H<sub>2</sub>O<sub>2</sub> + form + 100 μM epi; <i>p</i> = 0.0076). Statistical significance at the 0.05 level applies to all pairwise treatment comparisons via the Bonferroni–Holm method to adjust for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0010.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <sup>1</sup>H NMR spectra for slow synthesis of doxF in DMSO-<i>d</i><sub>6</sub>. The region from approximately 0.95 to 1.3 ppm encompasses the 5′-CH<sub>3</sub> resonance region (A), and the mid-downfield region of 3.9–4.6 ppm encompasses the AX patterns from oxazolidines (B). The sole doublet observed at the initial condition, which contains only dox free base (<b>1</b>), is quickly joined by doublets for three intermediates (i<sub>a</sub>, i<sub>b</sub>, and i<sub>c</sub>) after 1 h of reaction with approximately 1.5 equiv of washed paraformaldehyde. Between 3.5 and 20 h of reaction time, signals for doxF (<b>7</b>) and doxaz (<b>5</b>) are observed. After 20 h, the reaction progresses increasingly to <b>7</b>, <b>5</b>, and unreacted <b>1</b>, while all other intermediates disappear. The rise of 5′-CH<sub>3</sub> signals for <b>7</b> and <b>5</b> is accompanied by the appearance of oxazolidine AX patterns for each (Ox<sub>7</sub> and Ox<sub>5</sub>). All spectra were obtained at 500 MHz at room temperature in DMSO-<i>d</i><sub>6</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Proposed Structures for Intermediates between Dox (<b>1</b>) and DoxF (<b>7</b>) in DMSO-<i>d</i><sub>6</sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>In synthesis, minor intermediates i<sub>a</sub>, i<sub>b</sub>, and i<sub>c</sub> are hypothesized, and doxaz–aminol (<b>11</b>) is not observed. In hydrolysis, <b>11</b> and doxaz (<b>5</b>) are relatively stable. Only with the addition of TFA is <b>1</b> re-formed, which occurs without visible production of i<sub>a</sub>, i<sub>b</sub>, or i<sub>c</sub>. Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0011.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <sup>1</sup>H NMR spectra of hydrolysis of doxF with increasing concentrations of D<sub>2</sub>O. The region from approximately 0.95 to 1.3 ppm encompasses the 5′-CH<sub>3</sub> resonance region (A), and the mid-downfield region of 3.9–4.6 ppm encompasses the AX patterns from oxazolidines (B). Oxazolidine signals for <b>7</b> (Ox<sub>7</sub>), <b>5</b> (Ox<sub>5</sub>), and <b>11</b> (Ox<sub>11</sub>) are indicated. The last row shows the fully hydrolyzed state after addition of 0.1% TFA. All spectra were obtained at 500 MHz at room temperature in DMSO-<i>d</i><sub>6</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Activation of Doxorubicin–Formaldehyde Prodrugs Doxsaliform (doxSF, <b>12</b>) and Pentyl PABC-doxaz (PPD, <b>13</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(Top) DoxSF undergoes a first-order elimination of salicylamide with a half-life of 57 min under physiological conditions to release the dox–formaldehyde Schiff base <b>6b</b>. In aqueous medium, <b>6b</b> is in equilibrium with aminol <b>6a</b>. (Bottom) PPD is enzymatically cleaved by pig liver esterase (PLE) to release doxaz (<b>5</b>). Anth = 7-deoxydoxorubicin-7-yl.</p></p></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/medium/jm-2015-01956b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0012.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Cytotoxicity and kinetics of enzymatically released doxaz. In treatments of ADR cells with the doxaz prodrug PPD (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) and pig liver esterase (PLE), very little enzyme is required to elicit a profound cytotoxic effect, indicated by a large reduction of the IC<sub>50</sub> value relative to PPD treatment alone (A). The IC<sub>50</sub> value of the dox–aminol prodrug doxSF (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) is shown by a dotted line. When the PPD/PLE combinations were compared to doxSF at its 800 nM IC<sub>50</sub> value, the combinations resulted in 25–500-fold less growth (B), with most of the conditions resulting in near-complete cell death. In HPLC assays, 1 μM PPD reaction with three concentrations of PLE was well fit by first-order kinetics in which half-life was inversely correlated with enzyme concentration (C). In panels A and B, all bars represent the average and standard deviation of duplicated triplicate measurements. In panel C, the points are the average of duplicate measurements; error bars (standard deviation) are present for all points but in many cases are smaller than the size of the point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-5/acs.jmedchem.5b01956/20160310/images/large/jm-2015-01956b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01956&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Young, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span> </span><span class="NLM_article-title">The anthracycline antineoplastic drugs</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1056/NEJM198107163050305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1056%2FNEJM198107163050305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=7017406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL3MXkslartLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1981&pages=139-153&author=R.+C.+Youngauthor=R.+F.+Ozolsauthor=C.+E.+Myers&title=The+anthracycline+antineoplastic+drugs&doi=10.1056%2FNEJM198107163050305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The anthracycline antineoplastic drugs</span></div><div class="casAuthors">Young, Robert C.; Ozols, Robert F.; Myers, Charles E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">139-53</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A review with 166 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojq1MexPtSbrVg90H21EOLACvtfcHk0lgz4xjzJ67hhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslartLs%253D&md5=30b792d8c6e1f9d391c520e9385f1f74</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM198107163050305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198107163050305%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BC.%26aulast%3DOzols%26aufirst%3DR.%2BF.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26atitle%3DThe%2520anthracycline%2520antineoplastic%2520drugs%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1981%26volume%3D305%26spage%3D139%26epage%3D153%26doi%3D10.1056%2FNEJM198107163050305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Sordet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, Q. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Apoptosis induced by topoisomerase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span><span class="refDoi"> DOI: 10.2174/1568011033482378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.2174%2F1568011033482378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12769773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Giu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=271-290&author=O.+Sordetauthor=Q.+A.+Khanauthor=K.+W.+Kohnauthor=Y.+Pommier&title=Apoptosis+induced+by+topoisomerase+inhibitors&doi=10.2174%2F1568011033482378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis induced by topoisomerase inhibitors</span></div><div class="casAuthors">Sordet, Olivier; Khan, Qasim A.; Kohn, Kurt W.; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-290</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Topoisomerase inhibitors are among the most efficient inducers of apoptosis.  The main pathways leading from topoisomerase-mediated DNA damage to cell death involve activation of caspases in the cytoplasm by proapoptotic mols. released from mitochondria.  In some cells, apoptotic response also involves the death receptor Fas (APO-1/CD95).  The engagement of these apoptotic effector pathways is tightly controlled by upstream regulatory pathways that respond to DNA lesions-induced by topoisomerase inhibitors in cells undergoing apoptosis.  These include the proapoptotic Chk2, c-Abl and SAPK/JNK pathways, the survival PI(3)kinase-Akt-dependent pathway and the transcription factors p53 and NF-κB.  Initiation of cellular responses to DNA lesions-induced by topoisomerase inhibitors is ensured by the protein kinases DNA-PK, ATM and ATR, which bind to DNA breaks.  These kinases commonly called "DNA sensors" mediate their effects (DNA repair, cell cycle arrest and/or apoptosis) by phosphorylating a large no. of substrates, including several downstream kinases such as c-Abl and the checkpoint protein Chk2.  C-Abl induces apoptosis by activating cell death pathways (e.g., SAPK, p53 and p73) and inhibiting cell survival pathways [e.g., PI(3)kinase].  The DNA-damage regulating kinase Chk2, in addn. to its role in cell cycle arrest and/or DNA repair, can induce apoptosis by phosphorylation/activation of the promyelocytic leukemia (PML) protein and p53.  Finally, we will review the recent observations that support a role for topoisomerases in chromatin fragmentation during the execution phase of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKuE3P03H3HLVg90H21EOLACvtfcHk0lgz4xjzJ67hhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Giu7g%253D&md5=1ec5acb3cab774a42ef88fff75d1aa7c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1568011033482378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011033482378%26sid%3Dliteratum%253Aachs%26aulast%3DSordet%26aufirst%3DO.%26aulast%3DKhan%26aufirst%3DQ.%2BA.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DApoptosis%2520induced%2520by%2520topoisomerase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2003%26volume%3D3%26spage%3D271%26epage%3D290%26doi%3D10.2174%2F1568011033482378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wilstermann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osheroff, N.</span><span> </span><span class="NLM_article-title">Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.2174/1568026033452519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.2174%2F1568026033452519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12570766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=321-338&author=A.+M.+Wilstermannauthor=N.+Osheroff&title=Stabilization+of+eukaryotic+topoisomerase+II-DNA+cleavage+complexes&doi=10.2174%2F1568026033452519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes</span></div><div class="casAuthors">Wilstermann, Amy M.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-338</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Topoisomerase II is an essential enzyme that plays crit. roles in many DNA processes, including chromosome segregation.  To carry out its important physiol. functions, topoisomerase II creates and rejoins double-stranded breaks in the genetic material.  Thus, while the enzyme is necessary for cell survival, it also has the capacity to fragment the genome.  Topoisomerase II-mediated DNA breaks are sequestered within a covalent enzyme-DNA complex.  Normally, these "cleavage complexes" are present at low levels and are tolerated by the cell.  However, conditions that significantly increase the physiol. concn. or life-time of topoisomerase II-DNA cleavage complexes lead to chromosomal translocations and other mutagenic events, and can induce cell death pathways.  The potentially lethal aspect of enzyme mechanism has been exploited by a no. of highly successful anticancer agents.  Since drugs that increase levels of topoisomerase II-DNA cleavage complexes transform the enzyme into a potent cellular toxin, they are referred to as topoisomerase II "poisons" to distinguish them from compds. that inhibit the catalytic activity of the enzyme.  Recent evidence indicates that many DNA lesions also act as topoisomerase II poisons.  This finding has provided tremendous insight into enzyme and drug action and raises important questions regarding the physiol. interactions of topoisomerase II with DNA damage.  Since the DNA cleavage and ligation reactions of topoisomerase II are fundamental to its physiol. and pharmacol. functions, this review will focus on how the enzyme cuts and rejoins the double helix and how these reactions are altered by topoisomerase II poisons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3iQkF9Pd2rVg90H21EOLACvtfcHk0lgz4xjzJ67hhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Cksw%253D%253D&md5=fc0730783cab33ea45203e215aa6e7d1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026033452519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452519%26sid%3Dliteratum%253Aachs%26aulast%3DWilstermann%26aufirst%3DA.%2BM.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DStabilization%2520of%2520eukaryotic%2520topoisomerase%2520II-DNA%2520cleavage%2520complexes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D321%26epage%3D338%26doi%3D10.2174%2F1568026033452519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Larsen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escargueil, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skladanowski, A.</span><span> </span><span class="NLM_article-title">Catalytic topoisomerase II inhibitors in cancer therapy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1016/S0163-7258(03)00058-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2FS0163-7258%2803%2900058-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12888111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVWhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=167-181&author=A.+K.+Larsenauthor=A.+E.+Escargueilauthor=A.+Skladanowski&title=Catalytic+topoisomerase+II+inhibitors+in+cancer+therapy&doi=10.1016%2FS0163-7258%2803%2900058-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic topoisomerase II inhibitors in cancer therapy</span></div><div class="casAuthors">Larsen, Annette K.; Escargueil, Alexandre E.; Skladanowski, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-181</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The nuclear enzyme DNA topoisomerase II is a major target for antineoplastic agents.  All topoisomerase II-directed agents are able to interfere with at least one step of the catalytic cycle.  Agents able to stabilize the covalent DNA topoisomerase II complex (also known as the cleavable complex) are traditionally called topoisomerase II poisons, while agents acting on any of the other steps in the catalytic cycle are called catalytic inhibitors.  Thus, catalytic topoisomerase II inhibitors are a heterogeneous group of compds. that might interfere with the binding between DNA and topoisomerase II (aclarubicin and suramin), stabilize noncovalent DNA topoisomerase II complexes (merbarone, ICRF-187, and structurally related bisdioxopiperazine derivs.), or inhibit ATP binding (novobiocin).  Some, such as fostriecin, may also have alternative biol. targets.  Whereas topoisomerase II poisons are used solely for their antitumor activities, catalytic inhibitors are utilized for a variety of reasons, including their activity as antineoplastic agents (aclarubicin and MST-16), cardioprotectors (ICRF-187), or modulators in order to increase the efficacy of other agents (suramin and novobiocin).  In this review, the mechanism and biol. activity of different catalytic inhibitors is described, with emphasis on therapeutically used compds.  We will then discuss future development and applications of this interesting class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGote2bOTWP17bVg90H21EOLACvtfcHk0lggSjeugyHQtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVWhtL0%253D&md5=4207fb899e2b98345f97e91983514913</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900058-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900058-5%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BK.%26aulast%3DEscargueil%26aufirst%3DA.%2BE.%26aulast%3DSkladanowski%26aufirst%3DA.%26atitle%3DCatalytic%2520topoisomerase%2520II%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D99%26spage%3D167%26epage%3D181%26doi%3D10.1016%2FS0163-7258%2803%2900058-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Goormaghtigh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasseur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruysschaert, J. M.</span><span> </span><span class="NLM_article-title">Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity</span> <span class="citation_source-journal">Biophys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1016/0301-4622(90)80012-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0301-4622%2890%2980012-V" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1990&pages=247-257&author=E.+Goormaghtighauthor=P.+Huartauthor=M.+Praetauthor=R.+Brasseurauthor=J.+M.+Ruysschaert&title=Structure+of+the+adriamycin-cardiolipin+complex.+Role+in+mitochondrial+toxicity&doi=10.1016%2F0301-4622%2890%2980012-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0301-4622%2890%2980012-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-4622%252890%252980012-V%26sid%3Dliteratum%253Aachs%26aulast%3DGoormaghtigh%26aufirst%3DE.%26aulast%3DHuart%26aufirst%3DP.%26aulast%3DPraet%26aufirst%3DM.%26aulast%3DBrasseur%26aufirst%3DR.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520of%2520the%2520adriamycin-cardiolipin%2520complex.%2520Role%2520in%2520mitochondrial%2520toxicity%26jtitle%3DBiophys.%2520Chem.%26date%3D1990%26volume%3D35%26spage%3D247%26epage%3D257%26doi%3D10.1016%2F0301-4622%2890%2980012-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Keizer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinedo, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurhuis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joenje, H.</span><span> </span><span class="NLM_article-title">Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/0163-7258(90)90088-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0163-7258%2890%2990088-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=2203071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=219-231&author=H.+G.+Keizerauthor=H.+M.+Pinedoauthor=G.+J.+Schuurhuisauthor=H.+Joenje&title=Doxorubicin+%28adriamycin%29%3A+a+critical+review+of+free+radical-dependent+mechanisms+of+cytotoxicity&doi=10.1016%2F0163-7258%2890%2990088-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin (adriamycin):  a critical review of free radical-dependent mechanisms of cytotoxicity</span></div><div class="casAuthors">Keizer, H. G.; Pinedo, H. M.; Schuurhuis, G. J.; Joenje, H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-31</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼130 refs.  The antineoplastic drug doxorubicin is capable of generating a variety of free radical species in subcellular systems and this capacity has been considered crit. for its antitumor action.  However, for most tumor cell lines, this mechanism of cytotoxicity does not appear to play a major role.  Free radical-independent cytotoxicity mechanisms, taking place in the nuclear compartment of the cell, may more likely be involved in the antitumor effect of doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh7SgS1hAtL7Vg90H21EOLACvtfcHk0lggSjeugyHQtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1eqsbk%253D&md5=4dd568ea3172c73030b58b6822f9477f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2890%2990088-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252890%252990088-J%26sid%3Dliteratum%253Aachs%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DSchuurhuis%26aufirst%3DG.%2BJ.%26aulast%3DJoenje%26aufirst%3DH.%26atitle%3DDoxorubicin%2520%2528adriamycin%2529%253A%2520a%2520critical%2520review%2520of%2520free%2520radical-dependent%2520mechanisms%2520of%2520cytotoxicity%26jtitle%3DPharmacol.%2520Ther.%26date%3D1990%26volume%3D47%26spage%3D219%26epage%3D231%26doi%3D10.1016%2F0163-7258%2890%2990088-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Maestre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffrezou, J. P.</span><span> </span><span class="NLM_article-title">Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2558</span><span class="NLM_x">–</span> <span class="NLM_lpage">2561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2558-2561&author=N.+Maestreauthor=T.+R.+Trittonauthor=G.+Laurentauthor=J.+P.+Jaffrezou&title=Cell+surface-directed+interaction+of+anthracyclines+leads+to+cytotoxicity+and+nuclear+factor+kappaB+activation+but+not+apoptosis+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaestre%26aufirst%3DN.%26aulast%3DTritton%26aufirst%3DT.%2BR.%26aulast%3DLaurent%26aufirst%3DG.%26aulast%3DJaffrezou%26aufirst%3DJ.%2BP.%26atitle%3DCell%2520surface-directed%2520interaction%2520of%2520anthracyclines%2520leads%2520to%2520cytotoxicity%2520and%2520nuclear%2520factor%2520kappaB%2520activation%2520but%2520not%2520apoptosis%2520signaling%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2558%26epage%3D2561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velds, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groothuis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Tellingen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huijgens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neefjes, J.</span><span> </span><span class="NLM_article-title">Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="refDoi"> DOI: 10.1038/ncomms2921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1038%2Fncomms2921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=23715267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A280%3ADC%252BC3snnsFWqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1908&author=B.+Pangauthor=X.+Qiaoauthor=L.+Janssenauthor=A.+Veldsauthor=T.+Groothuisauthor=R.+Kerkhovenauthor=M.+Nieuwlandauthor=H.+Ovaaauthor=S.+Rottenbergauthor=O.+van+Tellingenauthor=J.+Janssenauthor=P.+Huijgensauthor=W.+Zwartauthor=J.+Neefjes&title=Drug-induced+histone+eviction+from+open+chromatin+contributes+to+the+chemotherapeutic+effects+of+doxorubicin&doi=10.1038%2Fncomms2921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin</span></div><div class="casAuthors">Pang Baoxu; Qiao Xiaohang; Janssen Lennert; Velds Arno; Groothuis Tom; Kerkhoven Ron; Nieuwland Marja; Ovaa Huib; Rottenberg Sven; van Tellingen Olaf; Janssen Jeroen; Huijgens Peter; Zwart Wilbert; Neefjes Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1908</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DNA topoisomerase II inhibitors are a major class of cancer chemotherapeutics, which are thought to eliminate cancer cells by inducing DNA double-strand breaks.  Here we identify a novel activity for the anthracycline class of DNA topoisomerase II inhibitors: histone eviction from open chromosomal areas.  We show that anthracyclines promote histone eviction irrespective of their ability to induce DNA double-strand breaks.  The histone variant H2AX, which is a key component of the DNA damage response, is also evicted by anthracyclines, and H2AX eviction is associated with attenuated DNA repair.  Histone eviction deregulates the transcriptome in cancer cells and organs such as the heart, and can drive apoptosis of topoisomerase-negative acute myeloid leukaemia blasts in patients.  We define a novel mechanism of action of anthracycline anticancer drugs doxorubicin and daunorubicin on chromatin biology, with important consequences for DNA damage responses, epigenetics, transcription, side effects and cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7JMlDyqgCydy3lHz94U-GfW6udTcc2ebiCFvMu_9Y27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snnsFWqsw%253D%253D&md5=035068cc31bb3817945d8b407d5ff89f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fncomms2921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2921%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DB.%26aulast%3DQiao%26aufirst%3DX.%26aulast%3DJanssen%26aufirst%3DL.%26aulast%3DVelds%26aufirst%3DA.%26aulast%3DGroothuis%26aufirst%3DT.%26aulast%3DKerkhoven%26aufirst%3DR.%26aulast%3DNieuwland%26aufirst%3DM.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DRottenberg%26aufirst%3DS.%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DJanssen%26aufirst%3DJ.%26aulast%3DHuijgens%26aufirst%3DP.%26aulast%3DZwart%26aufirst%3DW.%26aulast%3DNeefjes%26aufirst%3DJ.%26atitle%3DDrug-induced%2520histone%2520eviction%2520from%2520open%2520chromatin%2520contributes%2520to%2520the%2520chemotherapeutic%2520effects%2520of%2520doxorubicin%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1908%26doi%3D10.1038%2Fncomms2921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Olson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mushlin, P. S.</span><span> </span><span class="NLM_article-title">Doxorubicin cardiotoxicity: analyses of prevailing hypotheses</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=3076-3086&author=R.+D.+Olsonauthor=P.+S.+Mushlin&title=Doxorubicin+cardiotoxicity%3A+analyses+of+prevailing+hypotheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DR.%2BD.%26aulast%3DMushlin%26aufirst%3DP.%2BS.%26atitle%3DDoxorubicin%2520cardiotoxicity%253A%2520analyses%2520of%2520prevailing%2520hypotheses%26jtitle%3DFASEB%2520J.%26date%3D1990%26volume%3D4%26spage%3D3076%26epage%3D3086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Weiss, R. B.</span><span> </span><span class="NLM_article-title">The anthracyclines: will we ever find a better doxorubicin?</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1462166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1992&pages=670-686&author=R.+B.+Weiss&title=The+anthracyclines%3A+will+we+ever+find+a+better+doxorubicin%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The anthracyclines:  will we even find a better doxorubicin?</span></div><div class="casAuthors">Weiss, Raymond B.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">670-86</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">A review with 105 refs.  The anthracyclines are the class of antitumor drugs with the widest spectrum of activity in human cancers, and only a few cancers (eg., colon cancer) are unresponsive to them.  The first two anthracyclines were developed in the 1960s.  Doxorubicin (DOX) differs from daunorubicin (DNR) only by a single hydroxyl group.  This fact has spurred researchers worldwide to find analogs of DOX that have less acute toxicity, cause less cardiomyopathy, can be administered orally, and/or have different, or greater, antitumor efficacy.  Five DOX/DNR analogs are marketed in other countries, and one (idarubicin) is available in the United States.  None of these analogs have stronger antitumor efficacy than the original two anthracycline, but there are some differences in toxicity.  Methods have been fashioned to keep the peak plasma level of DOX muted to minimize cardiotoxicity, but the only apparently effective method available so far (prolonged drug infusion) is cumbersome.  The bisoxopiperazine class of drugs (esp. dexrazoxane) provides protection against anthracycline-induced cardiomyopathy and has much promise for helping mitigate this major obstacle to prolonged use of the anthracyclines.  The DOX analogs being evaluated in the 1990s have been selected for their ability to overcome multidrug resistance in cancer cells.  Thirty years after discovery of the anticancer activity of the first anthracycline, some means of reducing anthracycline toxicity have been devised.  Current studies are evaluating increased doses of epirubicin to improve anthracycline cytotoxicity, while limiting cardiotoxicity, but at present DOX still reigns in this drug class as the one having the most proven cancerocidal effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs1ERdJDycw7Vg90H21EOLACvtfcHk0liiSNyHcMD_Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2jsbo%253D&md5=62df8a9f6a9bb52567b34c90c677dd26</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DR.%2BB.%26atitle%3DThe%2520anthracyclines%253A%2520will%2520we%2520ever%2520find%2520a%2520better%2520doxorubicin%253F%26jtitle%3DSemin.%2520Oncol.%26date%3D1992%26volume%3D19%26spage%3D670%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Julka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, K. D.</span><span> </span><span class="NLM_article-title">A possible mechanism for adriamycin induced cardiotoxicity</span> <span class="citation_source-journal">Indian J. Exp. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1994&pages=146-148&author=D.+Julkaauthor=S.+Sarinauthor=K.+D.+Gill&title=A+possible+mechanism+for+adriamycin+induced+cardiotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJulka%26aufirst%3DD.%26aulast%3DSarin%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DK.%2BD.%26atitle%3DA%2520possible%2520mechanism%2520for%2520adriamycin%2520induced%2520cardiotoxicity%26jtitle%3DIndian%2520J.%2520Exp.%2520Biol.%26date%3D1994%26volume%3D32%26spage%3D146%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kartner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span><span class="refDoi"> DOI: 10.1126/science.6137059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1126%2Fscience.6137059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=6137059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL3sXlsFWku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1983&pages=1285-1288&author=N.+Kartnerauthor=J.+R.+Riordanauthor=V.+Ling&title=Cell+surface+P-glycoprotein+associated+with+multidrug+resistance+in+mammalian+cell+lines&doi=10.1126%2Fscience.6137059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines</span></div><div class="casAuthors">Kartner, Norbert; Riordan, John R.; Ling, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">4617</span>),
    <span class="NLM_cas:pages">1285-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The plasma membranes of hamster, mouse, and human tumor cell lines that display multiple resistance to drugs were examd. by gel electrophoresis and immunoblotting.  In every case, increased expression of a 170,000-dalton surface antigen was found to be correlated with multidrug resistance.  This membrane component is of identical mol. size and shares some immunogenic homol. with the previously characterized P-glycoprotein of colchicine-resistant Chinese hamster ovary cells.  This finding may have application to cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGxMo45kJlOLVg90H21EOLACvtfcHk0lhw521c-Y9vKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlsFWku7c%253D&md5=36b4cbc533fedb47e14ae9cc064682e3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.6137059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6137059%26sid%3Dliteratum%253Aachs%26aulast%3DKartner%26aufirst%3DN.%26aulast%3DRiordan%26aufirst%3DJ.%2BR.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DCell%2520surface%2520P-glycoprotein%2520associated%2520with%2520multidrug%2520resistance%2520in%2520mammalian%2520cell%2520lines%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1983%26volume%3D221%26spage%3D1285%26epage%3D1288%26doi%3D10.1126%2Fscience.6137059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kartner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer</span> <span class="citation_source-journal">Sci. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">260</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1038/scientificamerican0389-44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1038%2Fscientificamerican0389-44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=2564696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL1MXhsVKqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=1989&pages=44-51&author=N.+Kartnerauthor=V.+Ling&title=Multidrug+resistance+in+cancer&doi=10.1038%2Fscientificamerican0389-44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer</span></div><div class="casAuthors">Kartner, Norbert; Ling, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Scientific American</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">44-51</span>CODEN:
                <span class="NLM_cas:coden">SCAMAC</span>;
        ISSN:<span class="NLM_cas:issn">0036-8733</span>.
    </div><div class="casAbstract">A review with 4 refs. of historical perspectives in the study of the mol. mechanism of cancer cell multidrug resistance.  The discovery of P-glycoprotein, its function as a pump protein which removes toxins from the cells, and its implications for therapeutic strategies are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8IUyZ73wjLVg90H21EOLACvtfcHk0lhw521c-Y9vKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsVKqt74%253D&md5=5be9d9b59a2c9918636e1f2ef17147a4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fscientificamerican0389-44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fscientificamerican0389-44%26sid%3Dliteratum%253Aachs%26aulast%3DKartner%26aufirst%3DN.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%26jtitle%3DSci.%2520Am.%26date%3D1989%26volume%3D260%26spage%3D44%26epage%3D51%26doi%3D10.1038%2Fscientificamerican0389-44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nielsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovsgaard, T.</span><span> </span><span class="NLM_article-title">Cellular resistance to anthracyclines</span> <span class="citation_source-journal">Gen. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/0306-3623(95)02013-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0306-3623%2895%2902013-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=8919638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK28XisVKgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=251-255&author=D.+Nielsenauthor=C.+Maareauthor=T.+Skovsgaard&title=Cellular+resistance+to+anthracyclines&doi=10.1016%2F0306-3623%2895%2902013-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular resistance to anthracyclines</span></div><div class="casAuthors">Nielsen, Dorte; Maare, Christian; Skovsgaard, Torben</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-5</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 30 refs.  The antracyclines induce multiple intracellular effects; however, inhibition of the nuclear enzyme topoisomerase II (TOPO II) is the main mechanisms of action.  Resistance to anthracyclines in tumor cells is multifactorial.  The main mechanisms are: (1) the classic multidrug resistance (MDR) phenotype, which is due to the presence of P-glycoprotein (PGP) in plasma membrane, i.e., a "pump" that can extrude a wide range of anticaner drugs.  Membrane-active drugs (e.g., verapamil) have been found in vitro to reverse this phenotype.  Most clin. studies including chemosensitizers have, however, been disappointing.  (2) Non-PGP-mediated MDR: this phenotype is characterized by expression of other proteins in the plasma membrane which are also able to extrude anticancer drugs.  (3) Changes in the intracellular distribution of drug: this mechanism has been demonstrated in several cell lines, most often in combination with PGP or non-PGP-mediated resistance.  (4) Glutathione transferases (GST) and detoxification mechanisms: these represent a multigene family of enzymes that conjugate glutathione to chem. reactive groups.  Direct evidence for a causative role of GST in antracycline resistance is missing.  (5) Alterations in TOPO II (at-MDR): DNA topoisomerases are involved in several aspects of DNA metab., in particular genetic recombination, DNA transcription , and chromosome segregation.  Low levels of expression or alterations in TOPO II are assocd. in vitro with resistance.  (5) Alterations in TOPO II (at-MDR): DNA topoisomerases are involved in several aspects of DNA metab., in particular genetic recombinations, DNA transcription, and chromosome segregation.  Low levels of expression or alterations in TOPO II are assocd. in vitro with resistance.  (6) Increased DNA repair: in several cell lines, an increase in the efficacy of DNA repair has been assocd. with resistance to doxorubicin (DOX).  So far, only classic MDR has been shown to contribute to resistance in clin. conditions, whereas evidence for the other mechanisms of resistance is still missing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVm6blGZnXu7Vg90H21EOLACvtfcHk0lhw521c-Y9vKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVKgtrc%253D&md5=24b13b0dcd7f0e9dcf3a30013de091be</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2895%2902013-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252895%252902013-6%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DD.%26aulast%3DMaare%26aufirst%3DC.%26aulast%3DSkovsgaard%26aufirst%3DT.%26atitle%3DCellular%2520resistance%2520to%2520anthracyclines%26jtitle%3DGen.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D251%26epage%3D255%26doi%3D10.1016%2F0306-3623%2895%2902013-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Post, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagadorn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7648</span><span class="NLM_x">–</span> <span class="NLM_lpage">7657</span><span class="refDoi"> DOI: 10.1021/jm050678v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050678v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOisL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7648-7657&author=G.+C.+Postauthor=B.+L.+Barthelauthor=D.+J.+Burkhartauthor=J.+R.+Hagadornauthor=T.+H.+Koch&title=Doxazolidine%2C+a+proposed+active+metabolite+of+doxorubicin+that+cross-links+DNA&doi=10.1021%2Fjm050678v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Doxazolidine, a Proposed Active Metabolite of Doxorubicin That Cross-links DNA</span></div><div class="casAuthors">Post, Glen C.; Barthel, Benjamin L.; Burkhart, David J.; Hagadorn, John R.; Koch, Tad H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7648-7657</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A crystal structure establishes doxoform as a dimeric formaldehyde conjugate of the oxazolidine of doxorubicin.  Doxoform is a prodrug of doxazolidine, a monomeric doxorubicin formaldehyde-oxazolidine.  Both doxoform and doxazolidine inhibit the growth of cancer cells at 1-4 orders of magnitude lower concn. than doxorubicin.  They also inhibit the growth of cancer cells better than doxsaliform, a prodrug for an acyclic doxorubicin-formaldehyde conjugate.  Doxoform rapidly hydrolyzes to doxazolidine, which then hydrolyzes to doxorubicin with a half-life of 3 min in human serum at 37 °C.  Both doxoform and doxazolidine are taken up by multidrug-resistant MCF-7/Adr cells 3- to 4-fold better than doxorubicin.  A mol. model suggests that doxazolidine can cross-link DNA by direct reaction with a G-base in a tautomeric form with synchronous ring opening of the oxazolidine.  These results point to doxoform being a prodrug for doxazolidine that is the reactive species that directly cross-links DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLpgrk9qR0drVg90H21EOLACvtfcHk0lgYcw3AfD2DwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOisL3P&md5=a169e59558dcb2bd3eb775c004ff7f91</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm050678v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050678v%26sid%3Dliteratum%253Aachs%26aulast%3DPost%26aufirst%3DG.%2BC.%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DBurkhart%26aufirst%3DD.%2BJ.%26aulast%3DHagadorn%26aufirst%3DJ.%2BR.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxazolidine%252C%2520a%2520proposed%2520active%2520metabolite%2520of%2520doxorubicin%2520that%2520cross-links%2520DNA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7648%26epage%3D7657%26doi%3D10.1021%2Fjm050678v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kalet, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBryde, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4493</span><span class="NLM_x">–</span> <span class="NLM_lpage">4500</span><span class="refDoi"> DOI: 10.1021/jm070569b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070569b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4493-4500&author=B.+T.+Kaletauthor=M.+B.+McBrydeauthor=J.+M.+Espinosaauthor=T.+H.+Koch&title=Doxazolidine+induction+of+apoptosis+by+a+topoisomerase+II+independent+mechanism&doi=10.1021%2Fjm070569b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm070569b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070569b%26sid%3Dliteratum%253Aachs%26aulast%3DKalet%26aufirst%3DB.%2BT.%26aulast%3DMcBryde%26aufirst%3DM.%2BB.%26aulast%3DEspinosa%26aufirst%3DJ.%2BM.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxazolidine%2520induction%2520of%2520apoptosis%2520by%2520a%2520topoisomerase%2520II%2520independent%2520mechanism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4493%26epage%3D4500%26doi%3D10.1021%2Fjm070569b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fenick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2461</span><span class="refDoi"> DOI: 10.1021/jm970237e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970237e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2452-2461&author=D.+J.+Fenickauthor=D.+J.+Taatjesauthor=T.+H.+Koch&title=Doxoform+and+Daunoform%3A+anthracycline-formaldehyde+conjugates+toxic+to+resistant+tumor+cells&doi=10.1021%2Fjm970237e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm970237e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970237e%26sid%3Dliteratum%253Aachs%26aulast%3DFenick%26aufirst%3DD.%2BJ.%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxoform%2520and%2520Daunoform%253A%2520anthracycline-formaldehyde%2520conjugates%2520toxic%2520to%2520resistant%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2452%26epage%3D2461%26doi%3D10.1021%2Fjm970237e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Crabb, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. O.</span><span> </span><span class="NLM_article-title">The Reaction of trans-2-Aminocyclohexanol with Formaldehyde</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1002/jhet.5570040201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1002%2Fjhet.5570040201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1967&pages=169-170&author=T.+A.+Crabbauthor=R.+O.+Williams&title=The+Reaction+of+trans-2-Aminocyclohexanol+with+Formaldehyde&doi=10.1002%2Fjhet.5570040201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570040201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570040201%26sid%3Dliteratum%253Aachs%26aulast%3DCrabb%26aufirst%3DT.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26atitle%3DThe%2520Reaction%2520of%2520trans-2-Aminocyclohexanol%2520with%2520Formaldehyde%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1967%26volume%3D4%26spage%3D169%26epage%3D170%26doi%3D10.1002%2Fjhet.5570040201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Barkworth, P. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crabb, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, P.</span><span> </span><span class="NLM_article-title">Compounds with Bridgehead Nitrogen. Part 47. The Reaction between trans-1-Aminobenzocycloalkan-2-ols and Formaldehyde</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_fpage">2807</span><span class="NLM_x">–</span> <span class="NLM_lpage">2810</span><span class="refDoi"> DOI: 10.1039/p19830002807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1039%2Fp19830002807" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=2807-2810&author=P.+M.+R.+Barkworthauthor=T.+A.+Crabbauthor=P.+Robinson&title=Compounds+with+Bridgehead+Nitrogen.+Part+47.+The+Reaction+between+trans-1-Aminobenzocycloalkan-2-ols+and+Formaldehyde&doi=10.1039%2Fp19830002807"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2Fp19830002807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19830002807%26sid%3Dliteratum%253Aachs%26aulast%3DBarkworth%26aufirst%3DP.%2BM.%2BR.%26aulast%3DCrabb%26aufirst%3DT.%2BA.%26aulast%3DRobinson%26aufirst%3DP.%26atitle%3DCompounds%2520with%2520Bridgehead%2520Nitrogen.%2520Part%252047.%2520The%2520Reaction%2520between%2520trans-1-Aminobenzocycloalkan-2-ols%2520and%2520Formaldehyde%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1983%26spage%3D2807%26epage%3D2810%26doi%3D10.1039%2Fp19830002807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1314</span><span class="refDoi"> DOI: 10.1021/jm970739s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970739s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1306-1314&author=D.+J.+Taatjesauthor=D.+J.+Fenickauthor=T.+H.+Koch&title=Epidoxoform%3A+a+hydrolytically+more+stable+anthracycline-formaldehyde+conjugate+toxic+to+resistant+tumor+cells&doi=10.1021%2Fjm970739s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm970739s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970739s%26sid%3Dliteratum%253Aachs%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DFenick%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DEpidoxoform%253A%2520a%2520hydrolytically%2520more%2520stable%2520anthracycline-formaldehyde%2520conjugate%2520toxic%2520to%2520resistant%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1306%26epage%3D1314%26doi%3D10.1021%2Fjm970739s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.-g.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Marel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Boom, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.-J.</span><span> </span><span class="NLM_article-title">Simultaneous incorporations of two anticancer drugs into DNA. The structures of formaldehyde-cross-linked adducts of daunorubicin-d(CG(araC)GCG) and doxorubicin-d(CA(araC)GTG) complexes at high resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">10095</span><span class="NLM_x">–</span> <span class="NLM_lpage">10101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=10095-10101&author=H.+Zhangauthor=Y.-g.+Gaoauthor=G.+A.+van+der+Marelauthor=J.+H.+van+Boomauthor=A.+H.-J.+Wang&title=Simultaneous+incorporations+of+two+anticancer+drugs+into+DNA.+The+structures+of+formaldehyde-cross-linked+adducts+of+daunorubicin-d%28CG%28araC%29GCG%29+and+doxorubicin-d%28CA%28araC%29GTG%29+complexes+at+high+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DY.-g.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3Dvan%2BBoom%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DA.%2BH.-J.%26atitle%3DSimultaneous%2520incorporations%2520of%2520two%2520anticancer%2520drugs%2520into%2520DNA.%2520The%2520structures%2520of%2520formaldehyde-cross-linked%2520adducts%2520of%2520daunorubicin-d%2528CG%2528araC%2529GCG%2529%2520and%2520doxorubicin-d%2528CA%2528araC%2529GTG%2529%2520complexes%2520at%2520high%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D10095%26epage%3D10101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rephaeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Sequence specificity of adriamycin-DNA adducts in human tumor cells</span> <span class="citation_source-journal">Mol. Cancer Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=12883039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=661-670&author=S.+M.+Cuttsauthor=L.+P.+Swiftauthor=A.+Rephaeliauthor=A.+Nudelmanauthor=D.+R.+Phillips&title=Sequence+specificity+of+adriamycin-DNA+adducts+in+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence specificity of adriamycin-DNA adducts in human tumor cells</span></div><div class="casAuthors">Cutts, Suzanne M.; Swift, Lonnie P.; Rephaeli, Ada; Nudelman, Abraham; Phillips, Don R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-670</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The anticancer anthracycline compd. Adriamycin is a known topoisomerase II inhibitor but is also capable of exerting other cellular consequences.  After intercalation, Adriamycin can form covalent adducts with DNA, and the magnitude of these adducts appears to be limited by the cellular availability of formaldehyde.  Adducts produced by Adriamycin in the presence of formaldehyde have been well characterized in cell-free systems but not in cells.  In this study, we show that when Adriamycin is used in conjunction with the formaldehyde-releasing prodrug AN-9 in IMR-32 tumor cells, this allows the formation of sufficiently high levels of adducts in genomic DNA to enable detection of their DNA sequence specificity for the first time.  The 340-bp α-satellite EcoRI repeat sequence was isolated from drug-treated cells and digested with λ-exonuclease to det. adduct sites at which exonuclease digestion was blocked.  The Adriamycin adducts were formed predominantly at 5'-GC and GG sequences and unstable with respect to elevated temps. and extended times at 37°.  The use of three anthracycline derivs. lacking a 3'amino group demonstrated that this amino portion is crit. for the formation of anthracycline adducts in cells.  The structure of these drug-DNA adducts can therefore be considered to be identical to the Adriamycin adducts, which have been characterized rigorously in cell-free systems by x-ray crystallog., two-dimensional NMR, and mass spectrometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhW8JtuTHzLVg90H21EOLACvtfcHk0liTgoNZ6uYfHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFGktrw%253D&md5=91077435f5095086a18025692c0b79a7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DSwift%26aufirst%3DL.%2BP.%26aulast%3DRephaeli%26aufirst%3DA.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DSequence%2520specificity%2520of%2520adriamycin-DNA%2520adducts%2520in%2520human%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther%26date%3D2003%26volume%3D2%26spage%3D661%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. K.</span><span> </span><span class="NLM_article-title">Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3812</span><span class="NLM_x">–</span> <span class="NLM_lpage">3815</span><span class="refDoi"> DOI: 10.1021/bi00230a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00230a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=3812-3815&author=A.+H.+Wangauthor=Y.+G.+Gaoauthor=Y.+C.+Liawauthor=Y.+K.+Li&title=Formaldehyde+cross-links+daunorubicin+and+DNA+efficiently%3A+HPLC+and+X-ray+diffraction+studies&doi=10.1021%2Fbi00230a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi00230a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00230a002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DA.%2BH.%26aulast%3DGao%26aufirst%3DY.%2BG.%26aulast%3DLiaw%26aufirst%3DY.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BK.%26atitle%3DFormaldehyde%2520cross-links%2520daunorubicin%2520and%2520DNA%2520efficiently%253A%2520HPLC%2520and%2520X-ray%2520diffraction%2520studies%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26spage%3D3812%26epage%3D3815%26doi%3D10.1021%2Fbi00230a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Podell, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Crystal structure of epidoxorubicin-formaldehyde virtual crosslink of DNA and evidence for its formation in human breast-cancer cells</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1516</span><span class="NLM_x">–</span> <span class="NLM_lpage">1523</span><span class="refDoi"> DOI: 10.1107/S0907444999008161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1107%2FS0907444999008161" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=1516-1523&author=E.+R.+Podellauthor=D.+J.+Harringtonauthor=D.+J.+Taatjesauthor=T.+H.+Koch&title=Crystal+structure+of+epidoxorubicin-formaldehyde+virtual+crosslink+of+DNA+and+evidence+for+its+formation+in+human+breast-cancer+cells&doi=10.1107%2FS0907444999008161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0907444999008161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444999008161%26sid%3Dliteratum%253Aachs%26aulast%3DPodell%26aufirst%3DE.%2BR.%26aulast%3DHarrington%26aufirst%3DD.%2BJ.%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520epidoxorubicin-formaldehyde%2520virtual%2520crosslink%2520of%2520DNA%2520and%2520evidence%2520for%2520its%2520formation%2520in%2520human%2520breast-cancer%2520cells%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1999%26volume%3D55%26spage%3D1516%26epage%3D1523%26doi%3D10.1107%2FS0907444999008161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Forrest, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evison, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rephaeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutts, S. M.</span><span> </span><span class="NLM_article-title">The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1007/s00280-012-2049-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1007%2Fs00280-012-2049-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=23263186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Wmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=809-816&author=R.+A.+Forrestauthor=L.+P.+Swiftauthor=B.+J.+Evisonauthor=A.+Rephaeliauthor=A.+Nudelmanauthor=D.+R.+Phillipsauthor=S.+M.+Cutts&title=The+hydroxyl+epimer+of+doxorubicin+controls+the+rate+of+formation+of+cytotoxic+anthracycline-DNA+adducts&doi=10.1007%2Fs00280-012-2049-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts</span></div><div class="casAuthors">Forrest, Robert A.; Swift, Lonnie P.; Evison, Benny J.; Rephaeli, Ada; Nudelman, Abraham; Phillips, Don R.; Cutts, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">809-816</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Epirubicin was developed as a semi-synthetic anthracycline deriv. to circumvent the cardiotoxic limitations assocd. with the use of doxorubicin in the clinic.  Anthracycline compds. have been demonstrated to form covalent drug-DNA adducts utilizing endogenous and exogenous sources of formaldehyde; however, previous investigations of the formation of epirubicin-DNA adducts provide conflicting evidence for adduct formation.  This work provides evidence that epirubicin acts to form drug-DNA adducts at physiol. relevant concns. and demonstrates that the rate of formation of epirubicin-DNA adducts is slower than that obsd. for other anthracycline compds., explaining why they are only detectable under defined exptl. conditions.  Formation of covalent epirubicin-DNA adducts improves the apoptotic profile of epirubicin and provides opportunities to overcome drug resistance and cardiotoxic limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra55L5WAn6v7Vg90H21EOLACvtfcHk0liTgoNZ6uYfHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Wmt70%253D&md5=596311d7af909b6b6a907591aeae6cd7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00280-012-2049-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-012-2049-x%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DR.%2BA.%26aulast%3DSwift%26aufirst%3DL.%2BP.%26aulast%3DEvison%26aufirst%3DB.%2BJ.%26aulast%3DRephaeli%26aufirst%3DA.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DCutts%26aufirst%3DS.%2BM.%26atitle%3DThe%2520hydroxyl%2520epimer%2520of%2520doxorubicin%2520controls%2520the%2520rate%2520of%2520formation%2520of%2520cytotoxic%2520anthracycline-DNA%2520adducts%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2013%26volume%3D71%26spage%3D809%26epage%3D816%26doi%3D10.1007%2Fs00280-012-2049-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Coldwell, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ognibene, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">e100</span><span class="refDoi"> DOI: 10.1093/nar/gkn439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1093%2Fnar%2Fgkn439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=e100&author=K.+E.+Coldwellauthor=S.+M.+Cuttsauthor=T.+J.+Ognibeneauthor=P.+T.+Hendersonauthor=D.+R.+Phillips&title=Detection+of+Adriamycin-DNA+adducts+by+accelerator+mass+spectrometry+at+clinically+relevant+Adriamycin+concentrations&doi=10.1093%2Fnar%2Fgkn439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkn439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkn439%26sid%3Dliteratum%253Aachs%26aulast%3DColdwell%26aufirst%3DK.%2BE.%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DOgnibene%26aufirst%3DT.%2BJ.%26aulast%3DHenderson%26aufirst%3DP.%2BT.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DDetection%2520of%2520Adriamycin-DNA%2520adducts%2520by%2520accelerator%2520mass%2520spectrometry%2520at%2520clinically%2520relevant%2520Adriamycin%2520concentrations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2008%26volume%3D36%26spage%3De100%26doi%3D10.1093%2Fnar%2Fgkn439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudiano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4138</span><span class="refDoi"> DOI: 10.1021/jm960519z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960519z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4135-4138&author=D.+J.+Taatjesauthor=G.+Gaudianoauthor=K.+Resingauthor=T.+H.+Koch&title=Alkylation+of+DNA+by+the+anthracycline%2C+antitumor+drugs+adriamycin+and+daunomycin&doi=10.1021%2Fjm960519z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm960519z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960519z%26sid%3Dliteratum%253Aachs%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DGaudiano%26aufirst%3DG.%26aulast%3DResing%26aufirst%3DK.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DAlkylation%2520of%2520DNA%2520by%2520the%2520anthracycline%252C%2520antitumor%2520drugs%2520adriamycin%2520and%2520daunomycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4135%26epage%3D4138%26doi%3D10.1021%2Fjm960519z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Taatjes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudiano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1276</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span><span class="refDoi"> DOI: 10.1021/jm960835d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960835d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1276-1286&author=D.+J.+Taatjesauthor=G.+Gaudianoauthor=K.+Resingauthor=T.+H.+Koch&title=Redox+pathway+leading+to+the+alkylation+of+DNA+by+the+anthracycline%2C+antitumor+drugs+adriamycin+and+daunomycin&doi=10.1021%2Fjm960835d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm960835d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960835d%26sid%3Dliteratum%253Aachs%26aulast%3DTaatjes%26aufirst%3DD.%2BJ.%26aulast%3DGaudiano%26aufirst%3DG.%26aulast%3DResing%26aufirst%3DK.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DRedox%2520pathway%2520leading%2520to%2520the%2520alkylation%2520of%2520DNA%2520by%2520the%2520anthracycline%252C%2520antitumor%2520drugs%2520adriamycin%2520and%2520daunomycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1276%26epage%3D1286%26doi%3D10.1021%2Fjm960835d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zeman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crothers, D. M.</span><span> </span><span class="NLM_article-title">Characterization of covalent adriamycin-DNA adducts</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">11561</span><span class="NLM_x">–</span> <span class="NLM_lpage">11565</span><span class="refDoi"> DOI: 10.1073/pnas.95.20.11561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1073%2Fpnas.95.20.11561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=9751705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK1cXmsV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=11561-11565&author=S.+M.+Zemanauthor=D.+R.+Phillipsauthor=D.+M.+Crothers&title=Characterization+of+covalent+adriamycin-DNA+adducts&doi=10.1073%2Fpnas.95.20.11561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of covalent Adriamycin-DNA adducts</span></div><div class="casAuthors">Zeman, Steven M.; Phillips, Don R.; Crothers, Donald M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11561-11565</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Adriamycin is a popular antineoplastic agent whose ability to form covalent adducts with DNA has been correlated to cellular apoptosis (programmed cell death) in tumor models.  We have isolated and purified this adduct formed under oxido-reductive (Fenton) conditions in Tris buffer.  We show by homo- and heteronuclear NMR spectroscopy that the covalent Adriamycin-DNA adduct is structurally equiv. to that resulting from direct reaction with formaldehyde.  Covalent linkage of the drug to one of the DNA strands confers remarkable stability to the duplex, indicated by a 162-fold redn. in the rate of strand displacement compared with the complex with noncovalently bound drug.  Glyceraldehyde also engenders covalent Adriamycin-DNA complexes, providing a possible relevant biol. context for in vivo adduct formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnMVATKt9Ry7Vg90H21EOLACvtfcHk0liKUC2jj8CAPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsV2itbY%253D&md5=f222d0b71e69aae4fcf19575af419e60</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.20.11561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.20.11561%26sid%3Dliteratum%253Aachs%26aulast%3DZeman%26aufirst%3DS.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DCrothers%26aufirst%3DD.%2BM.%26atitle%3DCharacterization%2520of%2520covalent%2520adriamycin-DNA%2520adducts%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D11561%26epage%3D11565%26doi%3D10.1073%2Fpnas.95.20.11561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pfuhler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, H. U.</span><span> </span><span class="NLM_article-title">Detection of DNA-crosslinking agents with the alkaline comet assay</span> <span class="citation_source-journal">Environ. Mol. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1002/(SICI)1098-2280(1996)27:3<196::AID-EM4>3.0.CO;2-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=8625955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaK28XivFGqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=196-201&author=S.+Pfuhlerauthor=H.+U.+Wolf&title=Detection+of+DNA-crosslinking+agents+with+the+alkaline+comet+assay&doi=10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of DNA-crosslinking agents with the alkaline comet assay</span></div><div class="casAuthors">Pfuhler, Stefan; Wolf, Hans Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Environmental and Molecular Mutagenesis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">196-201</span>CODEN:
                <span class="NLM_cas:coden">EMMUEG</span>;
        ISSN:<span class="NLM_cas:issn">0893-6692</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">The single cell gel electrophoresis, or comet assay, under alk. conditions is a sensitive, simple and rapid method for the detection of DNA damage at the individual cell level.  Its applicability as an indicator for the DNA crosslinking potency of a test substance was investigated in human white blood cells by combined treatment with the DNA damaging agent Me methanesulfonate (MMS) for 2 h at 37°.  The known crosslinking agents cis-platinum, mitomycin C and formaldehyde, and the formaldehyde releasers diazolidinyl urea and dimethylol urea, were shown to reduce MMS-induced DNA migration in the comet assay in a concn.-dependent manner.  Two other protocols, adding MMS to the cells before or after treatment with a crosslinking agent, were carried out and achieved similar results.  The results of this study indicate that the comet assay is a useful tool for the detection of crosslinking agents.  Advantages and limitations of this method compared to the alk. elution technique are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpEnpUXLBj9bVg90H21EOLACvtfcHk0lgIRHQFrM_-Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFGqtb4%253D&md5=451732b43e81173500c44963b5fa1d2c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-2280%25281996%252927%253A3%253C196%253A%253AAID-EM4%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DPfuhler%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DH.%2BU.%26atitle%3DDetection%2520of%2520DNA-crosslinking%2520agents%2520with%2520the%2520alkaline%2520comet%2520assay%26jtitle%3DEnviron.%2520Mol.%2520Mutagen.%26date%3D1996%26volume%3D27%26spage%3D196%26epage%3D201%26doi%3D10.1002%2F%28SICI%291098-2280%281996%2927%3A3%3C196%3A%3AAID-EM4%3E3.0.CO%3B2-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cullinane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panousis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span><span class="refDoi"> DOI: 10.1093/nar/28.4.1019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1093%2Fnar%2F28.4.1019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1019-1025&author=C.+Cullinaneauthor=S.+M.+Cuttsauthor=C.+Panousisauthor=D.+R.+Phillips&title=Interstrand+cross-linking+by+adriamycin+in+nuclear+and+mitochondrial+DNA+of+MCF-7+cells&doi=10.1093%2Fnar%2F28.4.1019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.4.1019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.4.1019%26sid%3Dliteratum%253Aachs%26aulast%3DCullinane%26aufirst%3DC.%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DPanousis%26aufirst%3DC.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DInterstrand%2520cross-linking%2520by%2520adriamycin%2520in%2520nuclear%2520and%2520mitochondrial%2520DNA%2520of%2520MCF-7%2520cells%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D1019%26epage%3D1025%26doi%3D10.1093%2Fnar%2F28.4.1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cutts, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levovich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rephaeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span> </span><span class="NLM_article-title">Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance</span> <span class="citation_source-journal">Oncol Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.3727/096504005776382305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.3727%2F096504005776382305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=17822280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVeqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=199-213&author=S.+M.+Cuttsauthor=A.+Nudelmanauthor=V.+Pillayauthor=D.+M.+Spencerauthor=I.+Levovichauthor=A.+Rephaeliauthor=D.+R.+Phillips&title=Formaldehyde-releasing+prodrugs+in+combination+with+adriamycin+can+overcome+cellular+drug+resistance&doi=10.3727%2F096504005776382305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance</span></div><div class="casAuthors">Cutts, Suzanne M.; Nudelman, Abraham; Pillay, Vinochani; Spencer, Damian M. S.; Levovich, Inesa; Rephaeli, Ada; Phillips, Don R.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">199-213</span>CODEN:
                <span class="NLM_cas:coden">ONREE8</span>;
        ISSN:<span class="NLM_cas:issn">0965-0407</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">The anticancer drug Adriamycin is widely used in cancer chemotherapy and is classified as a topoisomerase II inhibitor.  However, in the presence of formaldehyde, Adriamycin also forms high levels of DNA adducts.  In this study, a new series of butyric acid and formaldehyde-releasing drugs related to AN9 (pivaloyloxymethyl butyrate) was assessed for their ability to facilitate Adriamycin-DNA adduct formation in Adriamycin-sensitive and -resistant cell lines (HL60 and HL60/MX2; MES-SA and MES-SA/Dx5).  Drugs that released two molar equivalents of formaldehyde per mol of prodrug were superior in their ability to enhance adduct formation compared to those that released one molar equivalent.  Adduct formation (as assessed by binding of radiolabeled Adriamycin to genomic DNA) was always lower in the resistant cell lines compared to the sensitive cell lines.  However, in growth inhibition expts., prodrug combinations were able to overcome Adriamycin resistance to varying degrees, and the combination of Adriamycin with selected prodrugs that release two moles of formaldehyde totally overcame resistance in HL60/MX2 cells.  These HL60-derived cells express altered levels of topoisomerase II and also express a mutant form of the enzyme.  Combinations of Adriamycin with selected prodrugs that release one or two moles of formaldehyde partially overcame P-glycoprotein-mediated resistance in MES-SA/Dx5 cells.  Formaldehyde-releasing prodrugs (as single agents) overcame both forms of resistance in the two resistant cell lines, demonstrating that they were not substrates of these resistance mechanisms.  Collectively, these results suggest that changing the mechanism via which Adriamycin exerts its anticancer effect by dramatically increasing adduct levels (requiring coadministration of formaldehyde-releasing prodrugs) may be a useful means of cancer treatment, as well as for overcoming Adriamycin-induced resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEtFlRlo9Md7Vg90H21EOLACvtfcHk0lgIRHQFrM_-Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVeqtbw%253D&md5=8c74ee15f77d2fcfa7af1d8de24c54d7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3727%2F096504005776382305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096504005776382305%26sid%3Dliteratum%253Aachs%26aulast%3DCutts%26aufirst%3DS.%2BM.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DPillay%26aufirst%3DV.%26aulast%3DSpencer%26aufirst%3DD.%2BM.%26aulast%3DLevovich%26aufirst%3DI.%26aulast%3DRephaeli%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26atitle%3DFormaldehyde-releasing%2520prodrugs%2520in%2520combination%2520with%2520adriamycin%2520can%2520overcome%2520cellular%2520drug%2520resistance%26jtitle%3DOncol%2520Res.%26date%3D2005%26volume%3D15%26spage%3D199%26epage%3D213%26doi%3D10.3727%2F096504005776382305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lambert, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. W.</span><span> </span><span class="NLM_article-title">Ring-Chain Tautomerism in 1,3-Diaza and 1,3-Oxaza Heterocycles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3588</span><span class="NLM_x">–</span> <span class="NLM_lpage">3591</span><span class="refDoi"> DOI: 10.1021/ja00530a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00530a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=3588-3591&author=J.+B.+Lambertauthor=M.+W.+Majchrzak&title=Ring-Chain+Tautomerism+in+1%2C3-Diaza+and+1%2C3-Oxaza+Heterocycles&doi=10.1021%2Fja00530a045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja00530a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00530a045%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BB.%26aulast%3DMajchrzak%26aufirst%3DM.%2BW.%26atitle%3DRing-Chain%2520Tautomerism%2520in%25201%252C3-Diaza%2520and%25201%252C3-Oxaza%2520Heterocycles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D3588%26epage%3D3591%26doi%3D10.1021%2Fja00530a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Cogan, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Doxsaliform: a novel N-Mannich base prodrug of a doxorubicin formaldehyde conjugate</span> <span class="citation_source-journal">Letters in Drug Design and Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.2174/1570180043399000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.2174%2F1570180043399000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFWltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=247-255&author=P.+S.+Coganauthor=C.+R.+Fowlerauthor=G.+C.+Postauthor=T.+H.+Koch&title=Doxsaliform%3A+a+novel+N-Mannich+base+prodrug+of+a+doxorubicin+formaldehyde+conjugate&doi=10.2174%2F1570180043399000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Doxsaliform: A novel N-Mannich base prodrug of a doxorubicin formaldehyde conjugate</span></div><div class="casAuthors">Cogan, P. S.; Fowler, C. R.; Post, G. C.; Koch, T. H.</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Drug Design & Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-255</span>CODEN:
                <span class="NLM_cas:coden">LDDDAW</span>;
        ISSN:<span class="NLM_cas:issn">1570-1808</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Development of a water-sol. prodrug of doxorubicin-formaldehyde conjugate, a labile, active metabolite of doxorubicin, was described.  The lead compd. was the doxorubicin-salicylamide N-Mannich base, N-(2-hydroxybenzamidomethyl)-doxorubicin (doxsaliform), prepd. in 72% yield from reaction of salicylamide with doxorubicin in the presence of formaldehyde.  Doxsaliform releases doxorubicin-formaldehyde conjugate under physiol. conditions with a half-life of 57 min.  The stability of the prodrug is augmented both by salt formation in acidic media and by covalent modification of the 2-hydroxyl of the salicylamide moiety.  Doxsaliform is 4 fold more active than doxorubicin against MCF-7 breast and PC-3 prostate cancer cell lines and 10 fold more active against the doxorubicin resistant MCF-7/ADR cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzxrxeka4WcLVg90H21EOLACvtfcHk0lgCKOFQyEt9IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFWltrc%253D&md5=c65291654545f3306879adf494040b16</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F1570180043399000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180043399000%26sid%3Dliteratum%253Aachs%26aulast%3DCogan%26aufirst%3DP.%2BS.%26aulast%3DFowler%26aufirst%3DC.%2BR.%26aulast%3DPost%26aufirst%3DG.%2BC.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDoxsaliform%253A%2520a%2520novel%2520N-Mannich%2520base%2520prodrug%2520of%2520a%2520doxorubicin%2520formaldehyde%2520conjugate%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520and%2520Discovery%26date%3D2004%26volume%3D1%26spage%3D247%26epage%3D255%26doi%3D10.2174%2F1570180043399000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyatt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrug</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1021/jm7011479</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7011479" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=298-304&author=B.+L.+Barthelauthor=R.+C.+Torresauthor=J.+L.+Hyattauthor=C.+C.+Edwardsauthor=M.+J.+Hatfieldauthor=P.+M.+Potterauthor=T.+H.+Koch&title=Identification+of+human+intestinal+carboxylesterase+as+the+primary+enzyme+for+activation+of+a+doxazolidine+carbamate+prodrug&doi=10.1021%2Fjm7011479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm7011479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7011479%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DTorres%26aufirst%3DR.%2BC.%26aulast%3DHyatt%26aufirst%3DJ.%2BL.%26aulast%3DEdwards%26aufirst%3DC.%2BC.%26aulast%3DHatfield%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DIdentification%2520of%2520human%2520intestinal%2520carboxylesterase%2520as%2520the%2520primary%2520enzyme%2520for%2520activation%2520of%2520a%2520doxazolidine%2520carbamate%2520prodrug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D298%26epage%3D304%26doi%3D10.1021%2Fjm7011479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Espenson, J. H.</span> <span class="citation_source-book">Chemical Kinetics and Reaction Mechanisms</span>. <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1981</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&author=J.+H.+Espenson&title=Chemical+Kinetics+and+Reaction+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEspenson%26aufirst%3DJ.%2BH.%26btitle%3DChemical%2520Kinetics%2520and%2520Reaction%2520Mechanisms%26pub%3DMcGraw-Hill%26date%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Crabb, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roch, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, P.</span><span> </span><span class="NLM_article-title">Compounds with Bridgehead Nitrogen. 50—<sup>1</sup>H NMR spectra and structures of the products derived from the reaction between trans-3-aminotetralin-2-ol and formaldehyde</span> <span class="citation_source-journal">Magn. Reson. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span><span class="refDoi"> DOI: 10.1002/mrc.1260241209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1002%2Fmrc.1260241209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL2sXkslOktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1986&pages=1069-1072&author=T.+A.+Crabbauthor=O.+G.+Rochauthor=P.+Robinson&title=Compounds+with+Bridgehead+Nitrogen.+50%E2%80%941H+NMR+spectra+and+structures+of+the+products+derived+from+the+reaction+between+trans-3-aminotetralin-2-ol+and+formaldehyde&doi=10.1002%2Fmrc.1260241209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds with bridgehead nitrogen.  50.  Proton NMR spectra and structures of the products derived from the reaction between trans-3-aminotetralin-2-ol and formaldehyde</span></div><div class="casAuthors">Crabb, Trevor A.; Roch, Olive G.; Robinson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Magnetic Resonance in Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1069-72</span>CODEN:
                <span class="NLM_cas:coden">MRCHEG</span>;
        ISSN:<span class="NLM_cas:issn">0749-1581</span>.
    </div><div class="casAbstract">In contrast to the reported reaction between trans-1-aminotetralin-2-ol and formaldehyde, which gives octahydro-9,18-methanodinaphtho[1,2-d:1',2'-i][1,6,3,8]dioxadiazecine (I), an examn. of the δ 4.0-5.0 region of the 1H NMR spectra of the products of the reaction between trans-3-aminotetralin-2-ol and formaldehyde showed these to be a 50:50 mixt. of II and III.  In a similar way, the reaction between trans-2-aminocyclohexanol and formaldehyde was reexamd. and found to produce initially a ca. 80:20 mixt. of IV and V.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrka3araVnKnbVg90H21EOLACvtfcHk0lgCKOFQyEt9IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkslOktb0%253D&md5=9c215d51de575e62d5f767dd81648b6c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fmrc.1260241209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmrc.1260241209%26sid%3Dliteratum%253Aachs%26aulast%3DCrabb%26aufirst%3DT.%2BA.%26aulast%3DRoch%26aufirst%3DO.%2BG.%26aulast%3DRobinson%26aufirst%3DP.%26atitle%3DCompounds%2520with%2520Bridgehead%2520Nitrogen.%252050%25E2%2580%25941H%2520NMR%2520spectra%2520and%2520structures%2520of%2520the%2520products%2520derived%2520from%2520the%2520reaction%2520between%2520trans-3-aminotetralin-2-ol%2520and%2520formaldehyde%26jtitle%3DMagn.%2520Reson.%2520Chem.%26date%3D1986%26volume%3D24%26spage%3D1069%26epage%3D1072%26doi%3D10.1002%2Fmrc.1260241209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudnicki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Synthesis and biological characterization of protease-activated prodrugs of doxazolidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6595</span><span class="NLM_x">–</span> <span class="NLM_lpage">6607</span><span class="refDoi"> DOI: 10.1021/jm300714p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300714p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6595-6607&author=B.+L.+Barthelauthor=D.+L.+Rudnickiauthor=T.+P.+Kirbyauthor=S.+M.+Colvinauthor=D.+J.+Burkhartauthor=T.+H.+Koch&title=Synthesis+and+biological+characterization+of+protease-activated+prodrugs+of+doxazolidine&doi=10.1021%2Fjm300714p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm300714p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300714p%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DRudnicki%26aufirst%3DD.%2BL.%26aulast%3DKirby%26aufirst%3DT.%2BP.%26aulast%3DColvin%26aufirst%3DS.%2BM.%26aulast%3DBurkhart%26aufirst%3DD.%2BJ.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DSynthesis%2520and%2520biological%2520characterization%2520of%2520protease-activated%2520prodrugs%2520of%2520doxazolidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6595%26epage%3D6607%26doi%3D10.1021%2Fjm300714p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chou, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talalay, P.</span><span> </span><span class="NLM_article-title">Analysis of combined drug effects: a new look at a very old problem</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1016/0165-6147(83)90490-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1016%2F0165-6147%2883%2990490-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=450-454&author=T.+C.+Chouauthor=P.+Talalay&title=Analysis+of+combined+drug+effects%3A+a+new+look+at+a+very+old+problem&doi=10.1016%2F0165-6147%2883%2990490-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of combined drug effects:  a new look at a very old problem</span></div><div class="casAuthors">Chou, Ting Chao; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">450-4</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A simple, general and novel method for the quant. anal. of combined drug effects is presented.  The procedure dets. if the drug combinations are additive, synergistic or antagonistic, regardless of whether the dose-effect curves are hyperbolic (first order) or sigmoidal (higher order), or whether the effects of the drugs are totally independent or not.  The proposed method (median-effect plot) suffers from fewer restrictions and is more widely applicable than the isobologram or the fractional product method.  It provides insight into the nature of the dose-effect relationship with relatively few measurements.  The procedure is illustrated by analyzing the combined lethal effects of 2 insecticides on house-flies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObQzLgU9z07Vg90H21EOLACvtfcHk0liy6KL-K0cQbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhslWhsA%253D%253D&md5=af5698ed81a74924a1a296dacc8ce691</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2883%2990490-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252883%252990490-X%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DAnalysis%2520of%2520combined%2520drug%2520effects%253A%2520a%2520new%2520look%2520at%2520a%2520very%2520old%2520problem%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1983%26volume%3D4%26spage%3D450%26epage%3D454%26doi%3D10.1016%2F0165-6147%2883%2990490-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Nadin, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas-Roig, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciocca, D. R.</span><span> </span><span class="NLM_article-title">A silver staining method for single-cell gel assay</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.1177/002215540104900912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=10.1177%2F002215540104900912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=11511687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFyltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=1183-1186&author=S.+B.+Nadinauthor=L.+M.+Vargas-Roigauthor=D.+R.+Ciocca&title=A+silver+staining+method+for+single-cell+gel+assay&doi=10.1177%2F002215540104900912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A silver staining method for single-cell gel assay</span></div><div class="casAuthors">Nadin, Silvina B.; Vargas-Roig, Laura M.; Ciocca, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1183-1186</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">The single-cell gel assay (comet assay) is a very useful microelectrophoretic technique for evaluation of DNA damage and repair in individual cells.  Usually, the comets are visualized and evaluated with fluorescent DNA stains.  This staining requires specific equipment (e.g., a high-quality fluorescence microscope), the slides must be analyzed immediately, and they cannot be stored for long periods of time.  Here the authors describe, using human lymphocytes, some modifications of the silver staining for comets that significantly increase the sensitivity/reproducibility of the assay.  This silver staining was compared with fluorescence staining and com. silver stains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH9rpku5Qf3LVg90H21EOLACvtfcHk0liy6KL-K0cQbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFyltLk%253D&md5=3d57cfdcbec34d2a08bec89ee85debf7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1177%2F002215540104900912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215540104900912%26sid%3Dliteratum%253Aachs%26aulast%3DNadin%26aufirst%3DS.%2BB.%26aulast%3DVargas-Roig%26aufirst%3DL.%2BM.%26aulast%3DCiocca%26aufirst%3DD.%2BR.%26atitle%3DA%2520silver%2520staining%2520method%2520for%2520single-cell%2520gel%2520assay%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2001%26volume%3D49%26spage%3D1183%26epage%3D1186%26doi%3D10.1177%2F002215540104900912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Burkhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalet, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nafie, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7002</span><span class="NLM_x">–</span> <span class="NLM_lpage">7012</span><span class="refDoi"> DOI: 10.1021/jm060597e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060597e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7002-7012&author=D.+J.+Burkhartauthor=B.+L.+Barthelauthor=G.+C.+Postauthor=B.+T.+Kaletauthor=J.+W.+Nafieauthor=R.+K.+Shoemakerauthor=T.+H.+Koch&title=Design%2C+synthesis%2C+and+preliminary+evaluation+of+doxazolidine+carbamates+as+prodrugs+activated+by+carboxylesterases&doi=10.1021%2Fjm060597e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060597e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060597e%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhart%26aufirst%3DD.%2BJ.%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DPost%26aufirst%3DG.%2BC.%26aulast%3DKalet%26aufirst%3DB.%2BT.%26aulast%3DNafie%26aufirst%3DJ.%2BW.%26aulast%3DShoemaker%26aufirst%3DR.%2BK.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preliminary%2520evaluation%2520of%2520doxazolidine%2520carbamates%2520as%2520prodrugs%2520activated%2520by%2520carboxylesterases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7002%26epage%3D7012%26doi%3D10.1021%2Fjm060597e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Barthel, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudnicki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coldren, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinkovsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T. H.</span><span> </span><span class="NLM_article-title">Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7678</span><span class="NLM_x">–</span> <span class="NLM_lpage">7688</span><span class="refDoi"> DOI: 10.1021/jm900694z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900694z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7678-7688&author=B.+L.+Barthelauthor=Z.+Zhangauthor=D.+L.+Rudnickiauthor=C.+D.+Coldrenauthor=M.+Polinkovskyauthor=H.+Sunauthor=G.+G.+Kochauthor=D.+C.+Chanauthor=T.+H.+Koch&title=Preclinical+efficacy+of+a+carboxylesterase+2-activated+prodrug+of+doxazolidine&doi=10.1021%2Fjm900694z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm900694z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900694z%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRudnicki%26aufirst%3DD.%2BL.%26aulast%3DColdren%26aufirst%3DC.%2BD.%26aulast%3DPolinkovsky%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DG.%2BG.%26aulast%3DChan%26aufirst%3DD.%2BC.%26aulast%3DKoch%26aufirst%3DT.%2BH.%26atitle%3DPreclinical%2520efficacy%2520of%2520a%2520carboxylesterase%25202-activated%2520prodrug%2520of%2520doxazolidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7678%26epage%3D7688%26doi%3D10.1021%2Fjm900694z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01956">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22022"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01956">10.1021/acs.jmedchem.5b01956</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Cartoon of the comet assay, full statistical analysis of comet assay data, detailed discussion of the restriction digest, and four figures showing effect of drug treatment on both <i>Nde</i>I and <i>Not</i>I digestion of <i>Sma</i>I-linearized pcDNA3.1(−) and reaction progress versus time for both <i>Nde</i>I and <i>Not</i>I enzymatic digests (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (SMILES) for <b>1</b>–<b>13</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_001.pdf">jm5b01956_si_001.pdf (1.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01956/suppl_file/jm5b01956_si_002.csv">jm5b01956_si_002.csv (1.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01956&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01956%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01956" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c3905f993bec","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
